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ABSTRACT 
 
NEUROPSYCHOLOGICAL FUNCTIONING AND ATTRITION RATES IN 
OUTPATIENT SUBSTANCE DEPENDENCE TREATMENT  
Sandra M. Adams, LCSW, CSAC, ICS 
Marquette University, 2010 
 
 
 
Numerous neuropsychological factors have been associated with substance 
dependence, however, very few studies have evaluated the relationship of the 
neuropsychological functioning and attrition rates in substance dependence treatment. 
This study examined the relationship of neuropsychological functioning and attrition 
rates in 68 homeless, substance dependent men participating in outpatient treatment at 
the 7C’s Community Counseling Clinic located in the Guesthouse of Milwaukee, 
Wisconsin. A neuropsychological battery including the Delis Kaplan Executive 
Functioning System, the Conners’ Continuous Performance Test II, the Wechsler 
Abbreviated Scale of Intelligence (WASI) and the Wechsler Test of Adult Reading 
was given to all participants to evaluate neuropsychological function. The 
neuropsychological functioning was used to predict attrition rates using Survival 
Analysis and Logistic Regression. The results indicate that the neuropsychological 
functioning of this group of adult males showed statistically significant impaired 
functioning on all measures. Of the neuropsychological variables, only the WASI IQ 
predicted attrition and length of stay which showed a curvilinear relationship to drop 
out and attrition. Participants with a moderately low WASI IQ score (77-95) were 
significantly more likely to drop out (p = .012) and more likely to have shorter 
lengths of stay in treatment (p= .028). In addition, the neuropsychological variables 
did show a relationship with drop out and length of stay when looking at cases with a 
median IQ below 94 and those with no prior AODA treatment. Finally, results of 
calculations on effect size and power analysis show that with a larger sample size (98-
170) we could increase the possibility that the neuropsychological variables would 
predict drop out and attrition and could attain power between .80 and .95. 
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Chapter I: Introduction 
 
Substance Abuse and Dependence in the United States 
 
Prevalence of Substance Use Disorders 
 
       Recent statistics from the National Survey on Drug Use and Health (NSDUH, 
2008) indicated that an estimated 22.3 million Americans aged 12 or older in 2007 
met diagnostic criteria for substance dependence or abuse over the past year. Of 
these, 3.2 million had dependence or abuse issues with both alcohol and illicit drugs, 
3.7 million were dependent on or abused drugs but not alcohol, and 15.5 million were 
dependent on or abused alcohol but not drugs (NSDUH, 2008). NSDUH (2008) also 
stated that between 2002 and 2007 there was no change in the number of people with 
substance dependence or abuse (22.0 million in 2002, 22.3 million in 2007; NSDUH, 
2008) 
Effects of Substance Use Disorders on Individuals and Society 
Substance use disorders have an impact on society, families and individuals 
(American Psychiatric Association {APA}, 2000). Substance use can be associated 
with violent behavior manifested by fights or criminal activity resulting in injury to 
the person using the substance or to others (APA, 2000). Likewise, automobile, home 
and industrial accidents can be a major complication of substance use (APA, 2000). 
Furthermore, according to the Diagnostic and Statistical Manual of Mental Disorders-
Fourth Edition, Text Revision (DSM-IV-TR) approximately half of all highway 
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fatalities involve either a driver or pedestrian who is intoxicated (APA, 2000). The 
DSM-IV-TR (APA, 2000) also reported that one in five intensive care admissions are 
related to alcohol.  In addition, most, if not all, psychoactive substances cross from a 
pregnant woman’s blood through the placenta, potentially causing adverse effects on 
the developing fetus (APA, 2000). When taken repeatedly in high doses by the 
mother, a number of substances (e.g., cocaine, opioids, alcohol, sedatives, hypnotics 
and anxiolytics) are capable of causing physiological dependence and withdrawal in 
the newborn (APA, 2000). Finally, the DSM-IV-TR (2000) reports that possibly 10 
percent of individuals with a substance dependence diagnosis commit suicide.  
Defining Substance Abuse and Dependence  
            Substance Abuse is defined based on the criteria listed in the DSM-IV-TR, 
2000 that include:  
 A. A maladaptive pattern of substance use leading to clinically significant 
impairment or distress, as manifested by one (or more) of the following, occurring 
within a 12 month period: 
(1) recurrent substance use resulting in a failure to fulfill major role obligations 
at work, school or home ( e.g., repeated absences or poor work performance 
related to substance use; substance-related absences, suspensions, or expulsions 
from school; neglect of children or household) 
(2) recurrent substance use in situations in which it is physically hazardous 
(e.g., driving an automobile or operating a machine when impaired by 
substance use),  
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(3) recurrent substance-related legal problems (e.g., arrests for substance-
related disorderly conduct),  
(4) continued substance use despite having persistent or recurrent social or 
interpersonal problems caused or exacerbated by the effects of the substance 
(e.g., arguments with spouse about consequences of intoxication, physical 
fights). 
B. The symptoms have never met the criteria for Substance Dependence for this        
class of substance (APA, 2000, p. 199).  
Substance Dependence is also defined based on the criteria listed in the DSM-
IV-TR which states: 
   A maladaptive pattern of substance use, leading to clinically significant impairment 
or distress, as manifested by three (or more) of the following, occurring at any time in 
the same 12-month period: 
     (1) tolerance, as defined by either of the following:  
(a) a need for markedly increased amounts of the substance to achieve 
intoxication   or desired effect,  
(b) markedly diminished effect with continued use of the same amount of the 
substance,  
     (2) withdrawal, as manifested by either of the following:  
(a) the characteristic withdrawal syndrome for the substance [For example, 
with alcohol withdrawal, two or more of the following symptoms are 
necessary: autonomic hyperactivity, increased hand tremor, insomnia, 
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psychomotor agitation, anxiety, nausea or vomiting; and rarely, grand mal 
seizures or transient visual, tactile, or auditory hallucinations or illusions.]  
(b) the same or closely related substance is taken to relieve or avoid 
withdrawal symptoms,   
(3) substance is often taken in larger amounts or over a longer period than 
intended, 
(4) there is persistent desire or unsuccessful efforts to cut down or control the 
substance use,  
(5) a great deal of time is spent in activities necessary to obtain the substance, use 
the substance, or recover from its effects,  
(6) important social, occupational, or recreational activities are given up or 
reduced because of substance use,  
(7) the substance use is continued despite knowledge of having a persistent or 
recurrent physical or psychological problem that is likely to have been caused or 
exacerbated by the substance  (e.g., current cocaine use despite recognition of 
cocaine-induced depression, or continued drinking despite recognition that an 
ulcer was made worse by alcohol consumption; APA, 2000, p. 197). 
This study is a pilot study and one of the first to investigate the effects of 
neurocognitive functioning on treatment retention. Therefore, in order to increase the 
likelihood of detecting smaller effect sizes this study aims to maximize the 
heterogeneity of the sample for this study by only including participants who meet the 
criteria for the diagnosis of Substance Dependence.  
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Health Related Effects on Individuals with Substance Use Disorders 
 Another important area to consider is the impact of substance abuse and 
dependence on the physical health of the individual. Individuals with substance 
related disorders often experience deterioration in their general health related to 
method of induction of substance (i.e., snorting), malnutrition and inadequate 
personal hygiene (APA, 2000). For example, using a substance intranasally can cause 
erosion of the nasal septum. The use of contaminated needles can result in human 
immunodeficiency virus (HIV), hepatitis, tetanus, endocarditis, malaria or other 
infectious or contagious diseases (APA, 2000). The use of stimulants can result in 
sudden death from cardiac arrhythmias, myocardial infarction, cerebral vascular 
accident or respiratory arrest (APA, 2000). Likewise, many medical conditions are 
commonly associated with alcohol use as alcohol affects nearly every organ in the 
body. For example, there is an increased rate of cancer of the esophagus and stomach, 
elevated triglycerides, and peripheral neuropathy in individuals with high alcohol use 
rates (APA, 2000). Furthermore, liver cirrhosis and pancreatitis are seen in 
approximately 15% of those who use alcohol heavily (APA, 2000). 
Neurological, Neuropsychological and Cognitive Effects of Substance Use Disorders 
 With regards to central nervous system impact, neurological effects on 
individuals with substance use disorders include cognitive deficits, memory 
impairment and degenerative changes in the cerebellum (APA, 2000; Oscar-Berman, 
Shagrin, Evert & Epstein, 1997). Likewise, multiple negative effects on the frontal 
lobe (which is associated with executive functions) of the brain, such as reduced 
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volume and blood flow, have been reported in people with substance use disorders 
(Bates, Bowden & Barry, 2002; Moselhy, Georgiou & Kahn, 2001; Sullivan, 
Harding, Pentney, Dlugos, Martin, & Parks, 2003). In fact, many neuropsychological 
and cognitive deficits have been associated with impairment in functioning for people 
with a substance use disorder. For example, in people with substance use disorders, 
reductions in problem solving abilities, abstracting abilities (Oscar-Berman et al., 
1997; Ratti, Giardini & Soragna, 2002), verbal fluency and response flexibility (all 
considered parts of executive functioning) have been found (Dao-Castellana et al., 
1998), as have impaired memory and overall executive functioning (Cunha & 
Novaes, 2004; Rosselli, Ardila, Lubomski, Murray & King, 2001).   
Executive functions as an area of interest for this study. 
 Of the many possible types of neuropsychological impairment, the 
impairment of the executive functions is what we are primarily interested in for this 
study. As mentioned above, multiple negative effects on the frontal lobe, which is the 
lobe associated with executive functioning, have been found in people with substance 
use disorders (Bates et al., 2002; Cunha & Novaes, 2004; Lezak, 1995; Moselhy et 
al., 2001; Sullivan et al., 2003). The executive functions are all “necessary for 
appropriate, socially responsible, and effectively self-serving adult conduct” (Lezak, 
1995, p. 650). There are multiple components and possible behavioral disorders 
associated with impairment in the executive functions which could result in 
misinterpretation by clinicians and observers (Lezak, 1995) possibly leading to 
further stigma of individuals with a substance use disorder.  The executive functions 
and impairments will be explicitly defined and discussed in Chapter II. 
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Homelessness and Substance Dependence 
 Though homelessness is not the primary area of interest for this study, it is 
important as the  individuals assessed in this study are homeless male residents of the 
Guesthouse of Milwaukee, Inc. In addition, just as the prevalence of individuals 
struggling with substance use issues has been well documented in the literature, the 
prevalence of individuals struggling with homelessness is also well documented 
(Institute for the Study of Homelessness and Poverty, retrieved January 12, 2006 & 
March 21, 2009; National Coalition for the Homeless, retrieved January 12, 2006 & 
March 21, 2009; U.S. Department of Health and Human Services, retrieved January 
12, 2006 & March 21, 2009). Finally, the relationship between homelessness and 
substance use disorders is also established in the literature (National Coalition for the 
Homeless, retrieved January 12, 2006 & March 21, 2009; SAMHSA, 2003; Solliday-
McRoy, Campbell, Melchert, Young & Cisler, 2004; U.S. Department of Health and 
Human Services, retrieved January 12, 2006 & March 21, 2009) as is the relationship 
of homelessness and neuropsychological deficits (Gonzalez, Dieter, Natale & Tanner, 
2001; Seidman et al., 1997; Solliday-McRoy et al., 2004). Therefore, assessing the 
relationship of executive functioning and attrition rates in homeless individuals 
involved in substance dependence treatment seems quite appropriate.  
Treatment for Substance Dependence  
The National Survey on Drug Use and Health (2008) classifies one as needing 
treatment if the person has a substance use disorder or one who received treatment at 
a specialty facility (i.e., hospital inpatient, drug or alcohol rehabilitation, or mental 
health centers). In 2007, the estimated number of people aged 12 or older needing 
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treatment for an alcohol or drug problem was 23.2 million (9.4 percent of the total 
population; NSDUH, 2008). Of these 23.2 million, 2.4 million received treatment at a 
specialty facility in the past year (NSDUH, 2008). Thus, 20.8 million people needed 
but did not receive treatment at a specialty treatment facility in 2004 (NSDUH, 2008).  
Barriers to Treatment for Substance Dependence 
Unfortunately, not everyone who needs substance use treatment actually 
receives substance use treatment. Of the 20.8 million people who needed but did not 
receive treatment in 2004, an estimated 1.3 million (6.4%) reported that they felt they 
needed treatment for their substance use problem (NSDUH, 2008). Of these 1.3 
million, 380,000 (28.5%) reported that they made an effort but were unable to get 
treatment and 955,000 (71.5%) reported making no effort to get to treatment 
(NSDUH, 20048).   
Based on combined data from 2003 and 2004, the NSDUH (2004) reports that 
of the people who felt they needed but did not receive treatment 40% stated they did 
not seek treatment because they were not ready to stop using and 34.5% reported cost 
or insurance barriers, 21.6% reported stigma and 13.9% reported they felt they did not 
need treatment (at the time) or could handle the problem without treatment. However, 
among the people who made an effort but were unable to get treatment, 42.5% 
reported cost or insurance barrier, 25.3% reported they were not ready to stop using, 
21.5% report other access barriers and 17.8% report stigma (NSDUH, 2004). 
Combined data from 2004 and 2007, the NSDUH (2008) reports that of people who 
felt they needed treatment but did not receive treatment 38.7% said they were not 
ready to stop, 31.1 % had no insurance and could not afford treatment, 11.6 % 
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reported concern regarding possible negative effect on job, 11.65% reported not 
knowing where to go for treatment and 11.1% reported concern of negative opinion 
of others (NSDUH, 2008).  A differentiation could be made between internal and 
external barriers as reasons people did not receive treatment. For example, lack of 
insurance and negative stigma could be considered external barriers whereas being 
not ready to quit or feeling one can handle the problem on their own could be 
considered internal barriers. Finally, along with lack of financial resources and health 
insurance, research has also indicated that lack of transportation may be a barrier to 
engaging in treatment (Knight & Longmore, 1994). For example, if the person has no 
reliable mode of transportation to the treatment facility, or if the treatment facility is 
located too far from the person’s geographical location, the person may not enter 
treatment, or may not stay engaged once starting treatment due to the difficulty in 
getting to treatment.    
Neuropsychological impairment as a barrier to treatment 
One possible barrier to substance dependence treatment currently under 
investigation is that of neuropsychological impairment. Bates, Bowden and Barry 
(2002) have suggested that neuropsychological impairment may limit an individual’s 
treatment engagement and/or may impede treatment completion in traditional 
outpatient substance abuse treatment. In fact, as discussed above, neuropsychological 
impairment resulting from substance use disorders is known to often be severe, but it 
is also true that neurological impairment frequently goes unassessed, unrecognized 
and untreated in individuals seeking treatment (Bates et al., 2002; Cunha & Novaes, 
2004). Although research has begun to evaluate the neuropsychological functioning 
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and impairment of patients with substance abuse and mental health diagnoses (e.g. 
Bates et al., 2002, Lezak, 1995; Ratti et al., 2002, Sullivan, Fama, Rosenbloom & 
Pfefferbaum, 2002; Uekermann, Daum, Schlebusch, Wiebel & Trenckmann, 2002), 
which will be discussed later, neuropsychology as it relates to substance use disorders 
is a relatively new arena of study (Fals-Stewart & Bates, 2003).  
Stigma and Substance Use Disorders   
As mentioned in the NSDUH (2008) study above, concern about stigma has 
also been identified as a treatment barrier. Stigma, which involves the harm that may 
come from the label of mental illness or substance dependence, may impede 
treatment participation (Corrigan, 2004). People who are labeled mentally ill or 
substance dependent can be harmed publicly with stereotypes (e.g., “All people with 
mental illness and/or substance dependence are dangerous”), prejudice (e.g., “I agree, 
people with mental illness and/or substance dependence are dangerous and I am 
afraid of them”), and discrimination (e.g., “I do not want to be near them; don’t hire 
them at my job”; Corrigan, 2004, p.617). Stigma may lead to people avoiding seeking 
treatment or staying in treatment in order to avoid the label and escape the public 
stigma (Corrigan, 2004). However, these barriers to treatment could also offer vital 
information for development of interventions specifically designed to break down 
treatment barriers.  
 “They must not have been ready.” “Maybe they didn’t want it bad enough.” 
“I guess he just doesn’t love us enough.” “The bottle is more important than his kid.” 
How often do we as counselors, as well as other people in the substance abuser’s life, 
make these statements about someone who has failed to follow through with a 
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treatment plan for a substance abuse or dependency problem? In fact, negative stigma 
and judgments are not only made about substance abusers who do not complete 
treatment, but individuals with substance abuse problems are often judged and 
stigmatized harshly for even having the problem in the first place (Knight & 
Longmore, 1994). Many people, inside and outside of the substance abuse treatment 
field, seem to assume that the path to solving the problem is obvious - if you have a 
substance abuse or dependence problem, you go to one of many treatment facilities 
and get it fixed. On the surface, failure to follow through with prescribed treatment 
may appear to be a compliance issue. I have heard the stigma substance abusers face 
reflected in many clinicians’ descriptions of people who do not follow through with 
treatment as “non-compliant,” “lazy,” “deviant,” or having “complete disregard for 
themselves or their families.” Overall, many researchers identify stigma as a barrier to 
substance use treatment (Corrigan, 2004; NSDUH, 2002 & 2004 & 2008; World 
Health Organization, 2004). Specifically, the World Health Organization (2004) 
identifies stigma as one of the main barriers to treatment and care of people with 
substance dependence and related problems. In addition, the National Mental Health 
Resource Center reported that no group encounters more stigma than homeless 
persons with co-occurring (mental health and substance use) disorders (National 
Mental Health Association retrieved January 12, 2006).  Regardless of the level of 
substance use or which substance a person takes, they have the same rights to health 
care, education and work opportunities as any other individual (World Health 
Organization, 2004).  
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In short, stigma has been identified as one of the relevant factors in 
identification and treatment of substance use disorders (Corrigan, 2004; NSDUH, 
2002 & 2004 & 2008; World Health Organization, 2004). Likewise, multiple 
neuropsychological deficits have been associated with substance use disorders (Bates 
et al., 2002; Lezak, 1995; Moselhy et al., 2001; Oscar-Berman et al., 1997; Sullivan 
et al., 2003) which may be affecting the level of stigma of individuals with a 
substance use disorder.  
Neuropsychology of Substance Use Disorders  
Research has suggested that alcoholism affects cognitive functioning such as 
recall, recognition (Knight & Longmore, 1994, Sullivan et al, 2002) abstract thinking, 
cognitive flexibility, and persistence and inhibition of competing responses (Zinn, 
Stein & Swartzwelder, 2004). Over the last decade, researchers have begun to 
specifically evaluate areas of the brain involved (Ratti et al., 2002). The same is true 
for drug abusing and dependent patients. Alcohol and drug abuse and dependence are 
associated with neuroanatomical changes that affect cognitive abilities such as 
reasoning, learning, memory, decision making and inhibition (Beatty, Tivis, Stott, 
Nixon & Parsons, 2000; Knight & Longmore, 1994, Pfefferbaum, Sullivan, 
Rosenbloom, Mathalon & Lim, 1998). Neuroimaging techniques reveal cortical 
shrinkage (Pfefferbaum et al., 1998), enlarged ventricles and increased space between 
the gyri of the cerebral cortex (Lilliquist & Bigler, 1992). This has been related to 
changes in neurobehavioral performance on specific neuropsychological tests of 
verbal problem solving, conceptual shifting, perceptual-spatial abilities, abstracting, 
motor speed, information processing and memory (Fals-Stewart & Bates, 2003).  
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Given these findings, when developing appropriate treatment programs, it 
would seem necessary to evaluate the patient’s abilities and deficits and develop a 
program that fits their needs. Though research suggests that the neuropsychological 
deficits may affect treatment efficacy and attrition rates (Sullivan et al., 2002; Zinn et 
al., 2004), there is a paucity of research connecting neuropsychological deficits and 
treatment attrition despite use of numerous search engines (including Medline, Ovid, 
PubMed, PsychInfo, PsychArticles, ScienceDirect, Google) and multiple library 
systems (including Marquette University and the Medical College of Wisconsin) 
using multiple search terms (including, but not limited to, “neuropsychology, 
neuropsychological impairment/deficit,  frontal lobe, attrition, drop out, treatment 
length, executive functioning, cognitive deficits” and various combinations of all of 
these).  
Identifying neuropsychological deficits may be helpful in the development of 
treatment programs aimed at those substance dependent clients who have 
neuropsychological impairments (Kass & Silver, 1990). For example, executive 
function deficits such as deficits in planning and strategizing could affect treatment 
compliance. If one struggles with planning future events, attendance at treatment 
could be affected (Zinn et al., 2004). All of these neuropsychological deficits could 
affect attrition rates which will both be discussed in further detail in Chapter II.  
Knight and Longmore (1994) have suggested that clients’ neuropsychological deficits 
related to substance use or of other origin may affect clients’ attrition rates in 
substance use disorder treatment programs. However, the connection between 
neuropsychological impairment and attrition has not been empirically well 
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established. To date, we do not know the extent to which neuropsychological 
impairment has an impact on client attrition from substance use disorder treatment. 
Without such knowledge, we cannot effectively plan and implement substance use 
disorder treatment programs that might aid individuals suffering from substance use 
disorders and neuropsychological impairment. 
Attrition and Relapse Rates Among Clients in Treatment for Substance Dependence  
            The purpose of this study is to explore the relationship of neuropsychological 
functioning and attrition rates in individuals who have engaged in outpatient 
substance use treatment. Attrition, referring to patients who enter but then drop out of 
treatment, has been studied through the National Outcomes Measures (2002) and 
reported on by many sources (Broome, Flynn & Simpson, 1999; DATOS, 2001; 
Franey & Ashton, 2002; Office of Applied Studies, 2004; Simpson et al., 1997; 
Simpson, Joe & Rowan-Szal, 1997; Stark, 1992). 
The specific statistics reported for drop out rates for people in substance 
dependence treatment help to confirm the problem of attrition. For example, the 
medium length of stay specific to outpatient treatment is 76 days, based on 34 states 
submitting discharge information in 2005 (SAMHSA, 2008). The National Outcomes 
Measures collected data from 23 states during the year 2002 and found that the 
median length of stay for completion of outpatient treatment was 78 days (Office of 
Applied Studies, 2004). However, the median length of stay prior to dropping out was 
only 32 days In 2002 (Office of Applied Studies, 2004) and 45 days in 2005 
(SAMHSA, 2008). Median length of stay for homeless individuals in intensive 
outpatient treatment was reported to be 45 days in 2005 (SAMHSA, 2008).  Likewise, 
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drop out rates for homeless people from substance abuse treatment have been 
reported at 66% (SAMHSA, 1998), drop out rates for people with cocaine addiction 
in outpatient have been reported at 55% (Agosti, Nunes, Ocepek-Welikson, 1996), 
people with drug abuse in general have been reported to have between 40% to 60% 
drop out rate according to Marlowe and Dematteo (2003) and 55% according to 
Sayre, Schmitz, Stotts, Averill, Rhoades and Grabowski (2002). The literature on 
predicting attrition has been inconclusive. Variables such as sociodemographics, 
gender, psychiatric comorbidity and substance use severity have all been evaluated in 
relation to treatment drop out (Sayre et al, 2002).  
Another important variable related to clients dropping out of treatment is 
client relapse. Relapse and attrition have an interactive relationship as each may be a 
cause or influence of the other. Many variables, including dropping out of treatment, 
have been related to relapse in substance abuse treatment (Franey & Ashton, 2002). 
Some of the variables identified include type of drug use (United Nations, 2002), 
gender (Stocker, retrieved September 20, 2005), support systems (United Nations, 
2002), certain medications (United Nations, 2002; World Health Organization, 2004), 
length and intensity of treatment (Franey & Ashton, 2002; United Nations, 2002) and 
neuropsychological impairment (Miller, 1991). All of these will be discussed in detail 
in Chapter II.  
  The discrepancy between amount of time to treatment completion and actual 
time spent in treatment for patients who drop out is very important as duration of 
treatment has been identified as one of the best predictors of outcome for substance 
abuse treatment (Corrigan, Bogner, Lamb-Hart, Heinemann & Moore, 2005). 
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Therefore, evaluating variables that may be related to treatment attrition and relapse, 
such as neuropsychological functioning, would provide valuable, useful information.  
Statement of the Problem 
           Substance abuse and dependence has tremendous effects on the individual and 
his or her family, as well as on society (APA, 2000). In addition, there are multiple 
barriers that have been identified as reasons people do not get the treatment they need 
(NSDUH, 2008). Likewise, many of the people who enter treatment do not complete 
treatment (NSDUH, 2008). Although we know that individuals suffering from 
substance dependence also may suffer from neuropsychological deficits, as well as 
that treatment attrition rates are high for those entering substance dependence 
treatment, we do not know if or how neuropsychological deficits may affect treatment 
engagement and attrition. It may be that an understanding of the potential relationship 
between neuropsychological functioning and attrition could aid researchers and 
clinicians who are endeavoring to develop helpful treatment programs to do so.      
Purpose of the Study 
      The purpose of this study was to assess the neuropsychological functioning of 
clients who meet diagnostic criteria for substance dependence according to the 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition - Text 
Revision (DSM IV-TR; APA, 2000) and to examine the relationship between 
neuropsychological functioning and treatment attrition rates. Specifically, the 
executive functioning of individuals was evaluated. Furthermore, the relationships 
between substance use diagnosis, treatment attrition, and neuropsychological 
functioning was investigated. It may be that understanding how deficits in 
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neuropsychological functioning affect an individual’s behaviors (e.g., relapse, 
missing treatment sessions, and dropping out of treatment) may help to change 
attitudes of clinicians and others who may currently negatively stigmatize those with 
substance use disorders (e.g., believing that the individual is lazy, unmotivated, etc.). 
Understanding the relationships between substance use diagnosis, attrition, and 
neuropsychological functioning could prove extremely useful in substance use 
disorder program development, treatment planning, clinician training and stigma 
reduction.       
Research Questions 
      This study intended to address the following research questions: 
(1) What is the level of neuropsychological functioning/impairment of this sample of 
substance dependent men?  
(2) Do deficits in client’s neuropsychological abilities including concept 
identification, cognitive flexibility, divided attention, perseveration, and impulse 
control predict rates of attrition from substance abuse treatment? 
(3) How does neuropsychological functioning relate to relapse rates in those clients 
seeking treatment for substance dependence?                                  
Definition of Terms 
Attrition – “A decline in a population over time” (Reber, 1985, p. 69). For the 
purpose of this study, attrition refers to the number of participants who begin, but do 
not complete, treatment due to dropping out.   
Executive Functioning - Those capacities that enable a person to engage successfully 
in independent, purposive, self-serving behavior (Lezak, 1995). Executive 
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functioning has to do with how a behavior is expressed. Questions about executive 
functions include how or whether a person goes about doing something, whereas 
questions about cognitive functions are phrased in terms of what or how much one 
knows (Lezak, 1995). Executive functioning has been identified as a function of the 
frontal lobe (Lezak, 1995; Moselhy, 2001; Snyder & Nussbaum, 1998).  
Homeless – The term “homeless” will be limited to those individuals seeking refuge 
at the Guesthouse of Milwaukee, Inc. (a local homeless shelter).  
 
Neuropsychological Functioning  
      Clinical Neuropsychology - The behavioral expression of brain dysfunction 
(Lezak, 1995); “a sub-discipline within physiological psychology that focuses on the 
interrelationships between neurological processes and behavior” (Reber, 1985, 
p.491).  
      Cognitive Functions - The information handling aspects of behavior, 
analogous to computer operations of input, storage, processing and output. In more 
detail, (a) receptive functions involve the ability to select, acquire, classify and 
integrate information; (b) memory and learning involve information storage and 
retrieval, (c) thinking concerns the mental organization and reorganization of 
information; and (d) expressive functions are the means though which information is 
communicated or acted upon (Lezak, 1995). Though these categories can be 
described as separate concepts, they are interdependent (Lezak, 1995).       
Relapse- Any episode of alcohol or drug use by the participant after the date of 
admission to the substance use treatment program will be considered a relapse. 
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Substance Dependence - Substance Dependence is defined based on the criteria listed 
in the DSM-IV-TR which states: 
    A maladaptive pattern of substance use, leading to clinically significant impairment 
or distress, as manifested by three (or more) of the following, occurring at any time in 
the same 12-month period: 
     (1) tolerance, as defined by either of the following:  
(a) a need for markedly increased amounts of the substance to achieve 
intoxication   or desired effect,  
(b) markedly diminished effect with continued use of the same amount of the 
substance,  
     (2) withdrawal, as manifested by either of the following:  
(a) the characteristic withdrawal syndrome for the substance [For example, 
with alcohol withdrawal, two or more of the following symptoms are 
necessary: autonomic hyperactivity, increased hand tremor, insomnia, 
psychomotor agitation, anxiety, nausea or vomiting; and rarely, grand mal 
seizures or transient visual, tactile, or auditory hallucinations or illusions.]  
(b) the same or closely related substance is taken to relieve or avoid 
withdrawal symptoms,   
(3) substance is often taken in larger amounts or over a longer period than 
intended, (4) there is persistent desire or unsuccessful efforts to cut down or 
control the substance use,  
(5) a great deal of time is spent in activities necessary to obtain the substance, use 
the substance, or recover from its effects,  
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(6) important social, occupational, or recreational activities are given up or 
reduced because of substance use,  
(7) the substance use is continued despite knowledge of having a persistent or 
recurrent physical or psychological problem that is likely to have been caused or 
exacerbated by the substance  (e.g., current cocaine use despite recognition of 
cocaine-induced depression, or continued drinking despite recognition that an 
ulcer was made worse by alcohol consumption; APA, 2000, p. 197). 
Importance of the Study 
      A mere 1.9 million of the 22.2 million people identified as needing treatment 
for a substance abuse or dependence disorder received treatment in 2003, 2.33 million 
received treatment of the 23.48 million identified in need in 2004 and 2.4 million of 
23.2 million identified as in need in 2008 (SAMHSA, 2005; NSDUH, 2008). For 
those who wanted but did not enter treatment, factors such as lack of resources 
including money, medical insurance and transportation, as well as the stigma 
associated with having a substance dependence problem have been identified as 
barriers to treatment (Knight & Longmore, 1994; SAMHSA, 2005; NSDUH, 2008). 
However, the specific reasons individuals enter treatment and then drop out appear to 
be less clearly understood. The Office of Applied Studies (2004) discussed the 
median day of dropout (i.e., day 32), but did not discuss why the participant dropped 
out. Often times when a client does not continue in treatment it is viewed as non-
compliance (Glyngdal, Sorenson & Kistrup, 2002). There is strong evidence that the 
degree to which clients engage and participate in treatment activities is related to the 
success of substance abuse treatment (Northwest Frontier Addiction Technology 
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Transfer Center, 2003). Success is not specifically defined in this article but seems to 
be suggested as following through with recommended treatment. Attrition from 
substance abuse treatment has been identified by some as one of the greatest 
problems interfering with the effectiveness of treatment programs (Jacobsen, 2004). 
To quote Shavelson (2001), “If there is a single consistent finding that has come out 
of rehab research it is that the longer clients can be maintained in the programs the 
more likely they are to emerge clean and sober, and stay that way.” (Shavelson, 2001, 
p. 300).  Quite obviously, one cannot be expected to benefit from treatment they are 
not present for.  Furthermore, although much research has been conducted regarding 
neuropsychological impairment resulting from substance abuse and dependence, the 
research is limited in regards to neuropsychological impairment and treatment 
attrition. Though over 150  resources were used to research this study, only one was 
found that researched neuropsychological functioning and attrition rates (Fals-Stewart 
& Lucente, 1994). However, Fals-Stewart and Lucente’s study (1994) included 
personality disorders with the neuropsychological impairment as it evaluated attrition 
rates. Likewise, as previously discussed, support exists for the problem of attrition 
including rates between 40% and 66% (Marlowe & Dematteo, 2003; SAMHSA, 
1998). The literature on predicting attrition has been inconclusive. Variables such as 
sociodemographics, gender, psychiatric comorbidity and substance use severity have 
all been evaluated in relation to treatment drop out (Sayre et al, 2002).  
 The purpose of this study is to explore the relationship of neuropsychological 
functioning and attrition rates in individuals who have engaged in outpatient 
treatment. These results may provide important implications for treatment planning, 
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program development and training of clinicians to more effectively meet the needs of 
patients with a substance dependence disorder.  
Brief Introduction to Proposed Methodology 
Participants were recruited from the population of clients entering outpatient 
treatment for substance use disorders at the 7C’s clinic within the Guesthouse. All 
participants agreed to informed, voluntary participation in the study. Participants all 
had  a substance use diagnosis as defined by the DSM-IV-TR and  confirmed by an 
assessment including the Form 90, Addiction Severity Index (ASI) and the Mini 
International Neuropsychiatric Interview (MINI). Participants had their current level 
of neuropsychological functioning assessed through the neuropsychological test 
battery established for this study which included subtests of the Delis-Kaplan, the 
Conners’ Continuous Performance Test II and the WASI. We intended to have data 
from our established sample size of 100  collected over the course of six months by 
four clinicians (Addiction Counseling students in training) trained in the use of all 
assessment tools by licensed psychologists (Dr. Campbell & Dr. Young). As will be 
discussed later, our final sample size was less than 100. Participants were observed 
for three months or until the date they dropped out or were discontinued from 
treatment. Therefore, we intended that over the course of six months, approximately 
four to five participants per week would need to be evaluated for the study. We 
intended to complete data collection within nine months which allowed for three 
months past the six month mark allowing for the three months of observation for the 
final participants included. This data collection was also supervised by a licensed 
psychologist (Dr. Todd Campbell) available on a regular basis for questions and 
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consultation and a neuropsychologist who was also available for questions and 
consultation (Dr. Terry Young).  
 The statistical methodologies proposed and used in this study are Survival 
Analysis (SA) and Logistic Regression (LR). Survival Analysis traditionally has been 
used for medical research as it is useful for longitudinal studies for things such as 
survival rates with cancer or organ transplants (Parmar & Machin, 1995). Survival 
Analysis can be utilized for longitudinal data such as the length in outpatient 
treatment that we will be studying (Corning & Malofeeva, 2004; Gerstman, 2003, 
Pamar & Machin, 1995). One difference between survival data and other types of 
numeric continuous data is that the time to the event occurring (e.g., day of drop out 
or end of successful treatment) might not be observed in all participants in particular 
studies due to variables such as death of participants or an end of treatment date that 
is beyond the length of the study. This non-observed event is accounted for in 
survival analysis (Corning & Malofeeva, 2004; Parmar & Machin, 1995) making it a 
very appropriate method for this study. Logistic Regression will allow us to evaluate 
the relationship between neuropsychological function and the dichotomous variables 
of drop out vs. no drop out.  The different statistical methods allow us to evaluate all 
important variables in this study.  
 The dependent variables for this study include the total length of time spent in 
outpatient treatment prior to drop out and whether or not the participant drops out. 
The independent variable is the level of neuropsychological functioning or 
impairment.  The null hypothesis of this study is that there will be no relationship 
between the level of neuropsychological functioning and a participant’s length of 
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attendance in outpatient substance dependence treatment or drop out status. We had 
also intended to evaluate relapse rates, but as will be discussed below, we were 
unable to address this issue.  
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Chapter II: Review of the Literature 
      This chapter will assist the reader in gaining an understanding of the history of 
neuropsychological assessment, as well as, the anatomy of neuropsychological 
functioning. Finally, research specific to executive functioning, substance dependence 
and dual diagnosis will be presented, as well as, research specific to attrition rates.  
Neuropsychology as a Clinical Discipline 
Defining Neuropsychology 
 Neuropsychology is an applied science concerned with the behavioral 
expression of brain dysfunction (Lezak, 1995; Lezak, Howieson, Loring, Hannay & 
Fischer, 2004). Clinical neuropsychologists deal with a variety of questions regarding 
human behavior and brain functioning, a wide range of normal and abnormal 
behaviors and  diverse people with regards to demographics, culture and pathology 
(Lezak, 1995). Therefore, the practice of neuropsychology requires of its practitioners 
flexibility of mind, curiosity about the myriad of factors of human behavior and 
inventiveness with regard to clinical interventions in even the most routine work 
undertaken (Lezak, 1995; Snyder & Nussbaum, 1998; Stirling, 2002)  
Neuropsychologists interact with professionals from many other 
psychological and medical clinical disciplines, including other psychologists, 
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psychiatirists, counselors, family practice physicians, gerontologists and emergency 
room personnel (Lezak, 1995; Lezak et al, 2004; Meier, 1992; Snyder & Nussbaum, 
1998). The interaction of neuropsychology with other disciplines allows for a more 
thorough diagnosis and treatment plan with attention to details regarding brain 
functioning, strengths and weaknesses for multiple presenting concerns including(but 
not limited to) behavioral disorders, mood disorders, head injuries, learning 
disabilities and  dementias (Lezak, 1995). At one time, clinical psycholgogists 
determined brain damage mainly with Wechsler’s intelligence tests. Traditional tests 
are still very useul, but not specific enough to identify specific signs of brain damage 
such as language deficits and attention problems (Lezak, 1995). With specialized 
training, neuropsychologists evaluate aspects of intelligence, reasoning, abstraction, 
attention, executive functions, learning, memory, language, auditory, visual, motor 
functions and constructional tasks (Lezak, 1995). The neuropsychologist uses 
specialized assessments to examine the relationship between the brain and behavior 
helping to identify brain damage, cognitive dysfunction and patient strengths and 
weaknesses, all of which can be extremely helpful in patient treatment planning and 
rehabilitation (Seidman, 1998).  
Development of Clinical Neuropsychology  
Clinical Neuropsychology evolved from its parent disciplines of neurology 
and psychology, developing an identity of its own in the 1940s (Lezak, 1995). In the 
1940s, prior to performing a craniotomy, neurosurgeons relied on 
electroencephalograms (EEG’s), X-rays and neuropsychological reports for 
localization giving the neuropsychologists a well-defined niche (Lezak, 1995; Ruff, 
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2003). However, in the 1970s when computerized tomography became available, the 
neuropsychologist’s role in localization became less important. Therefore, the 
neuropsychologist’s role shifted focus to obtaining quantitative descriptions of a 
patient’s cognitive status (Ruff, 2003). Likewise, Lezak (1995) reports, that in the 
1940s “psychology’s looser constructs were undergoing reexamination in the cold 
light of operationalism” (Lezak, 1995, p. 3). More specifically, the prominence of 
“intuitive modus operandi of the earlier armchair and couch theoreticians was giving 
way to more rigorous-appearing actuarial (statistical probability) techniques” (Lezak, 
1995, p. 3). In strict actuarial approaches, the neuropsychologist need not even see the 
patient, but rather draw conclusions from scores obtained by a technician (Lezak, 
1995). However, through the development of testing batteries developed by some of 
the leaders in the field, neuropsychology developed into more of a mix of the intuitive 
and actuarial (Lezak, 1995). Some of the leaders and batteries are discussed in the 
Neuropsychological Assessment section below.  
 
      To further distinguish the neuropsychologists in the field of psychology, the 
formation of the International Neuropsychological Society (INS) was organized in 
1966 at the Albert Einstein College of Medicine. This was a landmark for the formal 
organizational structure of clinical neuropsychology (Meier, 1992). The organization 
of the INS provided the necessary organizing of a group of neuropsychologists that 
had been gathering at APA (Meier, 1992).  In the 1970s, the organization grew to 
become international, as well as interdisciplinary, with psychologists, psychiatrists, 
neurolinguists, neurosurgeons and more becoming members (Meier, 1992). The INS 
also began publication of The Journal of Clinical Neuropsychology, later renamed 
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Journal of Clinical and Experimental Neuropsychology (Meier, 1992). As the INS 
continued to assume a position of leadership, the stage was set for establishing a 
division within the American Psychological Association (APA). Finally, in 1980, the 
Division of Clinical Neuropsychology (Division 40) was formed within APA (Meier, 
1992). Though relatively still young as a field, neuropsychology’s growth can be 
noted in an increasing number of clinical practicum sites, journals, clinical internship 
sites and curriculum planning focused specifically on neuropsychology (Snyder & 
Nussbaum, 1998).  
Neuropsychological Assessment 
Early Neuropsychological Test Batteries 
 
      As discussed by Lewis and Sinnett (1987), the first neuropsychological test 
battery was developed by Goldstein and Scheerer. Goldstein, a neuropsychiatrist, and 
Scheerer were both trained in the Gestalt psychology tradition drawing on experience 
with brain injured German soldiers in World War I (Lewis & Sinnett, 1987). 
However, the lack of standardization, lack of objective scoring, lack of reliability and 
validity data made clinicians hesitant to adopt the battery (Lewis & Sinnett, 1987). 
Halstead-Reitan Neuropsychological Test Battery.   
A few years later, in 1947 W.C. Halstead, a Northwestern University PhD, 
initiated the development of the first standardized neuropsychological test battery, as 
well as the formation of the first neuropsychology laboratory in the United States 
(Lewis & Sinnett, 1987). Halstead and his graduate student, Ralph Reitan, together 
developed the Halstead-Reitan Neuropsychological Test Battery (Lewis & Sinnett, 
1987), currently one of three commonly used batteries in the United States (Seidman, 
1998). 
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  The version of Halstead Reitan Battery (HRB) that is most commonly used 
at present consists of five subtests including the (a) Category Test, (b) Tactual 
Performance Test, (c) Rhythm Test, (d) Speech Sounds Perception Test, and (e) 
Finger Oscillation Test or Finger Tapping Test (Lezak, 1995). The two tests that were 
part of the original seven that are not commonly used any longer include the Critical 
Flicker Fusion Test and the Time Sense Test (Lezak, 1995). A distinctive feature of 
Reitan’s handling of examination data of the HRB was his reliance on test scores for 
predicting nature and site of a lesion (Lezak, 1995). Although the HRB has practical 
limitations in that it takes a long time to administer and is not considered suitable for 
thorough examination of patients with sensory or motor handicaps, it offers one of the 
more reliable psychological means for identifying patients with brain damage (Lezak, 
1995).  
Luria Nebraska Battery.  
Russian neuropsychologist A. R. Luria was the primary developer of the Luria 
Nebraska Battery (Lezak, 1995). Luria’s contributions to neuropsychological testing 
consist of obtaining sensitive, qualitative, behavioral descriptions, emphasizing the 
uniqueness of each individual patient (Lezak, 1995). Luria’s approach to 
neuropsychological assessment was clinically focused versus empirically focused 
(Lezak, 1995). He often administered his assessment battery at a patient’s bedside 
paying particular attention to the means the patient used to solve a problem rather 
than the outcome of the test (Lezak, 1995). Luria was more concerned with what he 
observed clinically versus what the results of the test indicated. As a result of the 
manner in which Luria approached and administered testing, the data collected on 
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each individual was rich, but due to the lack of standardized administration 
procedures (i.e., the testing procedures changed dependent upon the patient’s 
responses, Luria’s approach to testing did not allow for duplication (Lewis & Sinnett, 
1987). As Luria’s approach was very individualized and was difficult to duplicate, it 
had many qualitative characteristics. Luria’s approach to neuropsychological 
assessment led to many present day neuropsychologists approaching assessment from 
an integrated qualitative-quantitative approach (Lezak, 1995). Specifically, the 
assessor can take advantage of the standardized assessments for quantitative analysis 
while also using clinical training to assist in the attention to more qualitative features 
for a more eclectic evaluation (Lezak, 1995).  
 
Boston Process.  
According to Seidman (1998), the third neuropsychological test battery widely 
used at present is the Boston Process Neuropsychological Approach, which has many 
variants. The examiner begins with few measures and focuses the assessment more 
precisely as more information is learned about the patient (Seidman, 1998). This 
approach lends itself to a more flexible model of assessment again incorporating the 
qualitative and quantitative pieces (Seidman, 1998).  
Although the Boston approach has many variants, most versions include tests 
of intelligence, memory, abstraction, naming ability, visuo-constructional, 
organizational and tests of executive function (Seidman, 1998). Sometimes other tests 
are added to evaluate dementia, aphasia and personality issues. The emphasis with the 
Boston battery is more on how patients perform rather than merely whether they 
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succeed or fail (Seidman, 1998). Therefore, examiners can use the Boston approach 
to identify possible damage even when the final performance score falls within the 
identified normal range (Seidman, 1998). Furthermore, Seidman (1998) supports the 
use of the Boston Process battery when the possibility of malingering is high (such as 
legal cases with the possibility for monetary gain) because processes are more 
difficult to fake than are results (Seidman, 1998)  
 
Neuropsychological assessment battery for this study. 
 The instruments used for this study included specific subtests of the Delis-
Kaplan Executive Function System (D-KEFS) and the Conners’ Continuous 
Performance Test II (CPT II) for evaluation of neuropsychological strengths and 
weaknesses. Furthermore, the Wechsler Abbreviated Scale of Intelligence (WASI) 
was used for an estimate of general intellectual ability and the Form 90 and Addiction 
Severity Index (ASI) for substance dependence assessment. In addition, the Addiction 
Severity Index (ASI) was  used to evaluate the severity of problem areas associated 
with alcohol and drug dependence and the Mini International Neuropsychiatric 
Interview (MINI) was used to establish any other DSM-IV diagnoses. All of these 
assessments will be discussed in detail in Chapter III. 
Overview of Frontal Lobe Anatomy and Functions 
      Due to the complex nature of neuroanatomy, this review is meant to be basic, 
certainly not all-inclusive and exhaustive. The next section provides an overview of 
the anatomy and specific functions of the frontal lobe.  
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Frontal Lobe Anatomy 
      Very simply stated, the brain is divided into two hemispheres, left and right. 
Furthermore, the cerebral cortex is divided into four lobes: (a) frontal, (b) parietal, (c) 
temporal, and (d) occipital (Society for Neuroscience, 2002). For the purpose of this 
study, our focus will be on the frontal lobes.  
      In humans, the frontal lobes account for approximately one-third of the 
cerebral cortex (Goldman-Rakic, 1987). The frontal lobe can be subdivided into a 
number of functional subsystems including: (a) primary motor cortex – responsible 
for critical to fine motor movement, receives projections from posterior cortical areas 
involved in somatosensory perceptions as well as subcortical input from the ventral 
lateral thalamic nucleus, (b) premotor area - involved in sensorimotor integration and 
complex volitional movement having connections to the parietal lobe, (c) frontal eye 
fields - permit volitional eye movement in the contralateral visual fields necessary for 
voluntary gaze and visual search, (d) orbital and basal areas - affecting anosmia 
(deficiency in smell) and disinhibited personality changes, though few measures are 
available of orbitofrontal functions in humans, (e) supplemental motor and anterior 
cingulate gyrus - areas possibly forming a reciprocal system responsible for 
environmental search and inhibition of exploratory behavior, and (f) the dorsolateral 
prefrontal subsystem -  responsible for executive functions (Kandel, Schwartz & 
Jessell, 1991; Malloy & Richardson, 1994; Snyder & Nussbaum,1998). Due to the 
impact alcohol and drugs have been found to have on the dorsolateral prefrontal 
subsystem (which will be discussed in further detail in the next section), the executive 
functions of the dorsolateral prefrontal subsystem are the neuropsychological 
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components we are most interested in for the purpose of this study  (Knight & 
Longmore, 1995; Lezak, 1995; Moselhy, 2001). 
Dorsolateral Prefrontal Subsystem and the Executive Functions 
As previously mentioned, the dorsolateral prefrontal subsystem is considered 
mostly responsible for executive functions (Kandel, Schwartz & Jessell, 1991; Malloy 
& Richardson, 1994; Snyder & Nussbaum, 1998). The executive functions are 
necessary for appropriate, socially responsible and effective self-serving conduct 
(Lezak, 1995). The executive functions can be conceptualized as having four 
components, each involving a set of activity-related behaviors and all having a fair 
amount of overlap (Lezak, 1995). The four components are (a) volition, (b) planning 
(c) purposive action, and (d) effective performance (Lezak, 1995; Lezak et al, 2004).  
        
 
  Volition. 
Volition, in short, is the capacity for intentional behavior (Lezak, 1995). 
Volition requires the capacity to formulate a goal or intention. It may be easiest to 
describe volition by examining deficits in volition. People who lack volitional 
abilities simply cannot think of anything to do or may be unable to initiate activities 
except in response to external stimuli such as someone giving them continuous 
prompting. There are various levels of volitional impairment ranging from mild to 
much more severe (Lezak, 1995). A mild case of volitional impairment could involve 
someone successfully engaging in games, chores or familiar routines without 
prompting, but being unable to assume longer term responsibilities (such as 
  34 
 
employment) without outside guidance. Someone with more severe impairment may 
know the proper use of eating utensils, but may not take the initiative to eat the food 
placed in front of them without continuous prompting (Lezak, 1995; Shallice & 
Burgess, 1991).     
  
 Planning. 
Planning abilities involve the identification and organization of the necessary 
skills and resources needed to carry out a plan or goal (Klein, 2000). For example, a 
patient with planning deficits may not be able to plan a future activity such as the 
steps needed to assemble a swing set (Klein, 2000). One must be able to look ahead, 
conceive alternatives and weigh out choices. Planning abilities involve reasonably 
intact memory, good impulse control and capacity for sustained attention (Lezak, 
1995). One might find it necessary to repeat questions or instructions several times to 
patients with planning deficits in order for the patient to be able to direct his or her 
effort and concentration on completing the task (Stuss & Benson, 1984).  
Planning deficits would certainly have implications for treatment. For 
example, a clinician working with clients who have deficits in planning would need to 
use repetition when giving instructions or facilitating participation in therapy. 
Likewise, the clinician may need to use redirection and attention gathering tactics 
repeatedly and frequently. For example, the clinician may need to verbally redirect 
clients to remind them to stay on task and maintain their attention to a particular task. 
Finally, clients may need verbal reminders of appointments repeated in the form of 
letters, phone calls or any other available sources.  
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       Purposive action.  
The translation of a plan into an activity is purposive action (Lezak, 1995). 
This involves the ability to initiate, maintain, switch, and stop sequences of behavior 
in an ordered manner (Lezak, 1995). For example, a patient might have a plan to 
attend an Alcoholics Anonymous meeting, but actually turning that plan into the 
action of going does not happen. A deficit in purposive action is most important when 
the actions are not routine. Overlearned, familiar, or automatic tasks are much less 
vulnerable to frontal lobe damage than more novel tasks (Lezak, 1995). For example, 
the overlearned task of putting one’s shoes on is less likely to be impaired than the 
attendance at a new meeting in the community. 
There are multiple aspects of purposive action that can be impaired. One’s 
ability to self regulate can affect their success at productivity (Lezak, 1995). This gap 
between planning and activity becomes apparent in patients who are “all talk, no 
action”. This is different from the occasional tendency of someone to not follow 
through on their word. The gap between planning and action is frequent and persistent 
giving it a pathological flavor. Flexibility and the capacity to shift one’s behavior or 
thoughts can also be impaired (Zinn et al., 2004), resulting in difficulty conforming to 
social norms or expectations, rigidity in thinking or behaviors or a tendency to 
perseverate with behaviors or thought streams (Lezak, 1995; Ratti et al., 2002). For 
example, a patient who perseverates with behaviors or thought streams might have 
the exact same routine daily or tell the clinician the same story over and over. The 
client with rigidity or perseveration issues may present to clinicians as someone who 
is unmotivated, difficult to redirect or disruptive. Using multiple methods of 
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redirection and reinforcement could prove helpful versus becoming frustrated and 
assuming the client is not motivated to participate in treatment.  
        Effective performance.  
 A patient’s performance on any activity can only be as effective as his/her 
ability to monitor, self-correct and regulate the qualitative aspects of the delivery of 
the action (Lezak, 1995).  Some patients who suffer deficiencies in executive 
functioning, including problems in effective performance, may not perceive errors 
they have made on any task or may perceive errors but do nothing to correct them 
(Lezak, 1995). They may perform any task erratically or just simply unsuccessfully 
(Lezak, 1995). Patients with frontal lobe impairment may also have insensitivity to 
possible consequences (i.e., punishment or reward) which affects their ability to make 
sound decisions (Bechara, Tranel & Damasio, 2000). A patient’s lack of effective 
performance on any given task may be the result of not perceiving errors or 
perceiving but not correcting the errors (Lezak, 1995). The lack of self correction 
may result from an abnormal sense of self awareness or possibly just inertia (lack of 
purposive action; Lezak, 1995). If one does not perceive what they are doing, it is 
difficult to correct. Likewise, if one has no inertia, they also would not correct any 
possible errors.  
Another syndrome associated with abnormalities of self-awareness is that of 
confabulation (Lezak, 1995). Confabulation is defined as the presentation of 
incorrect, sometimes bizarre information to standard questions (Lezak, 1995). For 
example, when asked about their recent substance use, the client might report a long 
story about wild events at work. They might talk while the clinician is speaking and 
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not directly respond to specific questions without repeated redirection and 
clarification. Once the response is made, the answer might contain a series of 
formations of false memory, perceptions or beliefs mixed with some truth, pouring 
out of irrelevant associations or the response may contain no reality at all. 
Confabulation is not necessarily related to a memory disturbance, but instead is due to 
the ability to self correct (Stuss & Benson, 1984). Therefore, the patient’s lack of 
effectiveness with any task may be due to multiple issues of self correction, self 
awareness and self regulation (Stuss & Benson, 1984).       
 Frontal Lobe Functions 
Historically, frontal lobe functions have been poorly understood (Lezak, 1995; 
Snyder & Nussbaum, 1998). For example, for many years clinicians referred to the 
prefrontal lobes as the silent areas because sensorimotor signs were often absent after 
prefrontal damage (Snyder & Nussbaum, 1998). However, due to continued research 
on humans and animals, as well as developments in structural and functional 
neuroimaging, we now have a much greater understanding of this area of the brain 
(Snyder & Nussbaum, 1998).  
     As described with deficits in volition, planning, purposive action and effective 
performance, frontal lobe disorders affect how a person responds to others, which can 
affect the content of any response (Lezak, 1995). Disorders affecting the frontal lobes 
tend not to disrupt cognitive functions (such as reporting on specific knowledge) as 
obviously as does damage in other areas of the brain such as occipital (Lezak, 1995). 
Therefore, frontal lobe dysfunction may be harder to detect, go undetected or be 
attributed to other causes such as the client’s noncompliance or lack of desire to 
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participate or address problems (Lezak, 1995). This then impacts the judgments 
others make about the client and possibly resulting in increased stigma. 
 Deficits in functioning stemming from damage to the frontal cortex can also 
affect one’s ability to pay attention, as well as one’s prospective memory (i.e., one’s 
ability to remember to remember; Lezak, 1995). Therefore, if a patient has attention 
or memory deficits, they will have a difficult time retaining what is said in treatment, 
remembering appointments, locations, bus schedules and much more. The deficits in 
memory and attention could result in frustration and increased drop out rates. 
Likewise, the deficits in memory and attention may also be misperceived by 
clinicians and others resulting in continued stigma.  
Frontal lobe damage and cognitive functions.   
In regards to cognitive functions, frontal lobe disorders usually do not result in 
the loss of a specific skill or specific information (Bechara et al., 2000; Salloway, 
1994; Shallice & Burgess, 1991). In fact, patients with frontal lobe disorders often 
perform within normal ranges on formal ability tests such as tests of intelligence and 
tests where they have direction through a series of problems (Bechara et al., 2000; 
Shallice & Burgess, 1991). Tests of intelligence often ask for factual information 
which is not affected normally with frontal lobe disorders (Bechara et al., 2000; 
Shallice & Burgess, 1991). Likewise, in tests where they are directed through a series 
of tasks, they have the benefit of the examiner’s direction. Instead, the difficulties in 
functioning for people with frontal lobe deficits are related to initiating, planning, and 
organizing abilities, and therefore assessment must include tests designed to examine 
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the patient’s functioning in initiating action, planning tasks, and organizing abilities 
(Bechara et al., 2000; Shallice & Burgess, 1991).  
 (Often Misinterpreted) Behavioral Problems Associated with Damage to the 
 Frontal Lobe 
Misinterpretation and Stigma 
 Common complaints from the people around patients with frontal lobe 
disorders include that the patient seems apathetic, careless, has poor or unreliable 
judgment, poorly adapts to new situations and has a blunted sense of sensibility 
(Daffner et al., 2000; Lezak, 1995). In treatment, this might present as someone who 
does not want help or is uninterested in what the clinician or others have to say. 
Substance abusing patients with deficits such as information processing, 
distractibility, difficulty with attention and problem solving can result in the patient 
missing parts of what they are told leading to issues such as emotional lability, 
hypersensitivity, low frustration tolerance or paranoia in the patient (Fals-Stewart & 
Lucente, 1994). Substance abusing patients with such deficits are often described as 
irritable, impulsive, perseverative and socially disinhibited (Fals-Stewart & Lucente, 
1994). Similarly, Bates, Voelbel, Buckman, Labouvie and Barry (2005) reported that 
cognitive deficits in patients in substance abuse treatment “may lead to lack of 
motivation and treatment engagement, which are often  interpreted as negative client 
attributes by treatment providers” (Bates, Voelbel, Buckman, Labouvie & Barry, 
2005, p. 373). Furthermore, when therapists were informed of the deficits in 
functioning, the therapists rated participation and therapeutic alliance higher and 
patients subsequently stayed in treatment longer (Bates et al., 2005).  
  40 
 
As previously discussed, the stigma associated with substance use disorders is 
a relevant factor in why individuals do not engage in treatment (Corrigan, 2004). 
Understanding and reducing this stigma, which results at least partially from the 
neuropsychological deficits associated with substance use disorders, is an important 
reason for this study.  
Introduction to Behavior Problems   
There are five general behavioral problems that are often misinterpreted in 
patients with frontal lobe damage adding to the prevalence of stigma associated with 
substance use disorders (Lezak, 1995). The five behavioral problems, with much 
overlap amongst them, associated with damage to the frontal lobe include (a) 
problems in behavior starting, (b) difficulty making mental and behavioral shifts, (c) 
problems in stopping, (d) deficient self awareness, and (e) a concrete attitude (Lezak, 
1995). These five general behavioral problems are often misinterpreted by clinicians, 
family, friends, coworkers and society in general, leading to the development and 
perseveration of the stigma that accompanies individuals with frontal lobe damage 
(Lezak, 1995). The five behavioral problems and their possible misinterpretations are 
discussed below.   
Problems in behavior starting.  
The problem of behavior starting relates to the previously discussed volition 
and purposive action. When compared to their behaviors previous to frontal lobe 
damage, individuals who suffer with problems in behavior starting exhibit decreased 
spontaneity, decreased productivity, decreased rate at which behavior is emitted and 
decreased or lost initiative as compared to the patient’s normal level of functioning 
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(Lezak, 1995). As a result of these particular deficits, patients who exhibit problems 
in behavior starting may appear lazy or apathetic to the casual observer (Daffner et 
al., 2000). Many can “talk a good game” but are unable to transform words into 
action. An extreme dissociation between words and actions has been termed 
pathological inertia (Lezak, 1995). The frontal lobe patient has no problem in 
describing a viable course of action (e.g., verbally describes when, where and how 
they will attend a community support meeting), but is unable to carry out the plan 
(i.e., never actually go to the meeting; Lezak, 1995).  
Difficulty making mental and behavioral shifts. 
 A second behavioral problem associated with purposive action that may 
manifest as a result of damage to the frontal lobe is that of difficulty in making mental 
or behavioral shifts (Lezak, 1995). Referred to as perseveration or rigidity (Lezak, 
1995), difficulties are seen in the individual’s ability to shift attention from one thing 
to another, to make changes in physical movement or to maintain flexibility in 
attitude.  Specifically, perseveration refers to repetition or continuation of an act or 
response to a question or situation (Lezak, 1995). In patients who have damage to the 
frontal lobe, perseveration tends to be supramodal, meaning that perseveration is 
exhibited in a variety of situations and a variety of tasks (Lezak, 1995). For example, 
the client might like to tell the same story of the day they met the president every time 
they attend a session anywhere with anyone present. Similarly, activities such as 
stopping at the same bar every night or calling the same drinking friends for support 
may be due to the individual’s inability to change the behavior as the result of frontal 
lobe damage (i.e., perseveration) rather than being due to the individual’s choosing 
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the behavior, which is what the casual observer might assume without information to 
the contrary. Perseveration can manifest itself as repetitive prolongation or 
continuation of an act or sequence of activities, or similar responses to a variety of 
questions, tasks or situations (Lezak, 1995). I have heard clinicians become frustrated 
with clients who do the same act expecting different results-often the result of 
perseveration.  
Problems in stopping behaviors or responses.   
The third behavioral problem for individuals with frontal lobe damage 
involves the effective performance component of frontal lobe damage, or more 
specifically, difficulty stopping behaviors or responses (Bechara et al., 2000; Lezak, 
1995). The inability to stop behaviors results in the patient’s impulsivity, over 
reactivity, disinhibition and difficulty holding back a wrong or unwanted response 
(Lezak, 1995). Because of their behaviors, patients exhibiting difficulties with 
stopping behaviors are often classified as having a loss of control or control problems 
(Lezak, 1995). The difficulty in stopping behaviors could result in verbal outbursts 
that some might find offensive, as well as, an inability to maintain abstinence in any 
situation where the patient may be exposed to a substance of abuse. These types of 
behaviors might be misinterpreted as simple noncompliance by the unaware observer. 
Education regarding the inability to stop behaviors and specific behavioral plans for 
the client and the clinician could be helpful to the individuals struggling with 
disinhibition.  
Deficient self awareness.   
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Deficient self awareness, resulting in an inability to perceive performance 
errors on any given task (for example, forgetting to butter the bread prior to placing it 
in the frying pan to make grilled cheese, and then wondering why the pan is 
smoking), inability to appreciate the impact one makes on others, and/or to evaluate 
social situations appropriately (for example, not noticing that others are upset with 
you or giving you social cues meant to get you to leave) is the fourth behavioral 
problem (Lezak, 1995; Stirling, 2002). For example, people with deficient self 
awareness may be euphoric and self-satisfied at times when such feelings are 
unwarranted (for e.g., feeling satisfied with one’s parenting though only having 
contact with the child a couple times per year) causing a client to have multiple 
problems in relationships with friends, family or therapy connections (Lezak, 1995). 
Deficient self awareness may be misinterpreted as rude, lazy, insensitive or again as 
non-compliant.  Again, education focused on increasing the individual’s awareness of 
the problem and its effects on others, as well as, a plan for alternative actions versus 
ineffective actions would be imperative.  
Loss of abstract attitude.  
The fifth problem associated with frontal lobe disorders is due to the loss of 
the abstract attitude (Lezak, 1995). As a result of impairments in abstracting and 
conceptual thinking, the patient holds an extremely literal understanding of life where 
all objects, behaviors or experiences are evaluated only with regards to face value 
(Stirling, 2002). The patient becomes incapable of planning or sustaining goal 
directed behavior because they are responding in such a literal manner (Lezak, 1995). 
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Frustration can again arise with misinterpretations by clinicians and others. This 
client may be misinterpreted as being “difficult” or possibly immature.   
Summary of Executive Functioning Deficits Found in Individuals with Frontal Lobe 
Damage 
Overall, frontal lobe functions, and more specifically, executive functions are 
large and complex influences in human functioning and behavior. When examining 
the possible deficits caused by frontal lobe damage, several categories of behavioral 
problems have been defined (Lezak, 1995; Parsons & Nixon, 1993; Stirling, 2002). 
However, the behavioral problems exhibited are not exclusive to the defined 
categories; there is a fair amount of overlap, not to mention that much about the 
deficits remains unknown (Lezak, 1995; Stirling, 2002). For example, all of the 
behavioral problems discussed are described as if existing as separate concepts, but in 
real life the behaviors present as a mixture of some or all categories of possible 
deficits. Furthermore, the extent to what the exact presentation of behaviors in each 
individual will be, as related to any neuropsychological damage, is unknown (Lezak, 
1995; Snyder & Nussbaum, 1998). The overlap and complicated nature of frontal 
lobe functions makes assessment and identification of problems difficult (Lezak, 
1995). Likewise, the complex nature and presentation of the impairment in the 
individual, as well as, the misinterpretation by observers provides a breeding ground 
for frustration, labeling and stigmatization by those who interact with a person with 
frontal lobe damage.  Finally, the five specific behavioral problems discussed and 
their misinterpretations provide specific areas where stigma is born and magnified 
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due to the overlapping and often unrecognized problems associated with the frontal 
lobe (Lezak, 1995).         
Neuropsychological Functioning and Substance Dependence 
      Lewis and Sinnett (1987) discussed the fact that there are many “silent 
victims” of neuropsychological impairment, referring to the fact that many people’s 
impairments go undetected or misdiagnosed. Some of the silent victims include 
people with brain injuries, rare metabolic disorders, and more common disorders such 
as substance abuse  
(Lewis & Sinnett, 1987). Bates, Bowden and Barry (2002) estimated that between 
50% and 80% of individuals with alcohol use disorders experience mild to severe 
neurocognitive impairment (Bates et al., 2002). Likewise, Parsons and Nixon (1993) 
estimated that as many as 50% to 85% of individuals with alcohol use disorders will 
manifest mild to moderate impairment in some aspect of neuropsychological 
functioning (Parsons & Nixon, 1993). 
 Substance abuse and dependence can affect many complex areas and 
functions of the brain (Lezak, 1995; Parsons & Nixon, 1993). For example, alcohol 
dependence has been shown to affect the cerebellum, Pukinje cells and many other 
specific areas of the brain resulting in disruption of motor functioning as well as other 
specific frontal lobe functions including verbal learning, cognitive planning and 
attentional set shifting (Sullivan et al., 2003).  However, because this study seeks to 
evaluate the relationship of executive functioning and attrition rates in substance use 
treatment, I will present a brief overview of the possible effects of alcohol and drug 
use on the frontal lobe and executive functioning. 
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Effects of Alcohol Use on Frontal Lobe and Executive Functioning 
      Reduced brain weight, particularly affecting the frontal lobe has been shown 
among alcoholic patients upon autopsy and neuroimaging studies (Bates et al., 2002; 
Sullivan et al., 2003). With such information about the impact of chronic alcohol use 
on the frontal lobe, researchers have begun to look more seriously at executive 
functioning and substance use disorders. For instance, Ratti, Giardini and Soragna 
(2002) evaluated the neuropsychological functioning of 22 male alcoholics (met DSM 
IV criteria for alcohol dependence, no history of significant drug abuse, ages 30-65, 
no head injury or medical condition affecting cognitive functions) and 22 non 
alcoholic controls (no DSM IV diagnosis, no neurological disorders, healthy, right 
hand dominant, habitually drink less than 40 grams of alcohol per day) using results 
on several neuropsychological tests. The tests used were Digit Symbol (assessing 
psychomotor performance), Stroop (selective and focused attention, ability to 
suppress irrelevant information), Digit Cancellation (selective attention), Trail 
Making (visual conceptual and visual motor tracking skills, mental flexibility) and the 
Wisconsin Card Sort Test (WCST; problem solving, abstraction, cognitive flexibility, 
concept identification, hypothesis generation, ability to use feedback; Ratti, Giardini 
& Soragna, 2002). This test battery would be appropriate for the author’s purpose of 
evaluating executive functions. For all tests, mean and standard deviation were also 
calculated. The authors found the alcoholic participants to be impaired in almost 
every executive function assessed (Ratti et al., 2002). Specifically, results indicated 
statistically significant differences in the functioning levels between alcoholics and 
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non-alcoholics (Ratti et al., 2002). The alcoholic participants performed statistically 
significantly worse than did the non-alcoholic control group in the digit cancellation 
(M = 44.6 +/- 11.2, p = .0001), the digit symbol (M = 28.2 +/- 14.8, p = .005), the 
trail making test (M = 167.9 +/- 100.2, p = .01) and reaction test (M = 433 +/- 105, p 
= .001; Ratti et al., 2002). On the WCST, which evaluates problem solving and 
abstraction abilities, the alcoholics were also found to be impaired (M = 54.5 +/- 20.0, 
p = 0.00001). However, they were not impaired on the WCST in the area of 
perseveration (Ratti et al., 2002).  
The strengths of this study include the author’s use of a control group (i.e., the 
non-alcoholic group), and the evaluation of the participant’s physical health, so as to 
not interfere with results. Though the test participants and controls were matched for 
age, education and IQ, no mention was made of evaluation of socioeconomic status or 
ethnicity. If the authors were using assessments that were not normed for their 
participant’s socioeconomic status or ethnicity, this could adversely affect the results. 
Overall, the authors conclude that executive functions are impaired by alcohol 
dependence (Ratti et al., 2002).    
         Likewise, researchers have found metabolic abnormalities in the left 
dorsolateral prefrontal cortex on a study performed on 17 chronic alcoholics 
including 11 men and 6 women (Dao-Castellana et al., 1998). The subjects were ages 
25 to 65 and had been hospitalized for detox from one week to one month. All 
subjects had been abstinent from alcohol and illicit drugs since hospitalization. Nine 
normal, non-alcoholic participants were recruited as controls for the imaging studies 
and neuropsychological evaluations were performed on eight controls (Dao-
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Castellana et al., 1998). It is unclear within this study why nine were used for the 
imaging and only eight for the testing. Likewise, it is unclear why 17 alcoholic 
participants were studied and only a total of nine, non-alcoholic controls were 
studied. The controls had normal clinical, neurological and psychiatric examinations 
and normal MRI images (Dao-Castellana et al., 1998). All subjects had a PET scan 
and an MRI on the day they were administered the neuropsychological tests. The PET 
scans found a statistically significant decreased cortical metabolism in the left frontal 
lobe (p = 0.048), mediofrontal region (p = 0.002) and close to statistical significance 
(p =0.084) in the left prefrontal region in the alcoholic participants (Dao-Castellana et 
al., 1998). Similarly, the MRI showed significant cortical atrophy in the mediofrontal 
(p < 0 .001), right dorsolateral prefrontal (p = 0.005) and left dorsolateral prefrontal 
regions (p < 0.001) in the alcoholic participants (Dao-Castellana et al., 1998). 
Likewise, statistically significant reduced verbal fluency (p = 0.014) and impaired 
performance on the Stroop test (p = 0.003) were noted on these alcoholic participants 
(Dao-Castellana et al., 1998). To clarify, the Stroop test evaluates the participant’s 
ability to suppress irrelevant information and enhance relevant information (Lezak, 
1995). The Stroop is regarded as a measure of executive functions related to mental 
control and response flexibility associated with the frontal lobe (Lezak, 1995; Lezak 
et al, 2004). Verbal fluency, another measure of executive function, was evaluated by 
having subjects name as many animals as they could within a minute and list as many 
words as they could that started with the letters m, p, and d in a minute (Dao-
Castellana et al., 1998) all of which are measures of speed and ease of verbal 
production (Lezak, 1995) which was found to be impaired in the alcoholic 
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participants.  Dao-Castellana et al. (1998), concluded that these neuropsychological 
impairments including verbal fluency and ability to suppress irrelevant information 
and enhance relevant information may occur prior to other more obvious neurological 
impairments (such as severe behavioral abnormalities characterized by aggressiveness 
and breakdowns in family life) accounting for some of the behavioral changes. 
There are definite strengths and weaknesses of the Dao-Castellana et al. 
(1998) study. For example, a follow up study might define the prognosis for the 
participants or the reversibility of the impairment. One strength of this study includes 
the author’s use of the imaging studies in comparison with the neuropsychological 
tests, allowing the reader to understand physical changes in the brain as well as 
differences in an individual’s performance when tested. However, the participants in 
the Dao-Castellan et al. (1998) study range from one week to one month abstinent 
which could have an impact on their functioning or level of impairment from the 
substance use. Follow up studies might also want to look at a longitudinal study 
comparing the impairments in early and later recovery. In addition, Dao-Castellana et 
al. (1998), make no mention of baseline neuropsychological functioning in the 
participants so it is unclear how much damage in the participants has occurred due to 
the alcohol use. This piece would also be interesting to include in future research. 
There is no mention of previous academic or medical records being evaluated for the 
possibility of assessing for premorbid functioning or history of trauma and/or injury.  
Finally, Dao-Castellana et al. (1998), does not mention if the control group was 
matched to the alcoholic group in the areas of education, socioeconomic status or 
ethnicity which could all affect how comparable the groups actually are. Overall, this 
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study does continue to support the relationship between alcohol use disorders and 
impairment in the frontal lobe. 
      Sullivan, Fama, Rosenbloom and Pfefferbaum (2002) examined differences in 
executive functioning between 43 alcoholic women (ages 28-63 years) recruited from 
inpatient and outpatient programs at the Veterans Affairs Palo Alto Health Care 
System, outpatient programs at Stanford Medical Center and from community 
treatment programs and 47 non-alcoholic women (ages 20-85 years) recruited from 
the community. It is unclear how many of the controls were over age 63 (the top of 
the age range for the alcoholic group) which could affect the comparability of the two 
groups. Tests administered to examine executive function included the WCST, Trails 
B, digit ordering task, and the picture arrangement subtest of the WAIS-R (Sullivan et 
al., 2002). An ANOVA was performed using six composite scores from each of the 
two groups including measures of executive function, short term memory, upper limb 
motor ability, declarative memory, visuospatial ability and balance (Sullivan et al., 
2002). A statistically significant group effect was found between the alcoholic women 
and the control group, F(1,50) = 5.54, p = .02 (Sullivan et al., 2002). Follow up t tests 
revealed statistically significant performance deficits in the alcoholic group in five of 
the six areas (p </= .04), including all but upper limb motor ability composite 
(Sullivan et al., 2002).  
One strength of this study was the author’s assessment of premorbid 
intellectual functioning in the alcoholic group using the National Adult Reading Test 
(NART). The alcoholic group had a statistically significant lower score on the NART 
than the controls (p < 0.01; Sullivan et al., 2002). When the authors attempted to 
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control for this difference using an ANCOVA, the group differences remained 
significant for all domains except executive functioning (p = .41; Sullivan et al., 
2002). Due to the difference in premorbid functioning in alcoholics and controls, it is 
unclear if we can attribute the deficits to the substance use of the alcoholic. In 
addition, although the authors attempted to control for the difference, complete 
confidence can never be attained when simply using an ANCOVA to control for the 
difference and to compensate for study design weaknesses (Loftin & Madison, 1991; 
Thompson, 1992).  Sullivan et al. (2002), noted another weakness of this study was 
the fact that most of the alcoholic group reported being depressed and the control 
group did not. Previous research has suggested that one factor that may contribute to 
cognitive impairment in alcoholics is depression (Penick et al., 1994). Therefore, 
while the use of a control group is definitely a strength of the study by Sullivan et al. 
(2002), the depression reported by the alcoholic participants is an important 
difference between the study groups that may have affected the study’s results. In 
addition, the alcoholic group had only 11 of the 43 participants that were free of any 
comorbid DSM IV diagnosis. Nine of the alcoholic women met criteria for one other 
DSM IV diagnosis whereas the rest met criteria for two of more other Axis I 
diagnoses in the DSM IV. On the contrary, the control group was screened with the 
Structured Clinical Interview for the DSM IV (SCID) and potential controls were 
excluded if they met DSM IV diagnostic criteria. Therefore, it seems a rather large 
weakness of the Sullivan et al. (2002), study is the fact that we can not be sure that 
the results are due to the alcohol use in the test participants rather than their comorbid 
DSM IV diagnosis.  
  52 
 
However, results of other studies examining mood and alcoholism have 
contradicted the Penick et al. (1994) study mentioned above.  For example, 
Uekermann, Daum, Schlebusch, Wiebel and Trenckmann (2002) compared 
depressed, non alcoholic (n = 28) nondepressed alcoholic (n = 30) and healthy 
controls (n = 28). The assessments used included Wechsler Adult Intelligence Scales- 
Revised (short term memory), Benton Visual Retention Test (visual memory), 
immediate and delayed recall of three word lists (verbal memory), Fragmented 
Picture Test (perceptual priming) Mood Rating Scale (mood), three verbal fluency 
tests, Hayling Test (response suppression) and Cognitive Estimates Test (reasoning; 
Uekermann et al., 2002). For statistical analysis, ANOVA’s with subsequent t-tests 
using the Bonferroni correction were performed (Uekermann et al., 2002). ANOVA 
for present state mood revealed significantly (statistically) higher scores for the 
depressed group when compared to the alcoholic or control group (both p < 0.0001; 
Uekermann et al., 2002). Likewise, the patients with primary depression and the 
alcoholic group scored significantly higher than the healthy controls (p < 0.013; 
Uekermann et al., 2002). To assess the cumulative effect of depression and 
alcoholism, the cognitive profiles of depressed and nondepressed alcoholics were 
compared with those of the control group (Uekermann et al., 2002). It appears, that 
the authors developed a fourth group from the alcoholic group. They compare those 
within the alcoholic group that had a significantly higher (p = 0.0001) Beck’s 
Depression Inventory score (which is not listed as an instrument used in their section 
on the instruments used) to the others in the alcoholic group (Uekermann et al., 
2002). This results in the comparison of patients with alcoholism that are depressed to 
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patients with alcoholism that are not depressed. Unfortunately, this process is vaguely 
described in the article. In addition, the numbers in each group are not reported so it is 
unclear how many depressed alcoholics are being compared to nondepressed 
alcoholics. There were no statistically significant differences found with respect to 
age, general intelligence or history of alcoholism between the depressed alcoholic 
group and non depressed alcoholic group (p > 0.34; Uekermann et al., 2002). The 
comparisons of these two groups show no statistically significant differences on 
cognitive measures (p > 0.10). In conclusion, the results of the study showed that 
patients with primary depression and the alcoholic group were impaired with respect 
to executive functions and memory when compared to healthy controls (p < 0.05; 
Uekermann et al., 2002). In contradiction to Penick et al. (1994) the authors conclude 
that the lack of a significant difference between depressed and nondepressed 
alcoholics suggest that the deficits of alcoholics are not necessarily distorted by the 
depressive symptoms (Uekermann et al., 2002). Given the contradictory reports of the 
role depression plays with respect to executive functioning in alcoholic patients, 
further research would be useful in this area. Likewise, current researchers would 
need to use caution with regard to these variables when evaluating executive function 
in patients with a substance use issue and possible comorbid depression. 
Moselhy, Georgiou and Kahn (2001) have also reviewed the results of many 
studies that researched the effects of alcohol on the frontal lobe. The studies they 
reviewed included detailed testing (such as Halstead Category Test, Wechsler Adult 
Intelligence Scale, WCST and Trail Making test) across both genders, various age 
groups and multiple countries which indicated that individuals who are diagnosed 
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with alcohol dependence exhibit deficits in cognitive flexibility, problem solving, 
verbal and non-verbal abstraction, visuo-motor coordination, learning, conditioning 
and memory (Moselhy et al., 2001).  For example, within Moselhy, Georgiou & 
Kahn’s (2001) review of the literature, multiple studies revealed physical changes in 
the brain such as wider sulci and fissures. Likewise, younger (mean age 37.5) and 
older participants (mean age 52.7) had gray matter volume deficits with the older 
group showing more severe deficits in the prefrontal area through use of CT and MRI 
scans (Moselhy et al., 2001). Moselhy et al., (2001) referenced eighteen studies with 
regard to detailed testing across cultures revealing deficits in cognitive flexibility, 
problem solving, verbal and nonverbal abstraction, visuo-motor coordination, 
learning, conditioning and memory. Though the specifics of each study are not 
described, one study of 35 alcoholics compared to 35 nonalcoholic controls revealed 
significant differences on the Trail Making test and the Halstead Battery (Moselhy et 
al., 2001). Within this study, the alcoholics were found to be indistinguishable from 
the non-alcoholics in terms of I Q (Moselhy et al., 2001). Moselhy et al’s., literature 
review (2001) also summarized multiple studies which reported that  when several 
third variables such as anxiety, depression, head injury and family history of 
alcoholism are controlled for, deficits in neuropsychological measures can still be 
found. For example, in one of the studies reviewed, 27 alcoholic participants that had 
a first degree relative with alcoholism were compared to 21 alcoholic participants 
without a first degree relative with alcoholism (Moselhy et al., 2001). No differences 
were found between the two groups suggesting that a family history of alcoholism 
does not appear to impact the effects of alcoholism on the frontal lobe (Moselhy et 
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al., 2001). Overall, Moselhy et al’s extensive literature review provides support for 
the relationship between alcohol use disorders and frontal lobe impairment (Moselhy 
et al., 2001). 
In an attempt to control for confounding variables in the performance of 
participants with an alcohol use disorder, Sher, Martin, Wood and Rutledge (1997) 
used a MANCOVA to control for family history, anxiety, depression, conduct 
disorder, and loss of consciousness. Factor analysis of 17 neuropsychological tests 
was performed on 489 undergraduates, half of whom had a history of alcoholism in 
their biological fathers (Sher et al., 1997). Of the 489 participants, 88 were diagnosed 
with alcohol abuse and 31 with alcohol dependence (Sher et al., 1997). Confounding 
variables were diagnosed using the Diagnostic Interview Schedule III to diagnose 
conduct disorder and the Brief Symptom Inventory for diagnosis of depression and 
anxiety (Sher et al., 1997). Family history was assessed through the Short Michigan 
Alcoholism Screening Test (SMAST) and loss of consciousness was assessed with 
simple questioning (Sher et al., 1997). This is an interesting study as it was performed 
on undergraduate students instead of a clinical sample like many other studies. One 
might presume that this non-clinical study might not have the same pattern of deficits 
as a clinical population. In addition, the individuals with the alcohol use disorders 
were drawn from the same population as the controls (first year undergraduates at the 
same institution). The findings from this study indicate that alcohol use disorders are 
associated with poorer visual spatial ability and reduced motor speed (Sher et al., 
1997). These results essentially mirror results derived from studies of clinical samples 
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(Sher et al., 1997). When all confounds were controlled for through the use of a 
MANCOVA, statistically significant differences were still found (Sher et al., 1997).  
Effects of Drug Use on Frontal Lobe and Executive Functioning 
      The effects on the frontal lobe are not only applicable to patients with an 
alcohol abuse or dependence diagnosis. Similar results have been found with drug 
abusing and dependent patients (Roselli et al., 2001). Forty-two adult (28 male, 14 
female) cocaine abusers from a state rehabilitation facility were administered a 
neuropsychological test battery including the arithmetic and digit subtests from the 
WAIS-R, California Verbal Learning Test (CVLT), Trail making Test (TMT), Rey 
Osterrieth Complex Figure (ROCF), WCST, Benton Visual Retention Test (BVRT), 
Stroop Neurological Screening Test (SNST) and Hooper Visual Organization (Roselli 
et al., 2001). A control group of 11 females and 6 males with no history of alcohol or 
drug abuse and no psychiatric or neurological disorders was recruited from student 
advertisements (Roselli et al., 2001). The control group was given all of the same 
assessments as the drug dependent group. A MANOVA was performed and 
statistically significant differences between the drug abusing patient and the controls 
for the tests used were found on several of the executive function tests (Roselli et al., 
2001). The most abnormal scores were observed in attention, memory and the 
executive functions which could impair participation and retention in treatment 
(Rosselli et al., 2001). Specifically, statistically significant differences were observed 
in the WAIS-R arithmetic (F = 16.92, p = .001) and digit subtest (F = 13.52, p = .001, 
CVLT (F = 3.73, p = .05), TMT Form B (F = 10.28, p = .002), ROCF (F = 5.75, p = 
.02), WCST errors (F = 7.82, p = .007), WCST number of categories (F = 5.20, p = 
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.026), BVRT (F = 16.49, p = .001) and SNST (F = 4.09, p = .04; Roselli et al., 2001). 
Rosenberg, Grigsby, Dreisbach, Busenbark & Grisby (2002) have found similar 
results to Roselli et al., using similar assessment tools with solvent abusers. Fifty five 
solvent abusers (43 males, 12 females) and 61 users (49 males, 12 females) of other 
drugs, especially cocaine and alcohol,  were given a battery of neuropsychological 
tests including the Wechsler Memory Scale-Revised, Trail Making Test, Digit 
Cancellation Test, Stroop test, Boston Naming Test, WCST and Behavioral 
Dyscontrol Scale (Rosenberg et al., 2002). All participants performed poorly, scoring 
below the mean on most neuropsychological measures (Rosenberg et al., 2002). 
Solvent abusers performed even more poorly on executive functions than the others 
(Pillai’s Trace = 0.239, p < .001; Rosenberg et al., 2002). 
      Several neuroimaging techniques have also been used to evaluate the effect of 
substance abuse and dependence disorders on the brain. For example, computerized 
tomography has been used to confirm cortical shrinkage and ventricular dilatation 
among alcoholic samples (Ron, Acker, Shaw & Lishman, 1982). In addition, 
magnetic resonance imaging (MRI) studies have shown abnormalities among inhalant 
abusers, cocaine abusers and alcoholics (London, Ernst, Grant, Sonson, & Weistein, 
2000; Moselhy et al., 2001; Rosenberg et al., 2002). Functional MRI’s (fMRI) have 
also been used to support the impact on the frontocerebellar regions in chronic 
alcoholics (Sullivan et al., 2003). Likewise, positron emission tomography (PET) 
studies have also found abnormalities (Moselhy et al., 2001). Decreased frontal lobe 
glucose utilization and reduced cerebral blood flow suggest frontal lobe dysfunction 
(Moselhy et al., 2001). Others also found decreased metabolism of glucose and 
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reduced cerebral blood flow in the frontal lobes of individuals with alcohol use 
disorders which may be part of the cause of impaired executive functions (Bates et 
al., 2002). PET and fluorodeoxyglucose studies have also been used to confirm that 
specific neuropsychological tests do activate the dorsolateral prefrontal cortex 
including the Tower of London test (Moselhy et al., 2001). Likewise, the previously 
mentioned executive functions of volition, planning, purposive action and effective 
performance can be traced to the frontal lobe (Adams et al., 1995; Dagher, Owen, 
Boecker & Brooks, 1999). As these functions are related to the frontal lobe and the 
frontal lobe is found to be affected by substance use, the relationship between 
impaired executive function and substance dependence is strengthened. 
Summary 
      Overall, research has indicated that we can conclude that alcohol and drug use 
are associated with physical changes in the brains of users, including reduced size and 
blood flow in the frontal lobe (Bates et al., 2002; Ron et al., 1982; Sullivan, et al., 
2003). Likewise, studies have indicated that individuals who use alcohol and drugs 
have lowered functioning on a variety of tasks than do their non-abusing counterparts 
including deficits in digit cancellation, digit symbol, trail making, reaction test, 
WCST (Roselli et al., 2001), reduced verbal fluency, impaired Stroop performance 
(Dao-Castellana et al., 1998) visuo-spatial ability and balance (Sullivan et al., 2002), 
cognitive flexibility, problem solving, verbal and non-verbal abstraction, visuo-motor 
coordination, learning (Moselhy et al., 2001) and overall executive functions, 
attention and memory (Roselli et al., 2001; Rosenberg et al., 2002; Sullivan et al., 
2002). Additionally, there is some discrepancy in the research regarding the influence 
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of other factors, such as depression and anxiety on the cognitive functioning in 
alcoholic patients, and so we are, at present, uncertain if and how these other factors 
may affect functioning (Penick et al., 1994; Moselhy et al, 2001; Uekermann et al., 
2002). However, we do know that the frontal lobe is the area of the brain responsible 
for executive functions as we have assessments that can measure cognitive 
functioning and we also have proven imaging techniques that validate that specific 
neuropsychological tests do indeed examine frontal lobe functioning (Adams et al., 
1995; Dagher et al., 1999; Moselhy et al., 2001; Ratti et al., 2002; Roselli et al., 2001; 
Sullivan, et al., 2003). Therefore, within this study, I was able to evaluate the 
executive functioning of participants which may be impaired due to their substance 
dependence and may impact their ability to remain in treatment. 
Neuropsychological Functioning and Dual Diagnosis 
 It is quite possible that any relationship between substance use and 
neuropsychological deficit can be attributed to third variable confounds related to co-
occurring mental health disorders (Sher et al., 1997). Therefore, the relationship of 
substance use, cognitive/neuropsychological impairment and disorders such as 
depression, anxiety, personality disorders and thought disorders including 
schizophrenia will be reviewed.     
Mood Disorders 
 Carpenter and Hittner (1997) evaluated the effects of substance use history 
and depressive symptoms on the cognitive functioning of 149 male and 72 female 
dually diagnosed patients with alcohol abuse or dependence, cocaine abuse or 
dependence and comorbid DSM-III-R affective disorder (Carpenter & Hittner, 1997). 
  60 
 
All participants were administered the Beck Depression Inventory (BDI), the Shipley 
Institute of Living Scale (SILS) and the Screening Test for the Luria Nebraska 
Neuropsychological Battery (ST-LNNB; Carpenter & Hittner, 1997). Results of a 
logistic regression analyses using the traditional Shipley abstract indicated a 
significant effect for previous months alcohol use on probability of impaired 
classification based on the SILS reasoning performance (Z = 2.01; Carpenter & 
Hittner, 1997). A marginally significant (statistically) effect for life time alcohol use 
also emerged indicating that individuals with 5-10 years of regular drinking 
experience were 2.3 times more likely to be classified as impaired that those with less 
than 5 years regular consumption (Z = 1.93, p = .05; Carpenter & Hittner, 1997). No 
statistically significant parameter estimates were demonstrated for cocaine use, 
depressive symptoms, intravenous (IV) drug use or life time substance use (Carpenter 
& Hittner, 1997). Results of the logistic regression analyses using the modified 
Shipley (possible borderline cases omitted) indicated statistically significant effects 
for life time alcohol use (Z = 2.64) and total number of months of life time substance 
use other than alcohol and cocaine (Z = 2.23; Carpenter & Hittner, 1997). No 
statistically significant effects were found for 10 plus years of alcohol use, previous 
month’s alcohol use, cocaine use or depressive symptoms (Carpenter & Hittner, 
1997). Logistic regression analyses for the ST-LNNB demonstrated statistically 
significant effects for education (Z = -2.14) and life time cocaine use (Z = 2.41; 
Carpenter & Hittner, 1997). The effect for life time cocaine use remained even after 
controlling for age, education, depressive symptoms, other substance use, IV drug 
history and previous months use (Carpenter & Hittner, 1997). Overall, the authors 
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found “no statistically significant effects for age, previous month’s cocaine use, 
depressive symptoms or any of the interaction terms” (Carpenter & Hittner, 1997, p. 
752). Carpenter and Hittner (1997) do acknowledge the weaknesses of their study 
such as the fact that they are evaluating an inpatient population from a private 
psychiatric facility which may have resulted in higher functioning sample relative to 
other studies with other facilities. Likewise, Carpenter and Hittner (1997) did not 
assess for previous neurocognitive injuries, premorbid conditions (such as learning 
disabilities) or concurrent health conditions which could affect cognitive functioning 
such as HIV status.  Furthermore, they acknowledged that they did not evaluate Axis 
II diagnoses which may have provided additional information (Carpenter & Hittner, 
1997). 
 Likewise, Uekermann, Daum, Schlebusch, Wiebel and Trenckmann (2003) 
studied 30 patients suffering from alcoholism, 28 patients with depression but without 
alcoholism and 28 healthy controls. After performing an ANOVA, no statistically 
significant difference between depressed and alcoholic groups was found for short 
term memory (p > 0.27), visual memory (p > 0.13), verbal memory (p > 0.15) and 
verbal fluency (p > 0.39; Uekermann et al., 2003). However, the results did show that 
patients with primary depression and alcoholism are impaired with respect to 
executive functions and memory (Uekermann et al., 2003). The lack of difference 
found between depressed and nondepressed alcoholics suggests that the results are 
not distorted by the depressive symptoms (Uekermann et al., 2003). The use of the 
control group in this study provides interesting information in that we notice that both 
alcoholism and depression do indeed have an impact on executive functions vs. 
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healthy controls. However, Uekermann et al., (2003) acknowledge that 27% to 69% 
of all alcoholics have elevated depression scores and 15% to 28% suffer from major 
depression. Therefore, the mood disorders are still important variables to consider.  
  Others have also reported that mood disorders do appear to have a negative 
impact on neuropsychological functioning in clients with a substance use disorder 
(Bates et al., 2002; Blume, Davis & Schmaling, 1999; Fals-Stewart & Bates, 2003). 
Blume, Davis and Schmaling (1999) studied a sample of 22 psychiatric inpatients all 
with a substance abuse or dependence diagnosis and 14 diagnosed with depression, 3 
with schizoaffective disorder, 1 with paranoid schizophrenia and 4 with bipolar 
disorder (Blume et al., 1999). These authors did find that the full scale IQ scores of 
participants were at the low end of normal and that the general memory index of the 
Wechsler Memory Scale-Revised was one standard deviation below the mean (Blume 
et al., 1999). With these results, the authors stated that dually diagnosed patients 
would benefit from a thorough neuropsychological assessment (Blume et al., 1999). 
However, there was no distinction made between dually diagnosed and non-dually 
diagnosed patients. Therefore, it is unclear if the results of the Blume et al. (1999) 
study are attributable to the substance use diagnosis or the co-occurring mental health 
disorder.  Likewise, the type of the co-occurring disorder is not distinguished. 
Therefore, we can not evaluate any possible differences between depression, 
schizoaffective, schizophrenia and/or bipolar disorder from the Blume et al. (1999) 
study. 
Anxiety 
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 Anxiety, often times along with depression, has been shown to be related to 
neuropsychological test performance (Bates et al., 2002; Fals-Stewart & Bates, 2003;  
Glenn, Errico, Parsons, King & Nixon, 1993). For example, Glenn, Errico, Parsons, 
King & Nixon (1993) reported that neuropsychological test performance was 
moderately related to anxiety and depression in alcoholic samples but that these 
affective states did not fully explain their performance deficits. In a sample of 83 
male and 48 female alcoholics and 47 male and 36 female non alcoholic controls, a 
factor analysis revealed three factors including Antisocial Behaviors, Affective 
symptoms and Childhood Behavioral Disorders (Glenn et al., 1993). In regards to 
these factors, alcoholics and controls were clearly differentiated with no major 
difference between genders (multivariate main effect for group, alcoholic > controls, 
F(3, 184) = 44.01, p < 0.0001; Glenn et al., 1993). A multivariate analysis was then 
conducted using five neuropsychological factors as dependent variables and group, 
group times gender, and gender as independent variables. The main effect for group 
was again significant with alcoholics scoring lower than controls, F (5,193) = 8.40,  p 
< 0.0001, with no significant group times gender interaction (Glenn et al., 1993). A 
significant main effect for gender was also found with females receiving higher 
scores than males on three factors, F(5, 193) = 6.42,  p < 0.001 (Glenn et al., 1993). 
In the Glenn et al (1993) study, the best predictor of neuropsychological performance 
was Childhood Behavioral Disorders. . Secondly, the Affective symptoms were 
significant predictors of set shifting flexibility and verbal memory (Glenn et al., 
1993). The Antisocial Behaviors were not a significant predictor of 
neuropsychological function in alcoholics or controls (Glenn et al., 1993). The sample 
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size and use of a control group are definite strengths of the Glenn et al. (1993) study. 
Likewise, Glenn et al. (1993) perform multiple statistical comparisons to allow for 
evaluation of gender, alcoholic vs. nonalcoholic, multiple personality variables, mood 
variables and others. This resulted in a comprehensive evaluation of variables related 
to neuropsychological function, substance abuse and dual diagnosis.   
Personality Disorders 
 Personality disorders in general and antisocial personality disorder 
specifically, are acknowledged by many to have an impact on neuropsychological 
functioning as well as treatment attrition (Fals-Stewart & Lucente, 1994; Kokkevi, 
Stefanis, Anastasopoulou & Kostogianni, 1998; Roselli et al., 2001). For example, 
Roselli, Ardila, Lubomski, Murray and King (2001) studied a sample of 42 crack 
and/or cocaine dependent men and women. A control group of 17 subjects with no 
history of substance abuse or any psychiatric or neurological disorder was also used 
in the study (Roselli et al., 2001) The Personality Assessment Inventory (PAI) was 
given to all to establish an Axis II diagnosis and a neuropsychological test battery was 
given to all to establish any neuropsychological deficits (Roselli et al., 2001). A 
MANOVA was used to compare the PAI and neuropsychological test scores of the 
drug dependent subjects to the controls (Roselli et al., 2001). Statistically significant 
differences were found on the PAI between the drug dependent and controls (p > 
0.0001) indicating that there is a positive relationship between personality and drug 
dependence (Roselli et al., 2001). This is not an indication that personality is 
predicting NP function, but rather an indication of the relationship between 
personality and drug dependence. Specifically, 88% of the drug dependent subjects 
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obtained an abnormal PAI score (Roselli et al., 2001). Multiple regression analyses 
were then conducted, with all participants using the neuropsychological test scores as 
the dependent variable and PAI scores as the independent variable (Roselli et al., 
2001). The PAI score associated with drug use (DRG) did predict the score on the 
WAIS-R arithmetic subtest (p = 0.01), California Verbal Learning Test (p = 0.007), 
Stroop color word test (p = 0.004) and Benton Visual Retention Test (p = 0.017; 
Roselli et al., 2001). In addition, the PAI score associated with antisocial personality 
(ANT) predicted the Stroop color word test (p = 0.03) but no others (Roselli et al., 
2001). The authors therefore concluded that personality does not predict 
neuropsychological performance, but that there is a relationship between personality 
and drug dependence (Roselli et al., 2001).  
 Fals-Stewart and Lucente (1994) administered a battery of 
neuropsychological tests including the Category Test, the Tactual Performance test, 
Trails B, Block Design and Digit Symbol tests from the Wechsler Adult Intelligence 
Scale (WAIS) to 246 residents of a long term residential substance abuse treatment 
facility (Fals-Stewart & Lucente, 1994). In addition, personality was evaluated with 
the Millon Clinical Multiaxial Inventory (MCMI-II; Fals-Stewart & Lucente, 1994). 
Using a cutoff score of T < 40 on the neuropsychological test battery to indicate 
dysfunction, 55 (22.4%) of the residents were classified as cognitively impaired. Fals-
Stewart and Lucente (1994) found that patients with cognitive deficits generally 
scored higher on the MCMI-II than those without impairment (p < 0.05). Likewise, 
Fals-Stewart and Lucente (1994) found that the cognitively intact group stayed in 
treatment longer (M = 206.2 days) versus cognitively impaired (M = 132.4 days). The 
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authors did conduct further statistical analysis to evaluate the effect of the MCMI-II 
scores on the length of stay as well and concluded that personality and neurocognitive 
impairment do affect length of stay in substance abusing patients (Fals-Stewart & 
Lucente, 1994). However, Fals-Stewart and Lucente (1994) did not use a control 
group that had only cognitive impairment and only personality disorders co-occurring 
with the substance use disorder. Therefore, we can see that the cognitive impairment 
is related to the personality disorder, but we can not be sure if the cognitive 
impairment or the personality disorder affected length of treatment.   
Schizophrenia 
 There are relatively few studies published that evaluate the cognitive status of 
dually diagnosed people, and even fewer that compare the neurocognitive 
characteristics of dually diagnosed to non-substance-abusing patients with 
schizophrenia (Herman, 2004). Part of the difficulty is due to the impaired reality 
orientation and therefore invalid or unreliable self report data with regards to 
substance use and current functioning (National Institute on Drug Abuse, 1997). 
However difficult, Herman (2004) studied 46 dually diagnosed (schizophrenia and 
substance abuse) and 43 non-substance abusing patients with schizophrenia. The 
subjects were given subtests of the WAIS III to assess intellectual and memory 
function, and the Stroop, Controlled Oral Word Association (COWAT) and Trails A 
& B to assess executive function (Herman, 2004). In addition, quality of life was 
evaluated using the World Health Organization Quality of Life measure (Herman, 
2004). A stepwise multiple regression was used and showed no statistically 
significant difference between the dually diagnosed group and the non substance 
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abusing schizophrenic group on the tests of intelligence and memory (Herman, 2004). 
However, the dually diagnosed group did perform significantly better on tests of 
executive function including the COWAT (p < 0.01), Trails A (p < 0.00025), Trails B 
(p < 0.01) and Stroop (p < 0.05; Herman, 2004). Therefore, Herman’s study (2004) 
failed to show that dually diagnosed patients will have greater neurocognitive deficit 
than non-abusing patients with schizophrenia. 
Herman’s study (2004) could have been even more interesting had he used a 
third group of only substance abusing patients to give the reader another comparison. 
Similar results to Herman’s (2004) have been found by other researchers as well (see 
Cleghorn, Kaplan, Szechtman , Szechtman , Brown, Franco, 1991; Nixon, Hallford, 
Tivis, 1996) However, opposite results have also been found. For example, Sevy, 
Kay, Opler and van Praag (1990) divided 51 schizophrenic inpatients into two groups 
including those with a cocaine use history and those without. Sevy et al. (1990) found 
that the dually diagnosed patients were found to be more depressed, less socialized, 
and performed worse on conceptual encoding and verbal memory (Sevy, Kay, Opler 
& van Praag, 1990). 
In general, schizophrenic patients are found to have deficits in cognitive 
functions such as information processing and abstract planning (U.S. Department of 
Health and Human Services, 1999). Likewise, they are reported to have executive 
function deficits in areas including planning and regulating, goal directed behavior, 
cognitive flexibility and attention (U.S. Department of Health and Human Services, 
1999). More specifically, some believe that schizophrenia is a disorder of the 
prefrontal lobe which would therefore have an impact upon executive function 
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(Rains, Sauer & Kant, retrieved September 18, 2005; US Department of Health and 
Human Services, 1999). Given this information, we will need to be cautious in 
evaluating any participant who has been diagnosed with schizophrenia due to the 
intervening impact the schizophrenia could have on the neuropsychological test 
results.  
Summary 
 Overall, research has suggested the use of caution when evaluating 
neuropsychological functioning in substance dependent patients. Evidence suggests 
that disorders such as depression, anxiety, personality disorders and schizophrenia 
can co-occur with a substance dependence diagnosis and are also possibly related to 
neuropsychological functioning (Blume et al., 1999; Kokkevi et al., 1998; Roselli et 
al., 2001; Uekermann et al., 1997; U.S. Department of Health and Human Services, 
1999). Finally, these co-occurring disorders may also have an impact on treatment 
attrition and retention (Fals-Stewart & Lucente, 1994).  
 
Neuropsychological Functioning and Attrition  
     Of all areas of literature that were researched for this study, the reports on the  
relationship of neuropsychological functioning and attrition was the sparsest. As the 
field of neuropsychology is still somewhat new and growing, it seems timely for 
increased research related to neuropsychology and the impact on attrition rates. More 
specifically, there has been advancing technology in the field of neuropsychology and 
a lack of information available on the impact neuropsychological functioning has on 
attrition.  
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  Search terms used included “neuropsychology, neuropsychological 
functioning and dysfunction, neurocognitive function, executive function, executive 
dysfunction, cognitive functioning, cognitive deficits, frontal lobe, frontal lobe 
impairment, brain, brain impairment, dysexecutive syndrome, dropout rates, attrition, 
mortality, treatment retention, treatment completion, treatment attendance, treatment 
outcome, outpatient, substance abuse services, recovery, rehabilitation” and multiple 
combinations of all of these. I utilized Marquette University’s search engines, 
assistance from Marquette Library staff, a paid literature search by the Medical 
College of Wisconsin and all internet offerings such as Google. In addition, I 
obtained suggestions and direction from practicing neuropsychologists and 
researchers including Dr. Gina Rehkemper of Waukesha Memorial Hospital’s 
Neuropsychology Center, Dr. Terry Young of New Life Resources,  Dr. Todd 
Campbell of Marquette University, Dr. Swartzwelder of Duke University Medical 
Center, Dr. Steve Holliday-Chief of Psychological Services at South Texas Veterans 
Hospital, Dr. Joe Bleiberg of the National Rehabilitation Hospital in Washington, 
DC, and Dr. Lisa Drozdick, a neuropsychology researcher at Psych Corp. Through all 
of these efforts, the findings that actually related to neuropsychological functioning 
and attrition in outpatient treatment were limited. Over 150 publications were 
evaluated and only one (thus far) has specifically reviewed neuropsychological 
functioning and attrition rates in substance use treatment. Fals-Stewart and Lucente 
(1994) studied neuropsychological impairment along with personality variables and 
attrition as described in the previous section on neuropsychological function and dual 
diagnosis (Fals-Stewart & Lucente, 1994). However, even this one publication by 
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Fals-Stewart and Lucente was not purely addressing neuropsychological impairment 
with attrition. Therefore, I will present a brief overview of my current findings and 
will continue to research these issues as I pursue this project. 
      Researchers studying executive functions and attrition have suggested that 
executive function deficits might contribute to rates of attrition (Ihara, Berrios & 
London, 2000). Seventeen adults with chronic alcoholism, without amnesia, were 
given a battery of neuropsychological tests to assess executive function (Ihara et al., 
2000). The results of the Ihara et al. (2000) study showed that the participants 
displayed mild but significant dysexecutive syndrome (DES; meaning a syndrome of 
impaired executive functioning) even in the presence of unimpaired intelligence and 
memory. The results of the Ihara et al (2000) study suggest that alcoholic patients 
have difficulty when demonstrating abstract analysis, critical judgment and flexibility 
of thought processes. Therefore, the alcoholic patient’s ability to respond and 
participate effectively in conventional substance abuse programs may be limited 
(Ihara et al., 2000). However, Ihara et al. (2000) did not formally evaluate attrition, it 
is only suggested that the impairment would likely affect engagement and success in 
treatment. The suggestion of possible impact on attrition versus the actual evaluation 
of impact is common in many studies but not empirically investigated (Fals-Stewart 
& Bates, 2003; Moselhy et al., 2001; Sullivan et al., 2002). Bates, Bowden and Barry 
(2002) stated that “neurocognitive impairment interferes with the process of 
alcoholism treatment and is hypothesized to affect outcome as well” (Bates et al., 
2002, p. 193). The authors go on to discuss that clients with executive function 
deficits may have trouble getting to appointments, fail to complete assignments, 
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behave impulsively and have trouble regulating affect (Bates et al., 2002). Likewise, 
others have shown that patients with neurocognitive deficits (including spatial ability, 
mental flexibility, concept formation and nonverbal problem solving) in conjunction 
with personality disorders stayed in a substance abuse program a shorter amount of 
time (Fals-Stewart & Lucente, 1994). 
 Fals-Stewart and Lucente (1994) administered a battery of 
neuropsychological tests including the Category Test, the Tactual Performance test, 
Trails B, Block Design and Digit Symbol tests from the Wechsler Adult Intelligence 
Scale (WAIS) to 246 patients admitted to a long term residential substance abuse 
treatment facility. In addition, personality was evaluated with the Millon Clinical 
Multiaxial Inventory (MCMI-II).  The neuropsychological tests and the MCMI-II 
were not administered until 30 days after admission to ensure that residual effects 
from the substance abuse would not adversely affect performance (Fals-Stewart & 
Lucente, 1994). Patients who were admitted and stayed less than a month were not 
included in the study (Fals-Stewart & Lucente, 1994). There is no way of knowing if 
neuropsychological impairment affected the early drop out of those who did not stay 
past 30 days. Fals-Stewart and Lucente (1994) found that patients with cognitive 
deficits have different personality characteristics, as measured by the MCMI-II, and 
both of these factors influenced the length of stay.  Specifically, the cognitively intact 
group stayed in residential treatment longer (M = 206.2 days and SD = 30.5) than 
impaired residents (M = 132.4 days and SD = 39.6) which was found to be a 
significant difference in length of stay, F(1,242) = 6.83, p < .01 (Fals-Stewart & 
Lucente, 1994). However, the cognitively impaired group was significantly older (M 
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= 31 years and SD = 6.6) than the cognitively intact group (M = 26.3 years and SD = 
5.1), t(246) = 2.39, p < .01 (Fals-Stewart & Lucente, 1994). The patients in the 
impaired group also had longer substance abuse histories (M = 134.8 months and SD 
= 67.3) than the intact patients (M = 99.6 months and SD = 55.6), t(246) = 2.41, p < 
.01. Finally, using Wilk’s criterion, the impaired and intact group had profiles on the 
MCMI-II that were statistically significantly different, F(19,226) = 2.10, p < .01 
(Fals-Stewart & Lucente, 1994). The impaired residents generally scored higher on 
the MCMI-II subscales than those without impairment, F(1,242) = 5.01, p < .05 
(Fals-Stewart & Lucente, 1994). Fals-Stewart and Lucente (1994) controlled for age, 
length of drug use and MCMI-II scale scores through statistical means to conclude 
that the cognitive deficits indeed affected the length of treatment. However, one 
cannot be completely confident that variables are actually ‘controlled for’ without 
affecting other variables (Loftin & Madison, 1991; Thompson, 1992). Therefore, it is 
not clear if the neurocognitive deficits, the personality disorders, length of substance 
use or the combination are responsible for the impact on attrition in this study. In 
addition, Fals-Stewart and Lucente (1994) also acknowledge weaknesses in their 
study as the neuropsychological battery they chose was used only for screening and 
not to identify client strengths and weaknesses.  
      Multiple studies were reviewed evaluating neuropsychological functioning 
and substance abuse treatment and outcomes by Knight and Longmore (1994). The 
authors reviewed findings related to length of abstinence, compliance and relapse 
rates (Knight & Longmore, 1994). Similarly, cognitive function was compared to 
amount and length of alcohol usage. Many important factors to consider when 
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treating a patient with neuropsychological impairment are considered including 
methods of education, staff response and specific testing techniques (Knight and 
Longmore, 1994). For example, with specific neuropsychological tests, a patient’s 
strengths and weaknesses can be assessed. Clinicians can be trained on identification 
of deficits and more effective treatment options including repetition, concrete 
examples and assisting the client with planning and organizing (Knight & Longmore, 
1994). However, the specific relationship between level of neuropsychological 
impairment and attrition are not formally defined in this publication.  
      Other authors evaluated executive dysfunction and compared this to 
functional outcomes including resumption of drinking and occupational status 
(Moriyama et al., 2002). Moriyama et al. (2002) administered twelve 
neuropsychological tests to 22 chronic, male alcoholics. These authors found that six 
of the subtests of the Behavioral Assessment of Dysexecutive Syndrome (BADS) did 
predict an alcohol-nonspecific outcome (occupation) but not an alcohol-specific 
outcome (drinking; Moriyama et al., 2002). Other neuropsychological tests used did 
not predict either of the two outcomes (Moriyama et al., 2002). One reason given for 
the different performance of the neuropsychological tests was that the discriminative 
power of the BADS versus the other tests was due to its multicomponent impairment 
indices (Moriyama et al., 2002). However, once again, the relationship between 
neuropsychological impairment and length of treatment involvement was not 
evaluated.  
      In a more recent study, Zinn, Stein and Swartzwelder (2004) examined 
neuropsychological functioning in older, male alcoholics. The participants were 27 
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male, alcohol dependent veterans receiving treatment at the Durham Veterans Affairs 
Medical Center.  All participants met diagnostic criteria for alcohol dependence 
according to the DSM-IV and were abstinent six weeks or less (Zinn et al., 2004). 
Control participants (n = 18) were recruited from the Primary Care Clinic of the 
Durham Veterans Affairs Medical Center (Zinn et al., 2004). The alcohol dependent 
and control group were not significantly different in age or education. However, the 
alcohol dependent group had a higher proportion of African Americans (Zinn et al., 
2004). All participants were administered a fixed-order neuropsychological battery of 
seven tests including the COWAT (verbal fluency), Ruff Figural Fluency Test (non-
verbal fluency), ASI, Rey Osterrieth Complex Figure Test (nonverbal memory), 
Hopkins Verbal Learning Test (verbal memory), two subtests of the WAIS-II for 
abstract reasoning (similarities and matrix reasoning) and Trails Making Test (Trails 
A for psychomotor speed and Trails B for cognitive flexibility; Zinn et al., 2004). 
Zinn et al. (2004) found several deficits in executive functioning in treatment seeking, 
recently abstinent patients. These deficits included reasoning (similarities, p = .05 and 
matrix reasoning, p = .04), nonverbal fluency (p = .002), performance of timed 
complex tasks (Trails A, p = .01 and Trails B, p = .003) and discriminative memory 
(Rey Osterrieth delayed recall, p = .03; Zinn et al., 2004). 
Strengths of this study by Zinn et al. (2004) include the use of a control group 
of similar age to control for the relationship between age and executive function 
decline and the fact that the authors tested premorbid functioning with an estimated 
performance IQ. However, the difference in racial characteristics of the alcohol 
dependent versus control group is mentioned but not addressed which may have 
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provided interesting information or differences in results. In addition, Zinn et al. 
(2004) chose to include individuals with a history of non-severe head injuries (33% of 
controls and 52% of substance abuse patients) to reflect this reality in the greater 
population of individuals with a substance abuse issue. However, it is unclear what 
Zinn et al. (2004) considered ‘non-severe’ or how the results of the study can be 
linked to substance use versus the head injury. Finally, the authors acknowledged that 
neuropsychological impairment may affect attrition and treatment success but they do 
not formally evaluate retention and/or attrition (Zinn et al., 2004). I also had the 
pleasure of personal communication with Dr. Swartzwelder (of the Zinn, Stein & 
Swartzwelder, 2004) who acknowledged that he did not specifically know of any 
research that reviewed neuropsychological functioning and attrition rates (Personal 
communication, 10-5-2004). However, Dr. Swartzwelder did suggest other 
publications that were reviewed within this paper. Likewise, studies were found 
which evaluated length and/or amount of alcohol consumed and severity of 
neuropsychological deficits, but again the relationship between severity of the deficit 
and attrition was not evaluated, only speculated (Beatty et al., 2000; Munro, Saxton & 
Butters, 2000).  
      Part of the difficulty in evaluating or addressing neuropsychological function 
and attrition rates in outpatient might be the treatment provider’s lack of insight or 
knowledge. Fals-Stewart (1997) evaluated counselor’s ability to detect 
neuropsychological impairment among patients. The author found the counselor’s 
ability to detect impairment was poor (Fals Stewart, 1997). Fals-Stewart (1997) offers 
several suggestions for improvement including use of specific neuropsychological 
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evaluation tools upon entry into treatment, emphasizing the importance of 
incorporating the patient’s neuropsychological status into treatment planning, 
development of referral guidelines for neuropsychological testing, supervision by a 
trained neuropsychologist and development of more valid and reliable methods of 
identifying patients at risk for deficits. Likewise, the author mentioned that this is an 
important variable with treatment planning and success, but again does not formally 
evaluate the link between neuropsychological deficit and attrition (Fals-Stewart, 
1997).  
Others also agree that the neurocognitive deficits often go unrecognized in 
people with a substance use disorder when they seek treatment (Bates et al., 2002). 
What the clinician identifies as lack of motivation, apathy or noncompliance may all 
be a result of a neurocognitive deficit. Similarly, few treatment programs for 
substance use disorders consider the role of neurocognitive impairment (Bates et al., 
2002) again supporting the stigma often associated with a person with a substance use 
disorder. The counselor’s lack of success or lack of attempt at identifying 
neuropsychological deficits, as well as the resulting misperceptions by the clinician 
again provides reasoning for this current study.  
      Overall, there is support for the negative impact substance abuse has on 
neuropsychological functioning (Bates et al., 2002; Fals-Stewart & Lucente, 1997; 
Zinn et al., 2004). Likewise, there is support for the negative impact 
neuropsychological deficits have on treatment outcome variables such as relapse rates 
or occupational stability (Knight & Longmore, 1994; Moriyama et al., 2002). 
However, the issue of the specific relationship between level of neuropsychological 
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impairment and attrition rates is still left mostly unanswered. This missing link is 
what I will address with this study.  
Attrition and Retention 
      Duration of treatment is one of the best predictors of outcome for substance 
abuse treatment populations (Corrigan et al., 2005). In the United States during the 
1970s, the Drug Abuse Reporting Program (DARP) began collecting substance abuse 
data, followed by Treatment Outcome Prospective Studies (TOPS) that began 
collecting data from 1979-1981. To follow, from 1991-1993 the Drug Abuse 
Treatment Outcome Studies (DATOS) collected data in 11 cities, from 96 programs, 
over 10,000 patients from all treatment types. Together, DARP, TOPS and DATOS 
collected information from over 65,000 admissions and 272 programs. One of the 
major themes that resulted from these studies is that longer stays are consistently 
associated with better outcomes (Franey & Ashton, 2002; DATOS, 2001). For 
example, one year after treatment, 80% to 90% of long-stay (at least three months) 
clients who had been using heroin or cocaine weekly prior to treatment were no 
longer doing so (Franey & Ashton, 2002; DATOS, 2001). However, for clients who 
left earlier, the figure was 50% to 60%. Franey and Ashton (2002) reported that there 
is “nothing magical” about the retention periods they chose-longer stays were 
associated with better outcomes. However, very short stays can also be followed by 
great improvements (Franey & Ashton, 2002).  
      Though the relationship between treatment retention and outcome seems clear, 
there were differences between individual programs that DATOS (2001) studied. 
Although median lengths of stay were three months in long-term residential (LTR) 
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and outpatient drug-free treatments (ODF) and one year for clients in outpatient 
methadone treatment (OMT), there was variation between individual treatment 
providers. Though specific neuropsychological deficits are not reported, programs 
treating individuals with more psychological dysfunction usually had shorter 
retention rates (Simpson et al., 1997). Broome, Flynn and Simpson (1999) examined 
the psychiatric comorbidity as a predictor of treatment retention using the DATOS 
data. The psychiatric indicators included lifetime DSM-III-R diagnoses of 
depression/anxiety and antisocial personality (Broome et al., 1999). Dimensional 
measures of current symptoms of depression and hostility were also collected. The 
data collection included structured interviews with clients, a survey of treatment 
program administrators and program discharge records (Broome et al., 1999). 
Broome et al. (1999) found that the dimensional measure of current psychiatric 
symptoms emerged as better predictors of retention than the DSM-III-R diagnoses. In 
addition, on site mental health services in LTR were associated with better retention 
for clients with symptoms of hostility (Broome et al., 1999).  
      So what did DATOS identify as influencing retention? Interestingly enough, 
whether the client was black or white, male or female, age and drug use profile all 
made little difference according to Franey and Ashton (2002). What they did find was 
that more qualitative dimensions related to commitment and motivation were 
important for retention (Franey & Ashton, 2002). However, motivation is not a given 
in this sense. It arises from the therapeutic relationship between counselor and client 
(Franey & Ashton, 2002). In contrast, using logistic regression analysis, Simpson, Joe 
and Rowan-Szal (1997) found that 35 different patient attributes were associated with 
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increases in the likelihood of having favorable improved retention. Simpson, Joe and 
Rowan-Szal (1997) suggested that more comprehensive models of patient attributes, 
therapeutic processes and environmental influences are needed. Possibly, the patient 
attributes that need more comprehensive evaluation are neuropsychological strengths 
and weaknesses. With the DATOS studies, we do not know of the specific training 
and techniques of individual therapists. Could it be that the clinicians who were more 
successful at promoting the therapeutic relationship were also more sensitive to the 
strengths and weaknesses of the client, possibly related to neuropsychological deficit?  
  Though DATOS, TOPS and DARP did not discuss the neuropsychological 
functioning of individuals and treatment retention, the studies did emphasize that the  
“key thing is remaining in treatment” (Franey & Ashton, 2002, p. 6). In this study, we 
evaluate the impact neuropsychological functioning has on attrition to hopefully 
discover additional variables that may assist individuals in staying in treatment.  
 
 
Relapse 
 Substance abuse treatment is plagued by high relapse rates following 
substance abuse treatment (Walton, 2001). In addition, multiple researchers have 
evaluated the relationship between neuropsychological functioning and relapse in 
substance use treatment (Miller, 1991; Society for Neuroscience, 2005; Tapert, 
Ozyurt, Meyers & Brown, 2004). In the following section, multiple variables related 
to relapse, including neuropsychological functioning will be reviewed. 
Method and Intensity of Treatment, Drug Type and Relapse 
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 In the literature reviewed, relapse rates tended to be reported in conjunction 
with treatment type or type of drug use. For example, DATOS reported that in the 
year after completing at least three months of treatment (residential or non-
residential), 80-90% of weekly heroin or cocaine addicts were abstinent (Franey & 
Ashton, 2002). For the clients who left treatment earlier than three months, relapse 
rates increase with the number abstinent dropping to 50-60% (Franey & Ashton, 
2002). With primary cocaine users, only 15% relapsed to weekly cocaine use after at 
least three months of residential treatment (Franey & Ashton, 2002). Similar findings 
have been found with other substances. For example, the greatest levels of abstinence 
from opioids at one year post treatment were associated with 28 day inpatient versus 
shorter treatments (United Nations, 2002). Likewise, patients who stay for at least one 
year in outpatient methadone programs have better abstinence rates (specific numbers 
not reported) than those that leave earlier (United Nations, 2002). In general, it 
appears that more treatment and more intense levels of treatment lead to greater 
lengths of abstinence (Franey & Ashton, 2002; United Nations, 2002).  
Gender, Support, Pharmacotherapy and Relapse 
 Just as relapse is related to length and intensity of treatment, relapse is also 
related to other variables including gender, support and pharmacotherapy (Stocker, 
retrieved September 20, 2005; United Nations, 2002; World Health Organization, 
2004). For example, women have been reported to relapse less frequently than men 
(Stocker, retrieved September 20, 2005). In a study of 182 women and 148 men in 26 
public outpatient drug abuse treatment programs, only 22% of the women versus 32 
% of the men relapsed in six months (Stocker, retrieved September 20, 2005). Some 
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of the possible reasons explored included the intensity of the women’s drug use prior 
to treatment and social support differences (Stocker, retrieved September 20, 2005). 
However, when evaluated, the variable that was found to explain the difference in 
relapse rates between women and men was women’s willingness to engage in 
treatment, particularly group treatment (Stocker, retrieved September 20, 2005). 
Though not found to be a determinant of relapse in Stocker’s report (retrieved 
September 20, 2005), others have identified social support as an important variable 
related to relapse in substance use treatment (United Nations, 2002). According to a 
report by the United Nations on a review of evidenced based treatment, social support 
such as Alcoholics Anonymous meetings and the level of stressful life events such as 
loss of a job might be more powerful in determining relapse than the type of 
treatment (United Nations, 2002). Likewise, the United Nations study identifies 
treatment retention as an important variable in relapse prevention (United Nations, 
2002). Specifically, the United Nations study reported that the longer patients are 
retained in treatment, the more likely lifestyle improvements such as abstinence will 
be achieved (United Nations, 2002). The United Nations study also reported on the 
relationship of pharmacotherapy, retention and relapse prevention (United Nations, 
2002). Specifically, the use of methadone, buprenorphine, levoalphacetylmethadol, 
naltrexone and acamprosate were all found to improve retention and rates of relapse 
(United Nations, 2002; World Health Organization, 2004). However, compliance 
with patients using the medications as prescribed is paramount to the success of the 
medication (United Nations, 2002). 
Neuropsychological Functioning and Relapse 
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    Another area researchers review with relation to relapse in outpatient 
substance abuse treatment is the impact of neuropsychological functioning on rates of 
relapse (Miller, 1991; Society for Neuroscience, 2005; Tapert et al., 2004; World 
Health Organization, 2004). For example, specific areas of the forebrain have been 
shown through imaging techniques to be activated by stimuli that induce cravings in 
substance dependent people which could induce a relapse (World Health 
organization, 2004). Specifically, the nucleus accumbens area of the forebrain has 
been shown to be related to intense cravings in substance dependent individuals 
(Leshner, retrieved September 20, 2005; Society for Neuroscience, 2005). Many 
neurotransmitters, which are chemical messengers in the brain, have also been studied 
with relevance to cravings and relapse (Leshner, retrieved September 20, 2005). 
Specifically, dopamine, serotonin, norepinephrine, glutamate, endogenous opioids 
and GABA are all neurotransmitters that can affect cravings and relapse (Leshner, 
retrieved September 20, 2005; World Health Organization, 2004). Chronic substance 
use can affect the way the neurotransmitters function and  the individual’s response to 
the neurotransmitters which then can impact cravings, mood, sleep, sensitivity to 
pain, aggression and memory (Leshner, retrieved September 20, 2005) which all can 
impact decision making in recovery. 
 In a review of the literature, Miller (1991) evaluates neuropsychological and 
cognitive variables with regard to predicting relapse in substance abusers (Miller, 
1991). Miller finds that neuropsychological studies of substance abuse treatment 
outcomes have generally found intact functioning on most measures for successful 
recoverers whereas relapsers did more poorly on tests of language, abstract reasoning, 
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planning and cognitive flexibility which are related to the left hemisphere and frontal 
lobe (Miller, 1991). In addition, personality characteristics of successful recoverers 
(with or without treatment) include future goal orientation, frustration tolerance and 
self efficacy, whereas the relapsers were characterized by impulsivity, antisocial 
personality and affective traits (Miller, 1991). Through Miller’s (1991) review of 
multiple studies, he concluded that neuropsychodynamic trait of ego autonomy, 
which includes a reflective, nonimpulsive, goal directed cognitive style, is what is 
described in successful recoverers.  Miller (1991) reported that many researchers 
focus on programs and treatment techniques which neglect the individual variables 
which he reports are related to predicting relapse.  Miller (1991) admitted his review 
was not a meta-analysis, but instead a review of what he believed to be substantive 
issues related to substance abuse outcome. As his review is a selected group of 
studies, the results could be biased based on the studies he chose to review and 
include. Miller (1991) concluded with a discussion of individualized treatment 
options which may be helpful for this study if we find neuropsychological functioning 
to be related to attrition and relapse.   
 In addition to Miller’s (1991) identified neuropsychodynamic trait of ego 
autonomy, another individual characteristic reported to be related to neurocognitive 
ability and relapse in substance abuse treatment is coping style (Tapert et al., 2004). 
In a study of 43 alcohol dependent male adults, individuals with low levels of coping 
in role plays of drinking situations consumed more alcohol in six months following 
treatment than did individuals with high levels of coping (Tapert et al., 2004). The 
participants were given a neuropsychological battery (including the Halstead-Reitan 
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Trails A and B, WAIS-R vocabulary and digit symbol subtest, and the Visual Search 
Test) and the Ways of Coping Questionnaire (WOC; Tapert et al., 2004). The results 
of this study support a model in which neurocognitive abilities moderated the 
relationship between coping and substance use treatment outcome (Tapert et al., 
2004). Specifically, ten coping factors and five neurocognitive scores were evaluated 
in hierarchical linear regression with age, years of education and preadmission drinks. 
With alpha set at .001, the results indicated that maladaptive coping in potential 
relapse risk situations predict subsequent drinking, particularly for patients with 
better scores on neuropsychological tests (Tapert et al., 2004). Therefore, poor coping 
was particularly detrimental for those with good cognitive skills. It is unclear from 
this study if Tapert et al. (2004) is stating that coping skills do not matter if 
neurocognitive deficits exist, or that they do not matter as much. In addition, another 
limitation of Tapert et al’s (2004) study is that the sample size is small and the 
authors seem to be drawing many conclusions off the information gathered. For 
example, the coping style evaluated seems to be a self report measure which could be 
affected due to changes in responses from cognitively impaired versus not impaired 
individuals. Likewise, Tapert et al. (2004) did not discuss any comparison between 
coping styles of the impaired and unimpaired which would have been valuable in 
assessing this study. However, the issue of coping style as a variable in potential 
relapse of people with and without neurocognitive deficits is still an important issue. 
Tapert et al. (2004) concluded with suggestions for treatment matching that could 
prove valuable for recommendations following this study of the relationship between 
neuropsychological function and attrition.  
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Summary 
 In summary, many variables have been related to relapse in substance abuse 
treatment. Some of the variables identified include type of drug use (United Nations, 
2002), gender (Stocker, retrieved September 20, 2005), support systems (United 
Nations, 2002), certain medications (United Nations, 2002; World Health 
Organization, 2004), length and intensity of treatment (Franey & Ashton, 2002; 
United Nations, 2002) and neuropsychological impairment (Miller, 1991). 
Addressing an individual’s neuropsychological impairment might improve treatment 
retention resulting in reduced incidence of relapse. This study hopes to identify the 
relationship between neuropsychological impairment and relapse and attrition rates 
resulting in suggestions for improving retention in outpatient substance use treatment.  
Homelessness 
 As previously mentioned, the majority of data for this study was collected on 
homeless male residents of the Guesthouse of Milwaukee, Inc. The assessments were 
performed on individuals receiving treatment at the 7C’s Community Counseling 
Clinic which is located within the Guesthouse and therefore serves primarily 
homeless men.  The occurrence of individuals becoming homeless at some point in 
their life has been related to substance use issues, neuropsychological deficits, mental 
illness, socioeconomic status and other variables (Booth, Sullivan, Koegel & Burnam, 
2002; National Coalition for the Homeless, retrieved January 12, 2006). Therefore, 
for the purposes of this study, the relationship of homelessness with substance use 
issues, neuropsychological functioning and attrition in substance dependence 
treatment will be reviewed.  
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Defining and Identifying Homeless Individuals 
 In order to study homelessness, one must be able to define what actually 
constitutes homelessness. This is no easy task as the status of homelessness is 
oftentimes a temporary condition instead of a permanent condition (National 
Coalition for the Homeless, retrieved January 12, 2006). Likewise, many homeless 
individuals are invisible to the researchers due to staying in a car, park or other places 
researchers cannot effectively search (National Coalition for the Homeless, retrieved 
January 12, 2006). Furthermore, the definition itself leads to controversy for 
individuals and organizations due to legal issues, funding and allocation of available 
resources (Clark & Rich, 2003; National Coalition for the Homeless, retrieved 
January 12, 2006; U.S. Department of Health and Human Services, retrieved January 
12, 2006). Overall, many individuals have an interest in defining and redefining 
homelessness from a variety of perspectives to meet individual and organizational 
needs. Therefore, when reviewing the literature on homelessness, it is important to 
remain cognizant of the difficulties in defining homelessness. 
 Though controversy has existed on the definition of what exactly constitutes 
homelessness, researchers have still collected information on the occurrence of 
homelessness. For example, in a report by the Institute for the Study of Homelessness 
and Poverty at the Weingart Center (2005), the numbers of homeless people for 56 
cities across the United States were published (Institute for the Study of 
Homelessness and Poverty, retrieved January 12, 2006). Included in the results of the 
Weingart study (2005) were statistics for Milwaukee, Wisconsin which is where the 
data was collected for this study. In 2005, the regional population in Milwaukee was 
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583,624 according to the Weingart study (Institute for the Study of Homelessness and 
Poverty, retrieved January 12, 2006). The homeless population in Milwaukee was 
reported as 2,818 which was 0.5% of the population (Institute for the Study of 
Homelessness and Poverty, retrieved January 12, 2006). The results from all of the 
cities listed included a homeless population across the cities ranging from less than 
0.1% to 1.2% (many cities had <0.1%, Orange County, Arizona had 1.2%; Institute 
for the Study of Homelessness and Poverty, retrieved January 12, 2006). Likewise, in 
2007, the Milwaukee Continuum of Care estimated that there are 1,470 homeless 
adults and children on a given day (Milwaukee Continuum of Care, 2007). The total 
reported homeless for the state of Wisconsin in 2007 was 5,648 and for the United 
States as a whole was 671,859 (National Alliance to End Homelessness, retrieved 
May 25, 2009).  
 Many reasons are reported for why so many people have episodic or chronic 
homelessness including poverty, availability of affordable housing, availability of 
health care, domestic violence, weak social support, mental illness and addiction 
disorders (National Coalition for the Homeless, 2005; SAMHSA, 2005). Though all 
of these issues are important and influential, for the purpose of this study, we are 
interested in those related to addiction and mental health. 
Substance Use and the Homeless 
 The rates of alcohol and drug abuse are disproportionately high among the 
homeless population (National Coalition for the Homeless, 2005; SAMHSA, 2005). 
According to Glasser and Bridgman (1999) alcohol abuse has been found to be as 
high as 68% among homeless men and 30% among homeless women (Glasser & 
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Bridgman, 1999). Likewise, in a study by Solliday-McRoy et al., (2004) 93% of the 
90 homeless men studied reported having a substance abuse or dependence problem 
(Solliday-McRoy et al., 2004). Likewise, in a study by Clark and Rich (2003) of 172 
adults (79 male, 73 female) that either were homeless or at immediate risk of 
becoming homeless, approximately half had a diagnosis of a substance use disorder. 
Even higher numbers are reported by Jainchill, Hawke and Yagelka (2000) who 
reported that an estimated two-thirds of the homeless are alcohol abusers and half 
abuse other drugs. In addition, Jainchill, Hawke and Yagelka (2000) reported that 
among those in shelters, almost 90% are estimated to have alcohol problems and over 
60% have problems with other drugs. The extent of the relationship between 
homelessness and substance use disorders has also been recorded by treatment 
facilities. In a report from the Drug and Alcohol Services Information System (2003), 
more than 120,000 admissions to substance abuse treatment facilities were homeless 
at the time of admission (SAMHSA, retrieved January 12, 2006). It should be 
clarified that this number (120,000 admissions) represents admissions and not 
necessarily separate homeless individuals as an individual may have been admitted on 
more than one occasion.  
 
 
Mental Illness and the Homeless 
 Although some have identified substance abuse as the primary individual 
factor related to homelessness (Jainchill et al., 2000), mental illness is also frequently 
reported among homeless individuals (Booth et al., 2002; National Coalition for the 
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Homeless, retrieved January 12, 2006; SAMHSA, 2005). According to the National 
Coalition for the Homeless in a report dated July of 2005, 20-25% of the single adult 
homeless population suffers from some form of severe and persistent mental illness 
(National Coalition for the Homeless, 2005). Likewise, in a study of 438 individuals 
referred to receive acute psychiatric care in a hospital between 1990 and 1992, 24% 
were found to be homeless (Kuno, Rothbard, Averyt & Culhane, 2000). However, 
Kuno et al. (2000) defined homelessness as anyone who had an admission to a shelter 
between 1990 and 1993, they were not necessarily homeless at the time of admission 
to the hospital. In Solliday-McRoy et al. (2004) study of 90 homeless men, 50% 
reported previous mental health diagnoses with the majority (28%) for mood 
disorders. It is important to note that these reports of mental health issues were self 
reported by the participants and not specifically investigated by Solliday-McRoy et al 
(2004).  
Neuropsychological Functioning and the Homeless 
 Though the mental health diagnosis was not specifically investigated by 
Solliday-McRoy et al. (2004), the neuropsychological functioning of homeless men 
was assessed. A neuropsychological battery consisting of the Neurobehavioral 
Cognitive Status Examination, Wechsler Abbreviated Scale of Intelligence, Digit 
Span Subtest of the WAIS, Rey Auditory Verbal Learning Test (RAVLT), Rey 
Osterrieth Complex Figure Test (RCFT) and the Letter-Word Identification and 
Passage Comprehension subtests for the Woodcock Johnson Psychoeducational 
Battery Revised was given to 90 homeless men living in the Guesthouse shelter, 
which is the same shelter where I collected the data for this study (Solliday-McRoy et 
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al., 2004). Impaired cognitive functioning as demonstrated by performance on the 
Cognistat was found in 80% of the participants with the subtest assessing memory 
showing the most frequent (64%) impairment (Solliday-McRoy et al., 2004). In 
addition, the participants scored below average on general intellectual abilities on the 
WASI with mean Verbal IQ score of 83.73 (SD 16.03), mean Performance IQ of 
87.07 (SD 14.87) and mean Full Scale IQ of 83.92 (SD 15.24; Solliday-McRoy et al., 
2004). Nearly half of the sample received scores that fell below 85 on the WASI 
indicating impaired capacities in a broad range of cognitive abilities (Solliday-McRoy 
et al., 2004). Likewise, 28% received scores of less than 85 on the digit span subtest 
suggesting attentional deficits and results from the RAVLT suggested memory and 
verbal learning deficits in more than half the sample (Solliday-McRoy et al., 2004). 
Deficits in processing speeds, visuomotor, visual-perceptual integration skills and 
visuospatial memory were indicated for nearly three quarters of the sample from 
RCFT results (Solliday-McRoy et al., 2004).  
There are many strengths to the Solliday-McRoy et al. (2004) study including 
the voluntary participation of individuals, the comprehensive instruments used, 
sample size and the use of statistical procedures to attempt to evaluate the impact and 
relationship of TBI, substance use and mental illness. In addition, the authors reported 
that all participants were asked to abstain from any alcohol or drug use for 8 hours 
prior to testing so as to not interfere with the performance during assessment 
(Solliday-McRoy et al., 2004). However, it is unclear whether participants were 
tested for any alcohol or drugs in their system at time of assessment. In addition, it is 
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unclear why Solliday-McRoy et al. (2004) used an 8 hour gap versus a longer period 
to allow participants to recover somewhat from any and all substance use.  
Results similar to Solliday-McRoy et al. (2004) were found by Gonzalez, 
Dieter, Natale and Tanner (2001). Gonzalez et al. (2001) also concluded that large 
numbers of homeless individuals are neuropsychologically impaired. Sixty homeless 
individuals were given the Abbreviated Halstead-Reitan Battery and the Mini Mental 
Status Exam (MMSE; Gonzalez et al., 2001). A high incidence of neuropsychological 
dysfunction was concluded with 80% of participants showing impairment on the 
Abbreviated Halstead-Reitan and 35% showing impairment on the MMSE (Gonzalez 
et al., 2001). One strength of this study was the authors’ use of a regression analysis 
to suggest that 29% of the variance in the two instruments used was accounted for by 
patient education (Gonzalez et al., 2001). Overall, Gonzalez et al. (2001) concluded 
that as large numbers of the homeless are neuropsychologically impaired, this should 
be considered for treatment planning.  
Other authors have found very similar results to Gonzalez et al. (2001). In a 
study of 155 homeless men and 49 homeless women, Buhrich, Hodder and Teesson 
(2000) also found cognitive impairment using the MMSE. Buhrich et al. (2000) used 
the Composite International Diagnostic Interview, which included an alcohol use 
disorder section and the MMSE to assess the 204 participants. Of the 204 
participants, 20 (10%) were found to be cognitively impaired as compared to a 
reported 1.7% that are impaired in the general adult population (Buhrich et al., 2000). 
It is unclear if Buhrich et al. (2000) assessed for current health concerns, head injuries 
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or current alcohol or drug consumption which could have affected participant’s 
performance on the assessment instruments.   
Attrition Rates for Homeless Individuals Receiving Substance Use Services 
 As previously discussed, many issues influence an individual’s homeless 
status and can be influenced by the homeless status of an individual such as poverty, 
mental illness, substance use and abuse, health status, access to health care, 
transportation, support and neuropsychological deficits (National Coalition for the 
Homeless, 2005; National Mental Health Association, retrieved January 12, 2006). 
Another variable with an interactive relationship with homelessness, which has been 
previously reviewed in this paper, is stigma (NSDUH, 2004). Individuals in need of 
treatment for a substance use disorder that are also homeless face the added stigma of 
their homeless status (National Mental Health Association, retrieved January 12, 
2006). It can be due to any or all of these issues that a homeless individual’s ability to 
complete treatment for a substance use disorder can be compromised (National 
Mental Health Association, retrieved January 12, 2006).  
As mentioned, many variables can affect the rates of attrition for homeless 
individuals receiving substance abuse services. The substance abuse treatment 
services available for homeless individuals range from outreach offers of engagement 
in a human relationship (e.g., the Park Homeless Outreach Project in New York City) 
to formalized treatment programs inside of shelters (e.g., the 7C’clinic within the 
Guesthouse in Milwaukee; National Institute on Alcohol Abuse and Alcoholism, 
retrieved January 27, 2006). Likewise, there are multiple treatment programs of 
varying intensity that are open to many populations, including homeless individuals, 
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if they meet the admission criteria (e.g., any hospital program with outpatient 
treatment, day treatment, inpatient, etc.). Attrition rates for homeless individuals 
participating in substance abuse treatment can vary on the level of intensity of the 
program they attend (National Institute on Alcohol Abuse and Alcoholism, retrieved 
January 27, 2006). As previously discussed, attrition rates in general vary due to 
length, type and intensity of drug use as well as length, type and intensity of treatment 
(Franey & Ashton, 2002; Simpson, Joe & Rowan-Szal, 1997). However, the variable 
of treatment intensity may affect the attrition rates more so in homeless individuals as 
they simply have other survival demands to attend to if they are attempting to 
participate in a traditional outpatient program or an inpatient program that they are 
not immediately admitted into. Indeed, the delay in starting treatment after initial 
assessment has been reported by some as one of the main reasons for premature exit 
from a substance abuse treatment program (Zerger, 2002).  In addition, there are 
many variables that often times are depleted or nonexistent in an individual who is 
homeless that can also affect client attrition rates including employment status, social 
support networks, positive self efficacy and feeling as if one is close to their ideal self 
(Northwest Frontier Addiction Technology Transfer Center, 2003). Specifically, 
attrition rates as high as 58% to 66% have been reported for homeless individuals in 
substance use treatment (National Institute on Alcohol Abuse and Alcoholism, 
retrieved January 27, 2006; SAMHSA, 1998) with some reporting rates as high as 
80% (Zerger, 2002). The severity of these numbers supports the need for further 
research on attrition rates from substance abuse treatment for homeless individuals.  
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Summary 
 The extent of homelessness in the United States and more specifically in 
Milwaukee, Wisconsin is a severe and chronic concern (Institute for the Study of 
Homelessness and Poverty, retrieved January 12, 2006; U.S. Department of Health 
and Human Services, retrieved January 12, 2006). Homelessness has been found to be 
related to substance use disorders (Clark & Rich, 2003; Glasser & Bridgman, 1999; 
Jainchill et al., 2000), mental illness (Booth et al., 2002; Jainchill et al., 2000; 
National Coalition for the Homeless, 2005) and neuropsychological functioning 
deficits (Buhrich et al., 2000; Gonzalez et al., 2001; Solliday-McRoy et al., 2004). 
Furthermore, due to confounding variables, the attrition rates for homeless individuals 
receiving substance use treatment are reported at rates well over fifty percent 
(National Institute on Alcohol Abuse and Alcoholism, retrieved January 27, 2006; 
SAMHSA, 1998; Zerger, 2002). Though much research has been done on substance 
use treatment and the homeless, the research is lacking in regards to attrition from 
substance abuse treatment related to neuropsychological deficits. Indeed, not even 
one study was found that addressed the relationship between neuropsychological 
deficits and attrition rates from substance abuse treatment in homeless men. 
Therefore, the importance of this study evaluating neuropsychological functioning 
and the relationship to attrition rates in substance use treatment is again validated.  
Multicultural Considerations 
      When evaluating neuropsychological functioning one must remain cognizant 
of possible demographic and multicultural issues related to assessment and diagnosis. 
  95 
 
Participant’s age, gender and race can all affect performance on particular test 
instruments (Groth-Marnat, 1999; Posner & DiGirolamo, 2000; Sullivan et al., 2002).  
For example, aging can affect performance on many neuropsychological tests 
(Posner & DiGirolamo, 2000). Older adults are disproportionately disadvantaged on 
tests of executive function. Specifically, large age related differences are found on 
tasks that involve shifting sets, which is considered a primary example of executive 
functioning (Posner & DiGirolamo, 2000).  
      In relation to gender, Sullivan, Fama, Rosenbloom and Pfefferbaum (2002) 
reported that alcohol dependent women exhibit a similar pattern of impairment in 
cognitive tests as men. The areas most severely affected in the women, showing at 
least a -0.75 standard deviation difference from the healthy controls, involved short 
term memory and fluency (fluency involves the ability to write/speak as many words 
starting with a certain letter that one can come up with and creating a variety of 
designs within prearranged arrays of dots; Sullivan et al., 2002). Scientists have 
shown how alcoholism affects the nervous system and the brain for decades, but 
primarily in men (Sullivan et al., 2002). With regards to gender, the American 
Academy of Neurology (AAN) finds gender to have “consistent but minor effects on 
neuropsychological assessment” (American Academy of Neurology, 1996, p. 3). The 
AAN goes on to explain that women perform better on tests of verbal memory than 
men and suggest that men decline more than women on neuropsychological tests 
during the normal course of aging (American Academy of Neurology, 1996). 
      Not only has most of the research been performed with men, but also more 
specifically, it has been done with European American men (Groth-Marnat, 1999). 
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Critics believe that most psychological tests are heavily biased and reflect the values 
of European American middle class society (Groth-Marnat, 1999). Likewise, a study 
in the Journal of the International Neuropsychological Society (2004) reviewed past 
studies that investigated cultural bias and neuropsychological testing (Kennepohl, 
Shore, Nabors & Hanks, 2004). In summarizing several studies, Kennepohl et al. 
(2004) reported that many medically healthy minorities in the United States are 
considered cognitively impaired at a much higher rate than European Americans-even 
when they controlled for other variables such as years of education and 
socioeconomic status (SES).  The Kennepohl et al. (2004) study assessed 71 
participants using the African American Acculturation Scale with 40 being tested by a 
Black examiner and 31 by a White examiner. The results suggested a significant 
association between level of acculturation and neuropsychological performance even 
after controlling for other confounding variables such as age, sex, years of education 
and SES (Kennepohl et al., 2004). Similarly, researchers at Columbia Health Sciences 
studied whether quality, rather than quantity of education could help explain lower 
neuropsychological test scores (Dougherty, 2002). By administering a reading test to 
384 elderly African Americans and Whites, the researchers found they could 
eliminate the racial differences in the neuropsychological assessment scores 
(Dougherty, 2002). The results of the Columbia Health Science study suggest that 
including an assessment of reading skills will help the neuropsychologists know what 
scores to expect from people with diverse backgrounds (Dougherty, 2002).  
       With the issue of bias in mind, one must be cautious when interpreting scores 
of ethnic, racial, age or gender categories that a specific assessment tool was not 
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normed on (Groth-Marnat, 1999). For the purpose of this study, I needed to be 
cautious that the results of the neuropsychological tests are from neuropsychological 
deficits, not test bias. I wanted to be sure I was measuring executive function deficit 
in all participants, not just the White males. When evaluating the relationship of 
executive functioning and attrition, I wanted to be sure to capture those precise 
variables and not variables related to gender, ethnicity or test bias. Therefore, all of 
these variables were considered in selection and use of assessment materials. 
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Chapter III: Methodology 
      The primary purpose of this chapter is to describe the methodology employed 
in this study of the executive function of patients with a substance dependence 
diagnosis and effects on attrition. Descriptions of the proposed participants, research 
design, instruments and procedures are provided. 
Participants 
 Participants were recruited from the adult males seeking services at the 7C’s 
Community Counseling Clinic (7Cs) located within the Guesthouse of Milwaukee. 
Upon initial contact with 7C’s, individuals were assessed for substance related 
diagnoses. If an individual was identified as having a substance use diagnosis, the 
researcher presented the purpose and goals of the project, explained the nature of the 
test instruments, described time requirements and reviewed confidentiality 
procedures. In addition, it was explained that participation in the study was 
completely voluntary and had no effect on shelter admission, length of shelter stay or 
any other service offered at the shelter. An assessment was completed for all of those 
who agreed to participate. 
Funding 
In researching various funding opportunities, I contacted major breweries 
including Miller Brewery and local substance abuse organizations including Aurora 
and Cornerstone. In addition, many options for grants were researched through 
National Institute of Health, Division 40 of APA and multiple other online sources. 
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Unfortunately, no funding was retrieved through any of these sources. As the 
participants were people staying at the guesthouse, the financial incentive was 
somewhat less important as we were not be asking them to go anywhere outside of 
their home. In addition, as all clients who receive services from the 7C’s clinic in the 
Guesthouse are required to complete an initial intake assessment prior to receiving 
services, the participants would partake in an assessment whether or not they are part 
of the study. If the study participants are then paid for their time, this could cause 
discontent for all other and future 7C’s clients who are not paid for their time. 
Therefore, no payment was given to study participants. However, offering some form 
of payment to participants might have improved participant motivation throughout the 
assessment process. 
Design 
           The major domains of this study included executive functioning of people with 
a substance use diagnosis and attrition rates. The data collected was intended to be 
exploratory in nature and not to be assumed representative as a thorough investigation 
of these domains. 
Independent and Dependent Variables 
           The dependent variables for this study include the length of time the 
participant remains in treatment and number of sessions. I had also intended to 
evaluate time of relapse and frequency of relapse but was unable to gain access to 
relapse information. The independent variable is level of executive functioning as 
defined by the scores obtained by our chosen neuropsychological battery which 
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includes subtests of the Delis Kaplan and the Continuous Performance Test II (CPT 
II).  
 
Other Variables 
           A variety of other variables including demographic characteristics, health 
history (including head injury), and subjective level of fatigue and mood at time of 
assessment were considered as supplemental variables. All of these variables could be 
confounding variables when evaluating the impact of neuropsychological functioning 
and attrition. We  want to be sure that any relationship found between 
neuropsychological functioning and attrition is a true relationship and not one 
modified by one of these other variables. In addition, if we found that one of the other 
variables was an important predictor, we would highlight this for treatment 
suggestions and future research directions as is discussed in detail below. 
Sample Size 
           Sample size is an important variable to consider as the sample size needs to be 
large enough that an effect of such magnitude to be of scientific significance will also 
be statistically significant. However, it is just as important that the sample size not be 
too big that an effect of little scientific importance is still detected as statistically 
significant (Lenth, 2001). I intended to exert energy and resources in ways that would 
be clinically and statistically significant. Factors that affect sample size include the 
Type I error rate, power of the test, and the effect size (Friedman, Furberg & DeMets, 
1998). The calculation of sample size, with provisions for adequate levels of 
significance, power and effect size is discussed below.  
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 The level of significance or alpha (α) level is the probability of making of 
Type I error or rejecting the null hypotheses when it is true (Grimm & Yarnold, 
1995). The determination of where to set alpha is a function of balancing Type I and 
Type II errors (Grimm & Yarnold, 1995). Type II error occurs when the researcher 
does not reject a false null hypothesis, a probability called beta (β). For example, 
raising the level of significance (raising the probability of making a Type I error) 
from .05 to .10 decreases the probability of making a Type II error.  Therefore, in 
order to find an acceptable balance between Type I and Type II errors, alpha was set 
at .05 (α = .05) which is the preferred standard alpha of many researchers (Friedman 
et al., 1998). 
 It is also important to consider Power in the design of a study. Power is 
defined as the probability of rejecting the null when it is false and is calculated as 1 – 
β (Hinkle, Wiersma & Jurs, 1998; Huck, 2000). Due to the inverse relationship of 
alpha and beta, as alpha (α) increases, beta (β) decreases and power (1 – β) then 
increases. Therefore, the larger the power, the more likely one is to reject the null 
when it is false (Norussis, 2002). Hinkle, Wiersma and Jurs (1998) state that several 
authors have indicated that Type I errors are typically more serious than Type II 
errors and therefore suggest a 4:1 ratio of β to α. Therefore, as we have established 
alpha at .05, the corresponding power is 1 – 4(.05) = .80 (Hinkle, Wiersma & Jurs, 
1998). This power is large enough to help control for Type II errors, but not too large 
to put unrealistic demands on the researcher for huge sample sizes (Huck, 2000).  
 Effect size is also considered when determining sample size. Cohen defines 
effect size as the “degree to which a phenomenon exists” (Cohen, 1977, p. 9). The 
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effect size score represents the magnitude of the intervening treatment’s effect 
(Grimm & Yarnold, 1995). Huck (2000) describes how Jacob Cohen has suggested 
that researchers can set the effect size to .20, .50 and .80 depending on whether they 
are interested in detecting a small, medium or large deviation from the null. However, 
many researchers warn that identifying the effect size is not so simple (Hinkle, 
Wiersma & Jurs, 1998). In fact, Cohen himself warns that it is always better for the 
researcher to specify effect size by thinking about the particular study being 
conducted rather than just deciding to use one of the accepted values for small, 
medium and large effect (Huck, 2000). Therefore, to calculate effect size for this 
study, we should not have arbitrarily picked an effect size, but rather considered what 
distinguished trivial from meaningful deviations from the null. Although this is not 
typically a difficult task, determining this requires knowledge about variability in the 
population being studied (Huck, 2000). For this study, I needed to find similar 
research on the relationship between neuropsychological function and attrition rates 
with an effect size reported. As previously discussed, this specific research is 
extremely rare in current publications. In addition, I reviewed similar types of 
research, such as attrition rates in outpatient substance dependence treatment, and was 
unsuccessful at finding any reported effect sizes. The majority of social research 
produces a small to medium effect size (Grimm & Yarnold, 1995). Therefore, I chose 
a small effect size as defined by Cohen as an effect size between .20 and .30 realizing 
this is an inadequate method of determining effect size.  
 With alpha set at .05, power at .80 and an effect size of .20 to .30, sample size 
can be chosen using a chart on page 651 of Hinkle, Wiersma and Jurs (1998). 
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According to this chart, the sample size needed would be between 71 and 155 for a 
small effect size between .20 and .30 (Hinkle, Wiersma & Jurs, 1998). Again, this 
determination of sample size is not adequate, but instead a result of the limited data I 
was working with. Part of the value of this study will be the reported information on 
effect size for future researchers interested in similar areas of study.  
 With the limited information available for calculating sample size, sample size 
was determined mostly as a result of practicality related to resources of this study 
including time, available participants and manpower to conduct the necessary 
assessments. With these variables in mind, as well as the variables of power, alpha 
and effect size, the sample size was arbitrarily set at 100. This allowed for a sample 
size which is reasonable with the resources available, as well as a sample size that fits 
with the partial calculations I was able to perform. The 100 needed assessments was 
feasible to obtain but yet we were unable to complete the 100 assessment due to a 
change in management of the 7C’s clinic.  
Instruments 
            The instruments used for this study included specific subtests of the Delis-
Kaplan Executive Function System (D-KEFS) and the Conners’ Continuous 
Performance Test II (CPT II) for evaluation of neuropsychological strengths and 
weaknesses, the Wechsler Abbreviated Scale of Intelligence (WASI) for an estimate 
of general intellectual ability. In addition, the Addiction Severity Index (ASI) was 
used to evaluate the severity of problem areas associated with alcohol and drug 
dependence and the Mini International Neuropsychiatric Interview (MINI) was used 
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to establish any other DSM-IV diagnoses. All of these instruments are reviewed in 
detail below.  
Delis-Kaplan Executive Function System (D-KEFS) 
 The D-KEFS was published by Dean Delis, Edith Kaplan and Joel Kramer to 
assess key components of executive function (Psychological Corporation, n.d.). The 
D-KEFS is a neuropsychological test battery consisting of nine subtests that assess 
higher level cognitive abilities described as executive functions (Dugbartey & 
Ramsden, in press). The D-KEFS is individually administered in a game like format 
designed to be engaging for participants to encourage optimal performance in 
children and adults (Psychological Corporation, retrieved December 13, 2004). Each 
of the nine subtests comprising the D-KEFS were developed as stand alone measures 
and include the Trail Making Test, Verbal Fluency Test, Color Word Interference 
Test, Sorting Test, Twenty Questions Test, Word Context Test, Design Fluency Test, 
Tower Test and Proverb Test (Dugbartey & Ramsden, in press). The tests of interest 
for this study included Tower Test, Color Word Interference Test, Trail Making Test 
and Verbal Fluency. The decision was made to use four rather than all nine of the 
subtests to focus specifically on executive functions and reduce the time commitment 
associated with facilitating all nine subtests. These four subtests included in the 
battery for this study will be discussed in more detail below.   
 D-KEFS subtests 
 The nine subtests of the D-KEFS were designed to be autonomous 
instruments that could be used individually or in combination with other D-KEFS 
subtests. The selection of which tests to use is determined by the needs and time 
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constraints of the examiner (Dugbartey & Ramsden, in press). Each subtest takes 
approximately 20 minutes to administer and score (Dugbartey & Ramsden, in press). 
In addition, computer scoring software is available which can further reduce the time 
involved in manual scoring of the subtests (Psychological Corporation, retrieved 
December 13, 2004). Of the nine subtests of the D-KEFS, the decision was made to 
use four particular tests to focus specifically on executive functions and reduce the 
time commitment associated with facilitating all nine subtests. 
 The four D-KEFS subtests I used for this project included the Tower Test, 
Color Word Interference, Trail Making Test and Verbal Fluency. We had also 
intended to use the Sorting Test, but under the guidance of Dr. Terry Young we 
decided to eliminate it due to time constraints and repetition with other measures. The 
Tower Test is similar to the Towers of Hanoi test and the Tower of London test. The 
Tower Test measures spatial planning, rule learning, inhibition of impulsive 
responding, inhibition of perseverative responding and establishing and maintaining 
the instructional set (Dugbartey & Ramsden, in press). The Tower Test is a task in 
which the participant attempts to move five rings across three pegs to build a tower in 
the fewest number of moves possible (Dugbartey & Ramsden, in press). The Color 
Word Interference Test is a modified version of the Stroop (1935) test. It measures 
inhibition of a more autonomic verbal response (reading) in order to generate a 
conflicting response naming the dissonant ink colors (Dugbartey & Ramsden, in 
press). The third subtest used was the Trail Making Test. The Trail Making Test is a 
modified version of the Trail Making test and consists of five conditions instead of 
two (Dugbartey & Ramsden, in press). The D-KEFS Trail Making Test measures 
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flexibility of thinking on a visual motor task and assesses whether a deficient score on 
the switching condition is related to a higher level deficit in cognitive flexibility 
(Dugbartey & Ramsden, in press). The last subtest of the D-KEFS I used is the 
Verbal Fluency test. The Verbal Fluency test is a modified version of the Controlled 
Oral Word Association Test (COWAT, 1969). The Verbal Fluency test is sensitive to 
frontal lobe involvement in general and left-frontal lobe damage in particular 
(Dugbartey & Ramsden, in press). The Verbal Fluency test measure fluent 
productivity in the verbal domain by requiring the participant to generate words in 
phonemic format from overlearned concepts (Dugbartey & Ramsden, in press).  
D-KEFS psychometrics. 
 The D-KEFS was standardized on a stratified sample of  1,750 
individuals including 700 people aged 8-15 years old, 700 people between 16 and 59 
years old and 350 between 60 and 89 years old (Dugbartey & Ramsden, in press). 
The D-KEFS is considered to have “adequate psychometric properties and a strong 
norming base” (Dugbartey & Ramsden, in press, p. 286). Internal consistency 
reliability was adequate for composite scores on the Trail Making Test (from .57 to 
.81), Verbal Fluency Test (from .32 to .90) and Color Word Interference Test (.62 to 
.86). The test-retest reliability estimate of the D-KEFS was found to be “generally 
impressive” though “quite variable across age groupings” (Dugbartey & Ramsden, in 
press, p.283). 
 In regards to validity, the Mental Measurement Yearbook (15th edition) 
reported that adequate data was presented on the intercorrelations of various intratest 
measures of the D-KEFS (Dugbartey & Ramsden, in press). Likewise, some of the D-
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KEFS subtests (such as the Sorting Test) showed some impressive correlation results 
(Dugbartey & Ramsden, in press). However, very limited concurrent validity 
evidence was available comparing the D-KEFS and other neurocognitive 
assessments. For example, the correlations between the D-KEFS and the California 
Verbal Learning Test-Second Edition was rather low (Dugbartey & Ramsden, in 
press). Overall, the reliability and validity of the D-KEFS are considered to be 
adequate for researchers (Dugbartey & Ramsden, in press). Furthermore, as the D-
KEFS is able to evaluate multiple aspects of executive functions, which are a primary 
focus for this study, the D-KEFS is a necessity for this study. 
Conners’ Continuous Performance Test II (CPT II) 
 The CPT II was developed by C. Keith Conners as a visual performance task 
which evaluates attentional variables in individuals age six or older (IPS, 2005). The 
response patterns identified by the CPT II provide information on attention, 
impulsivity, activation/arousal and difficulties in maintaining vigilance (IPS, 2005). 
The CPT II is computer administered and scored in approximately 14 minutes (IPS, 
2005). After a practice exercise on the computer, the administration begins requiring 
the participant to press the space bar or click the mouse when any letter except ‘X’ 
appears on the computer screen. The computerized program of the CPT II captures 
response times and records them to the nearest millisecond (Klecker & Sime, in 
press). Scores are automatically computed, graphed and converted to a text which 
explains the results to the administrator (Klecker & Sime, in press). The instructions 
and administration are simple for the participant and the administrator.  
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 CPT II psychometrics. 
 The CPT II was normed on a sample of 2,682 subjects including clinical and 
nonclinical samples (IPS, 2005). Normative data include a clinical sample of 378 
cases diagnosed with ADHD, 223 adult individuals with neurological impairment and 
a nonclinical sample of 1920 individuals from the general population (Klecker & 
Sime, in press).  Reliability and validity information is provided in the CPT II 
Technical Guide and Software Manual (IPS, 2005). Two types of reliability including 
split half and standard error provide support for the psychometric soundness of the 
CPT II. The CPT II shows adequate consistency with regards to split half reliability 
and the standard error measurement values show that scores from the instrument are a 
reasonable match to the true performance of individuals (IPS, 2005). However, 
according to a review in the Mental Measurement Yearbook (15th edition), the split 
half procedure was found to be difficult to follow and the correlations nearly 
impossible to interpret (Klecker & Sime, in press). Test-retest reliability resulted in a 
range of .05 to .92 (Klecker & Sime, in press). Statistical validation is discussed in 
the CPT II manual with regards to demonstrating the tests ability to discriminate 
between general populations and clinical groups (IPS, retrieved April 27, 2006). The 
Mental Measurement Yearbook (15th edition) review considers the CPT II a reliable 
instrument with moderate validity which can be easily used and interpreted (Klecker 
& Sime, in press). However, the authors of the CPT II do caution that it is not to be 
used alone as a diagnostic tool (Klecker & Sime, in press). Given the CPT II’s 
positive psychometrics, brief administration and the necessity of attentional 
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information for evaluating executive function, the CPT II is a valuable tool for this 
study in conjunction with the other identified assessment tools. 
Wechsler Abbreviated Scale of Intelligence (WASI)  
 The two subtest format of the WASI was developed in 1999 to provide 
clinicians a reliable method to obtain a brief measure of intelligence on individuals 
aged 6-89 years old (Harcourt Assessment, retrieved April  27, 2006). Though many 
short forms of the Wechsler Scales exist, the WASI was developed to provide a 
consistent, well normed, brief measure of intelligence (Keith, Lindskog & Smith, 
2004).  The WASI is available in a four or two subtest format giving the administrator 
control over the time and depth of the assessment (Keith, Lindskog & Smith, 2004). 
The four subtest format results in a Full Scale IQ (FSIQ, Verbal IQ (VIQ) and 
Performance IQ (PIQ) with a 30 - minute administration time (Harcourt Assessment, 
retrieved April 27, 2006). The two subtest form of the WASI includes the Vocabulary 
subtest and the Matrix Reasoning subtest resulting in a Full Scale IQ (FSIQ) score 
with a 15 - minute administration time (Harcourt Assessment, retrieved April 27, 
2006). For all subtests, raw scores are converted to T scores with all IQ scores having 
a mean of 100 and a standard deviation of 15 (Keith et al., 2004). For the purposes of 
this study, we utilized the two subtest form of the WASI to reduce the time the 
participant is involved in testing.   
 WASI psychometrics.  
 The Wechsler Abbreviated Scale of Intelligence was standardized on a 
national sample of 2,245 children and adults with ages ranging from 6-89 years old 
(Keith et al, 2004) is considered to have strong psychometric properties (Harcourt 
  110 
 
Assessment, retrieved April 27, 2006). The average reliability coefficient for adults 
on the two subtest format is reported at .96 (Harcourt Assessment, retrieved April 27, 
2006). Likewise, the test-retest reliability for the two subtest format is .88 (Harcourt 
Assessment, retrieved April 27, 2006). In addition, the validity information on the 
WASI included correlations with other tests, and exploratory and confirmatory factor 
analysis (Keith et al., 2004). Correlations between the WASI and WAIS III ranged 
from .66 to .88 for subtests and .76 to .92 for IQ’s (Keith et al., 2004). The Mental 
Measurement Yearbook (2004) review of the WASI considers the correlation with the 
WAIS III to be the WASI’s greatest strength and its greatest weakness as it is not 
connected to anything but the Wechsler scales (Keith et al., 2004). Overall, the 
Mental Measurement Yearbook (2004) review considers the WASI to be well 
standardized and have adequate reliability and validity (Keith et al., 2004). As a brief 
estimate of intelligence versus a detailed description of intelligence is what we need 
for this study, the WASI is an appropriate addition to our battery. 
Addiction Severity Index (ASI) 
 The Addiction Severity Index (ASI) was developed in 1980 by A. Thomas 
McLellan and collaborators from the University of Pennsylvania’s Center for the 
Studies of Addiction (Treatment Research Institute, retrieved February 3, 2006). The 
ASI is a standardized, multidimensional instrument widely used in the field of 
substance abuse treatment (Treatment Research Institute, retrieved February 3, 2006). 
This semi-structured interview was designed to address seven potential problem areas 
in individuals with a substance use disorder. The seven areas include: (a) medical, (b) 
employment, (c) alcohol, (d) drug, (e) legal, (f) family/social, and (g) psychiatric 
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status (McGahan, Griffith, Parente & McLellan, 1986; McLellan, Luborsky, O’Brien 
& Woody, 1980). The interviewer can gather information on recent substance use 
(past thirty days) and lifetime problems in all seven of the problem areas (McGahan 
et al., 1986; McLellan et al., 1980). Therefore, the ASI provides an overview of the 
problems rather than focusing on any one single area.  
 ASI psychometrics. 
The ASI has been normed on treatment groups including users of alcohol, 
opiates and cocaine (McLellan et al., 1980). In addition, it has been normed on public 
and private inpatient and outpatient treatment (McLellan et al., 1980). Finally, it has 
been normed on males, females, psychiatrically ill substance users, gamblers, 
homeless, probationers and employee assistance clients (McLellan et al., 1980). 
Therefore, it is appropriate for the  homeless, male, substance abusing population 
included in this research. The ASI has shown test-retest reliability, split half 
reliability and internal consistency (McLellan et al., 1980). Likewise, the ASI has 
shown content, criterion and construct validity (McLellan et al., 1980). Finally, the 
ASI can be administered in approximately 50 to 60 minutes and can be used free of 
charge (McLellan et al., 1980) making it a positive part of our chosen assessment 
battery.  
Mini International Neuropsychiatric Interview (MINI) 
 The Mini International Neuropsychiatric Interview (MINI) is an abbreviated 
psychiatric structured interview first developed in 1992 by David Sheehan and Yves 
Lecrubier to meet the need for a short but accurate psychiatric interview (Sheehan et 
al., 1998). The MINI is designed to assess the major adult Axis I diagnostic 
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categories, one Axis II diagnosis (antisocial personality disorder) and suicidality 
(Sheehan et al., 1998). The MINI is available in an electronic version allowing for 
simple computer administration and scoring which takes approximately 15 minutes. 
 MINI psychometrics. 
  The reliability of the MINI was tested with interrater reliability and test-retest 
reliability. The interrater reliability showed kappa values all above .75 (Sheehan et 
al., 1998). In addition, 70% of the kappa values were .90 or greater indicating 
excellent interrater reliability (Sheehan et al., 1998). The test-retest reliability scores 
included 61% with values over .75 and only one value was below .45. With regards to 
validity, the MINI was compared to the Structured Clinical Interview for the DSM-
III-R (SCID) and the Composite International Diagnostic Interview (CIDI). When 
compared to the SCID, the MINI showed good or very good kappa values with only 
one score (current drug dependence) falling below .50 (Sheehan et al., 1998). When 
comparing the MINI and the CIDI, kappa values were also good or very good for 
most diagnoses with only two values (simple phobia and generalized anxiety 
disorder) falling below .50 (Sheehan et al., 1998). The MINI has shown high 
validation and reliability scores and can be administered in less time (15-30 minutes) 
than other comparable instruments such as the Structured Clinical Interview for the 
DSM-III (Sheehan et al., 1998) making it a useful instrument for this study.  
Procedures 
Informed Consent 
      When participants arrived for their assessment session, they were read an 
informed consent document in compliance with current Health Insurance Portability 
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& Accountability Act 2004 (HIPAA) regulations. This provided them with 
information regarding voluntary participation, confidentiality, the purpose of the 
study, and potential risks and/or benefits of participating in this study. Any questions 
regarding these issues were answered, they signed the consent and were offered a 
copy of it.  
Assessment      
      All clients of the 7C’s clinic are administered the ASI and MINI upon general 
admission. These instruments are part of the 7C’s clinic intake process and therefore 
all clients entering the clinic are given these assessments, not just the participants for 
this study. All administrators were Registered Alcohol and Drug Counselors or 
Certified Alcohol and Drug counselors by the state of Wisconsin and were supervised 
by Certified Clinical Supervisors. Subsequently, if a substance use diagnosis was 
established, the neuropsychological test battery including the D-KEFS, CPT II and 
the WASI were administered after completion of the informed consent procedures. 
Standard administration was followed for each of the instruments as well as a 
standard order of administration. The average length of time to complete the 
neuropsychological test battery was approximately 90 minutes. Multiple clinicians 
were trained and supervised in the administration of this battery. A licensed 
psychologist qualified in administration and scoring of the neuropsychological 
assessment instruments (Dr. Terry Young) provided training prior to the time of 
assessment and provided supervision throughout the course of this study.  All 
batteries were hand scored first by the assessor for the WASI. The D-KEFS and CPT 
II are computer scored. The hand scored subtests were then rescored by the lead 
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investigator to insure accurate scoring. A sample of the assessments were then 
reviewed by the supervising neuropsychologist and another psychologist (14 batteries 
or approximately 20%).  
Follow Up 
 Participants were asked to provide contact information at intake to allow for 
follow up information to be gathered if and when the participant left treatment. 
Participants were informed of when this person will be contacted and what 
information would be asked of them. The appropriate releases were signed and 
attempts were made to contact the listed person when a participant dropped out of 
treatment to get information on reaching the participant for information on why they 
left treatment. We were hoping this information would provide a qualitative report of 
the participant’s perception of why they left treatment allowing the study to evaluate 
the relationship between neuropsychological function and attrition to the participant’s 
report of reasons for attrition. However, we had limited success actually reaching 
people due to wrong names, 
wrong numbers, disconnected numbers and the cooperation of the listed contact 
person. 
Therefore, we were unable to report the intended qualitative piece of this research. 
 
Data Analysis 
      As we are comparing the relationship between the neuropsychological 
functioning, attrition rates and relapse rates in outpatient treatment for substance 
dependent males, there are several variables to evaluate requiring multiple data 
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analytic techniques. Survival Analysis (SA) and Logistic Regression (LR) are the two 
primary statistical applications we will used for this study. 
Survival Analysis (SA) 
 Survival Analysis (SA) refers to a group of techniques designed for studying 
the occurrence of events in longitudinal data (Corning & Malofeeva, 2004). Given 
that I am evaluating attrition rates from outpatient treatment, which have a well-
defined starting point and a ‘failure’ point, this is an appropriate model for my data 
(Dobson, 2002; Parmar &Machin, 1995). In SA, the dependent variable is the length 
of time to an event (Parmar & Machin, 1995). Classically, the event of interest was 
death-hence the term survival analysis (Luke & Homan, 1998). However, for the 
purpose of this study, the dependent variables assessed by SA were the number of 
outpatient sessions attended and total length of time in treatment prior to dropping 
out.  In short, SA assists us in predicting the risk of occurrence of an event given the 
event has not yet occurred (Corning & Malofeeva, 2004; Luke & Homan, 1998). The 
advantages of SA over more traditional means of analysis, such as regression and 
analysis of variance (ANOVA), relate to the longitudinal nature of outpatient 
treatment that may not be well addressed by other methods (Corning & Malofeeva, 
2004). Survival Analysis is important when analyzing data in which risks vary over 
time (Gerstman, 2003). Survival Analysis allows us to estimate the survival time of 
participants who complete the study as well as those who do not (Gerstman, 2003). 
This is considered a distinguishing feature of survival analysis and is referred to as 
censoring (Parmar & Machin, 1995; Venables & Ripley, 2002). Data is considered 
right censored in the event that we do not observe the outcome (end of treatment) for 
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all participants since data collection ends but the people are still in treatment 
(Gerstman, 2003; Luke & Homan, 1998). In SA studies, this is the most common type 
of censoring. However, if participants become unavailable due to physically moving 
out of the area, death or illness, this is considered mid censoring (Gerstman, 2003). 
We are no longer able to observe them, but they were not necessarily lost due to 
dropping out in the manner we are concerned with in this study. Therefore, if we had 
participants in our study that moved, died or otherwise do not represent the 
dichotomy of someone participating in treatment or dropping out, we could still 
account for the data and not allow it to have as big of a negative impact on our 
results. Furthermore, with SA, I could evaluate the time to the event (days or sessions 
to drop out) and what is known as censor-status (observation or non-observation of 
the event-drop out; Luke & Homan, 1998). Or, I could also investigate other variables 
which influenced survival times such as the neuropsychological functioning of the 
individual. Survival Analysis can incorporate categorical or continuous variables 
(Luke & Homan, 1998). With the multiple types of data that my chosen assessment 
battery produces, I had the opportunity to evaluate the data from both perspectives 
using impaired vs. non-impaired neuropsychological scores and the continuous type 
of data that the CPT II reaction time scores offer. Therefore, I was able to evaluate the 
impact of the client’s neuropsychological functioning on survival or time in treatment 
prior to relapse or dropping out.  
      Within Survival Analysis there are parametric and nonparametric approaches 
available for our use. Some researchers report that the parametric approaches have 
‘fallen out of fashion’ with the advent of the more nonparametric approaches 
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(Venables & Ripley, 2002). Some of the analytic techniques offered by SA include 
the Cox Proportional Hazards Model, Kaplan-Meier survival function estimation and 
Life Table analysis (Parmar & Machin, 1995; StatSoft, retrieved March 16, 2006). 
For this study, we used the Cox Model which is discussed later. 
Logistic Regression (LR) 
 In addition to Survival Analysis, Logistic Regression was also used in analysis 
of the data. Logistic Regression can be used when the predictor variables are 
qualitative or quantitative, continuous or categorical, and the criterion variable is 
dichotomous (Grimm and Yarnold, 2000; Huck, 2000). Our predictor variable of 
interest is neuropsychological function which is quantitative and continuous and the 
dichotomous criterion variable was whether the participant dropped out or not. With 
SA we are able to address the participant’s survival in treatment (continuous time 
oriented variable) as related to neuropsychological functioning, whereas with LR we 
address whether a relationship exists between neuropsychological function and 
whether the participant drops out or not (dichotomous variable). Logistic Regression 
can be used to determine the increase in probability of dropping out of treatment that 
is associated with neuropsychological functioning while controlling for other 
variables such age, IQ and types of substances used (Grimm & Yarnold, 2000). Like 
Linear Regression, Logistic Regression gives each regressor variable a coefficient 
value that measures the regressor’s independent contribution to variations in the 
dependent variable (University of Exeter, retrieved May 10, 2006). With LR, we can 
assess whether the independent variables, as a whole, significantly affect the 
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dependent variable and identify the best variables to use in prediction of treatment 
drop out (University of Exeter, retrieved May 10, 2006).  
Summary of Data Analysis 
Survival Analysis and Logistic Regression were used to answer all study 
questions including identifying the level of neuropsychological impairment, if the 
impairment predicts rates of attrition from treatment and if a relationship exists 
between neuropsychological function and attrition. Using the two forms of statistical 
analysis (LR and SA) allowed us to more precisely and accurately evaluate all 
variables involved in this study.  
In regards to the level of neuropsychological impairment, descriptive statistics 
and a verbal summary of findings is reported. As it is possible that 
neuropsychological functioning would improve over the course of the study, the 
neuropsychological assessment (Delis-Kaplan subtests and CPT II) was to be 
administered a second time half way through the 90 days we will be monitoring for 
drop out (45 days into treatment) and again at the 90 day mark. This would provide a 
quantitative description of any improvement in neuropsychological functioning over 
time. However, due to limited participation in this aspect of the research, we were 
unable to report any substantial data related to follow up assessments. 
Attrition from substance abuse treatment was evaluated using Logistic 
Regression with attrition being treated as a dichotomous variable (drop out or no drop 
out). We intended to predict drop out from the indicators of neuropsychological 
functioning and control for other variables including age, IQ and any other treatment 
participation. In addition, Survival Analysis was also used in which the days in 
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treatment prior to drop out were the dependent variable and neuropsychological 
functioning was the independent variable. The relationship between 
neuropsychological function and drop out was evaluated with LR and the relationship 
between neuropsychological function and survival in treatment was evaluated with 
SA. Finally, the Cox Proportional Hazards model was used with the Survival 
Analysis. 
In addition to the quantitative data collected, we intended to have a qualitative 
component to be reported on from the information gathered through the follow up 
procedures. This information would provide us with the participant’s description of 
why they left treatment which could be compared to the quantitative data. However, 
as discussed above, this information was not successfully gathered.  
Finally, as previously mentioned, no relative effect sizes could be found to be 
used to determine sample size for this study. Therefore, effect sizes were calculated 
and reported on as another valuable outcome of this study.  
Overall, the use of the multiple statistical techniques allowed for assessment 
of all independent and dependent variables of interest. In addition, the statistical 
techniques allowed for evaluation of any confounding variables. Finally, these 
methods of analysis will provide an enormous amount of information on any 
relationships between neuropsychological function, attrition, relapse and multiple 
other potential variables.  
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Chapter IV: Results 
Demographic Description 
The present study utilized data from 68 participants.  We had planned an n of 
100 but due to a change in management of the clinic where we were collecting data, 
our n was reduced. We collected 75 total neuropsychological assessments on adult 
males in the 7C’s Clinic of the Guesthouse of Milwaukee. Of the 75 completed 
assessments, seven (initial assessments completed) were eliminated due to facilitator 
error (initial assessments, facilitator skipped parts of subtest). The average age of our 
sample was 45 years (SD = 9 years).  Education levels varied widely: 28% did not 
finish high school, 37% were high school graduates, and 12% had some college 
education or an associates degree, 18% graduated from college, and 5% had further 
education beyond college.  None of the participants reported being married: 63% of 
the participants were single, 23% were divorced, 9% were separated, and 3% were 
widowed.  Two in every three participants were African-American (66.2%), while 
25% were Caucasian, and 9% belonged to other racial or ethnic groups (2.9 % 
Hispanic, 2.9% multiple races, 1.5 % Asian, 1.5% Native American), Three in every 
four (74.6 %) participants had received prior AODA treatment. 
Neuropsychological Functioning       
To determine the neuropsychological functioning of the present sample and 
answer our first research question, we utilized four subtests of the Delis Kaplan 
including the Tower Test, Color Word Interference, Trail Making Test and Verbal 
Fluency.  We had originally planned to utilize the Sorting Test as well, but for the 
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sake of time and due to some duplicate information obtained by the sorting test, we 
limited the Delis Kaplan evaluation to these four subtests.  We also used the CPTII, 
WTAR and WASI to evaluate neuropsychological functioning. All of these results 
will be reviewed. 
 D-KEFS. 
 The Delis Kaplan Executive Function subtests give us multiple scores for each 
subtest administered. A few key variables that are considered more global 
achievement measures will be discussed and the rest presented in a table. For most of 
the measures provided by the D-KEFS, the raw scores are converted to scaled scores 
with a mean of 10 and a standard deviation of 3.  In order to determine whether the 
sample means in the present study were significantly different than the population 
norms for each test, a one-sample z-test was employed.  Specifically, a two-tailed test 
was employed with an alpha level of .05. With a sample of 68, and the population 
parameters specified above, sample means that are 0.71 units higher or lower than the 
stated population mean are significantly different than the mean. By this criterion, a 
sample mean of 9.29 is significantly lower than the population mean of 10. 
In addition to the standardized scores, the D-KEFS also provides contrast 
scores that quantify performance on a baseline task and a higher level task or two 
higher level tasks.  These will be discussed more extensively below. 
Tower Test. 
The Tower Test measures spatial planning, rule learning, inhibition of 
impulsive responding, inhibition of perseverative responding and establishing and 
maintaining the instructional set (Dugbartey & Ramsden, in press).  To assess how 
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the sample performed relative to the norm, the distribution of cases according to 
performance standards was examined.  Of the 67 valid scores from the participants on 
the Tower Test total achievement score, 22 scored below average, 12 scored above 
average and 33 scored within average range (M = 9.25, SD = 2.97).  In the present 
sample, the mean standardized scale scores for the Tower Test was lower than the 
criterion level of 9.29 set for rejecting the null hypothesis based on the one-sample z 
test.  This finding suggests that the sample was drawn from a population with a lower 
than average level of performance on this measure.  
Table 4.1 
 
Tower Test total achievement score scaled 
  
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 2 1 1.4 1.5 1.5 
3 1 1.4 1.5 3.0 
4 1 1.4 1.5 4.5 
5 5 7.2 7.5 11.9 
6 6 8.7 9.0 20.9 
7 8 11.6 11.9 32.8 
8 4 5.8 6.0 38.8 
9 8 11.6 11.9 50.7 
10 5 7.2 7.5 58.2 
11 10 14.5 14.9 73.1 
12 6 8.7 9.0 82.1 
13 10 14.5 14.9 97.0 
14 2 2.9 3.0 100.0 
Total 67 97.1 100.0  
Missing 999 2 2.9   
Total 69 100.0   
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 Trails.     
The Trail Making Test is a modified version of the Trail Making test and 
consists of five conditions instead of two (Dugbartey & Ramsden, in press). The D-
KEFS Trail Making Test measures flexibility of thinking on a visual motor task and 
assesses whether a deficient score on the switching condition is related to a higher 
level deficit in cognitive flexibility (Dugbartey & Ramsden, in press).  The primary 
scoring measure for each of the five conditions of the D-KEFS Trail Making Test is 
the number of seconds that the examinee takes to complete each condition again with 
a mean of 10 and a standard deviation of 3.  The first score is the Trail Making test 
visual scanning score, which is a timed score where the examinee seeks out the 
number 3 on a page of scattered numbers. Of the 68 valid responses, 18 were below 
average, 5 were above average and 45 were average (M = 8.8, SD  = 3.45). The 
second score is the number sequencing score where the participant has to seek out and 
sequence numbers in chronological order. Of the 68 valid responses, 30 were below 
average, 5 were above average and 33 were average (M = 7.48, SD = 3.95). The third 
score is the letter sequencing score where the participant has to seek out and sequence 
letters in alphabetical order. Of the 68 valid responses, 28 were below average, 7 
were above average and 33 were average (M = 7.48, SD = 3.93).  The fourth score is 
the number-letter sequencing score where the participant has to sequence numbers 
and letters in order alternating between the two. Of the 66 valid responses, 29 were 
below average, 4 were above average and 33 were average (M = 7.6, SD = 3.89). The 
fifth score is a motor speed score that is calculated by having the participant trace a 
line while being timed. Of the 67 valid responses, 19 scored below average, 3 scored 
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above average and 45 scored within the average range (M = 8.8, SD  = 2.95).   In the 
present sample, the mean standardized scale scores for the Trail Making Test was 
lower than the criterion level of 9.29 set for rejecting the null hypothesis based on the 
one-sample z test.  This finding suggests that the sample was drawn from a 
population with a lower than average level of performance on this measure. 
 
 
 
Table 4.2 
Trail making test visual scanning scaled 
  
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 1 6 8.7 8.8 8.8 
2 1 1.4 1.5 10.3 
3 1 1.4 1.5 11.8 
4 1 1.4 1.5 13.2 
5 2 2.9 2.9 16.2 
6 1 1.4 1.5 17.6 
7 6 8.7 8.8 26.5 
8 5 7.2 7.4 33.8 
9 10 14.5 14.7 48.5 
10 12 17.4 17.6 66.2 
11 7 10.1 10.3 76.5 
12 11 15.9 16.2 92.6 
13 3 4.3 4.4 97.1 
14 2 2.9 2.9 100.0 
Total 68 98.6 100.0  
Missing 999 1 1.4   
Total 69 100.0   
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Table 4.3 
 
Trail Making test number sequence scaled 
  
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 1 10 14.5 14.7 14.7 
2 2 2.9 2.9 17.6 
3 1 1.4 1.5 19.1 
4 4 5.8 5.9 25.0 
5 3 4.3 4.4 29.4 
6 6 8.7 8.8 38.2 
7 4 5.8 5.9 44.1 
8 6 8.7 8.8 52.9 
9 5 7.2 7.4 60.3 
10 13 18.8 19.1 79.4 
11 4 5.8 5.9 85.3 
12 5 7.2 7.4 92.6 
13 3 4.3 4.4 97.1 
15 1 1.4 1.5 98.5 
16 1 1.4 1.5 100.0 
Total 68 98.6 100.0  
Missing 999 1 1.4   
Total 69 100.0   
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Table 4.4 
Trail Making test letter sequence scaled 
  
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 1 10 14.5 14.7 14.7 
3 5 7.2 7.4 22.1 
4 2 2.9 2.9 25.0 
5 4 5.8 5.9 30.9 
6 4 5.8 5.9 36.8 
7 3 4.3 4.4 41.2 
8 10 14.5 14.7 55.9 
9 6 8.7 8.8 64.7 
10 7 10.1 10.3 75.0 
11 6 8.7 8.8 83.8 
12 4 5.8 5.9 89.7 
13 6 8.7 8.8 98.5 
15 1 1.4 1.5 100.0 
Total 68 98.6 100.0  
Missing 999 1 1.4   
Total 69 100.0   
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Table 4.5 
 Trail Making number letter sequencing scaled score 
  
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 1 10 14.5 15.2 15.2 
2 1 1.4 1.5 16.7 
3 3 4.3 4.5 21.2 
4 1 1.4 1.5 22.7 
5 3 4.3 4.5 27.3 
6 4 5.8 6.1 33.3 
7 7 10.1 10.6 43.9 
8 5 7.2 7.6 51.5 
9 8 11.6 12.1 63.6 
10 3 4.3 4.5 68.2 
11 9 13.0 13.6 81.8 
12 8 11.6 12.1 93.9 
13 4 5.8 6.1 100.0 
Total 66 95.7 100.0  
Missing 999 3 4.3   
Total 69 100.0   
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Table 4.6 
Trail Making motor speed scaled 
  
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 1 1 1.4 1.5 1.5 
2 1 1.4 1.5 3.0 
3 2 2.9 3.0 6.0 
4 3 4.3 4.5 10.4 
5 6 8.7 9.0 19.4 
6 1 1.4 1.5 20.9 
7 5 7.2 7.5 28.4 
8 5 7.2 7.5 35.8 
9 7 10.1 10.4 46.3 
10 11 15.9 16.4 62.7 
11 16 23.2 23.9 86.6 
12 6 8.7 9.0 95.5 
13 2 2.9 3.0 98.5 
14 1 1.4 1.5 100.0 
Total 67 97.1 100.0  
Missing 999 2 2.9   
Total 69 100.0   
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 Color Word Interference Test. 
The Color Word Interference Test is a modified version of the Stroop (1935) test. It 
measures inhibition of a more autonomic verbal response (reading) in order to 
generate a conflicting response naming the dissonant ink colors (Dugbartey & 
Ramsden, in press). The completion time for each of four measures provides a global 
measure of performance, again with a mean of 10 and standard deviation of 3. The 
first condition is color naming which tests the speed at which an examinee can name 
repeating stimuli of color patches. Of the 68 valid responses, 31 were below average, 
4 were above average and 33 were average (M = 7.52, SD = 3.8). The second 
condition is word reading, which evaluates the examinee’s ability to read repeating 
words as quickly as possible. Of the 68 valid responses, 30 were below average, 5 
were above average and 33 were average (M = 7.64, SD = 3.85).  The third condition 
is inhibition, which reflects the examinee’s ability to inhibit the more automatic task 
of reading words in order to name the dissonant ink color. Of the 68 valid responses, 
25 were below average, 9 were above average and 34 were average (M = 8.22, SD = 
3.78). The fourth condition is inhibition/switching, which requires adequate naming 
speed, reading speed, verbal inhibition and cognitive flexibility. Of the 68 valid 
responses, 26 were below average, 6 were above average and 36 were average (M = 
8.33, SD = 3.64).  The mean standardized scale scores for each of the Color Word 
measures was lower than the criterion level of 9.29 set for rejecting the null 
hypothesis based on the one-sample z test.  This finding suggests that the sample was 
drawn from a population with a lower than average level of performance on this 
measure. 
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Table 4.7 
 
Color Word color naming scaled 
  
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 1 8 11.6 11.8 11.8 
2 1 1.4 1.5 13.2 
3 4 5.8 5.9 19.1 
4 5 7.2 7.4 26.5 
5 1 1.4 1.5 27.9 
6 7 10.1 10.3 38.2 
7 5 7.2 7.4 45.6 
8 3 4.3 4.4 50.0 
9 7 10.1 10.3 60.3 
10 11 15.9 16.2 76.5 
11 9 13.0 13.2 89.7 
12 3 4.3 4.4 94.1 
13 3 4.3 4.4 98.5 
17 1 1.4 1.5 100.0 
Total 68 98.6 100.0  
Missing 999 1 1.4   
Total 69 100.0   
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Table 4.8 
Color Word word reading scaled 
  
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 1 8 11.6 11.8 11.8 
2 2 2.9 2.9 14.7 
3 1 1.4 1.5 16.2 
4 3 4.3 4.4 20.6 
5 6 8.7 8.8 29.4 
6 6 8.7 8.8 38.2 
7 4 5.8 5.9 44.1 
8 10 14.5 14.7 58.8 
9 3 4.3 4.4 63.2 
10 4 5.8 5.9 69.1 
11 10 14.5 14.7 83.8 
12 6 8.7 8.8 92.6 
14 5 7.2 7.4 100.0 
Total 68 98.6 100.0  
Missing 999 1 1.4   
Total 69 100.0   
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Table 4.9 
Color Word inhibition scaled 
  
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 1 5 7.2 7.4 7.4 
2 2 2.9 2.9 10.3 
3 3 4.3 4.4 14.7 
4 4 5.8 5.9 20.6 
5 5 7.2 7.4 27.9 
6 2 2.9 2.9 30.9 
7 4 5.8 5.9 36.8 
8 4 5.8 5.9 42.6 
9 11 15.9 16.2 58.8 
10 6 8.7 8.8 67.6 
11 7 10.1 10.3 77.9 
12 6 8.7 8.8 86.8 
13 6 8.7 8.8 95.6 
14 3 4.3 4.4 100.0 
Total 68 98.6 100.0  
Missing 999 1 1.4   
Total 69 100.0   
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Table 4.10 
Color Word inhibition/switching scaled 
  
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 1 5 7.2 7.4 7.4 
2 1 1.4 1.5 8.8 
3 5 7.2 7.4 16.2 
5 3 4.3 4.4 20.6 
6 4 5.8 5.9 26.5 
7 8 11.6 11.8 38.2 
8 4 5.8 5.9 44.1 
9 8 11.6 11.8 55.9 
10 8 11.6 11.8 67.6 
11 9 13.0 13.2 80.9 
12 7 10.1 10.3 91.2 
13 3 4.3 4.4 95.6 
14 1 1.4 1.5 97.1 
15 2 2.9 2.9 100.0 
Total 68 98.6 100.0  
Missing 999 1 1.4   
Total 69 100.0   
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 Verbal Fluency. 
  The Verbal Fluency test is a modified version of the Controlled Oral Word 
Association Test (COWAT, 1969). The Verbal Fluency test is sensitive to frontal lobe 
involvement in general and left-frontal lobe damage in particular (Dugbartey & 
Ramsden, in press). The Verbal Fluency test measures fluent productivity in the 
verbal domain by requiring the participant to generate words in phonemic format 
from over learned concepts (Dugbartey & Ramsden, in press). The total correct score 
for each of three conditions provides a global measure of performance on this task, 
again with a mean of 10 and standard deviation of 3.  The first condition is letter 
fluency where the examinee generates lexical items while simultaneously observing 
several rules or restrictions. Of the 68 valid responses, 29 were below average, 6 were 
above average and 33 were average (M = 8.39, SD = 3.56). The second condition is 
category fluency, which requires the examinee to retrieve multiple words from high 
frequency semantic categories. Of the 68 valid responses, 24 were below average, 6 
were above average and 36 were average (M = 9.2, SD = 6.8).  The third condition is 
category switching which requires the examinee to retrieve semantic knowledge 
shifting between two categories. Of the 68 valid responses, 23 were below average, 6 
were above average and 39 were average (M = 8.36, SD  =3.98).   The mean 
standardized scale scores for each of the Verbal Fluency measures was lower than the 
criterion level of 9.29 set for rejecting the null hypothesis based on the one-sample z 
test.  This finding suggests that the sample was drawn from a population with a lower 
than average level of performance on this measure.  
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 As this subtest, as well as all of the D-KEFS subtests were chosen due to their 
specific relationship with frontal lobe functioning, it makes sense that we would see 
impairment in each of these measures. This is consistent with our expectations of 
frontal lobe impairment in this population. More specifically, it is consistent with 
impairment in the dorsal lateral frontal lobe that is related to executive functioning.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.11 
 
Verbal Fluency letter fluency total scaled 
  
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 1 2 2.9 2.9 2.9 
2 1 1.4 1.5 4.4 
3 4 5.8 5.9 10.3 
4 4 5.8 5.9 16.2 
5 1 1.4 1.5 17.6 
6 7 10.1 10.3 27.9 
7 10 14.5 14.7 42.6 
8 4 5.8 5.9 48.5 
9 11 15.9 16.2 64.7 
10 5 7.2 7.4 72.1 
11 4 5.8 5.9 77.9 
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12 9 13.0 13.2 91.2 
13 2 2.9 2.9 94.1 
14 1 1.4 1.5 95.6 
15 2 2.9 2.9 98.5 
19 1 1.4 1.5 100.0 
Total 68 98.6 100.0  
Missing 999 1 1.4   
Total 69 100.0   
 
 
 
 
 
 
 
Table 4.12 
Verbal Fluency category fluency total scaled 
  
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 1 3 4.3 4.4 4.4 
2 2 2.9 2.9 7.4 
3 2 2.9 2.9 10.3 
4 1 1.4 1.5 11.8 
5 6 8.7 8.8 20.6 
6 4 5.8 5.9 26.5 
7 6 8.7 8.8 35.3 
8 11 15.9 16.2 51.5 
9 3 4.3 4.4 55.9 
10 13 18.8 19.1 75.0 
11 2 2.9 2.9 77.9 
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Verbal Fluency category fluency total scaled 
12 7 10.1 10.3 88.2 
13 2 2.9 2.9 91.2 
14 2 2.9 2.9 94.1 
16 1 1.4 1.5 95.6 
18 2 2.9 2.9 98.5 
56 1 1.4 1.5 100.0 
Total 68 98.6 100.0  
Missing 999 1 1.4   
Total 69 100.0   
 
 
 
 
 
Table 4.13 
Verbal Fluency category switching total correct scaled 
  
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 1 2 2.9 2.9 2.9 
2 3 4.3 4.4 7.4 
3 8 11.6 11.8 19.1 
4 3 4.3 4.4 23.5 
5 2 2.9 2.9 26.5 
6 4 5.8 5.9 32.4 
7 1 1.4 1.5 33.8 
8 6 8.7 8.8 42.6 
9 11 15.9 16.2 58.8 
10 5 7.2 7.4 66.2 
11 11 15.9 16.2 82.4 
12 6 8.7 8.8 91.2 
  138 
 
14 1 1.4 1.5 92.6 
15 2 2.9 2.9 95.6 
16 1 1.4 1.5 97.1 
17 2 2.9 2.9 100.0 
Total 68 98.6 100.0  
Missing 999 1 1.4   
Total 69 100.0   
 
 
  
 CPT II. 
The CPT II was developed by C. Keith Conners as a visual performance task 
which evaluates attentional variables in individuals age six or older (IPS, 2005). The 
response patterns identified by the CPT II provide information on attention, 
impulsivity, activation/arousal and difficulties in maintaining vigilance (IPS, 2005). 
The CPT II provides a confidence index value that helps evaluate whether the 
examinee matches a clinical or non- clinical respondent. In general, values above 
50% indicate a closer match to a clinical population, values below 50% indicate a 
match closer to a nonclinical profile and values at 50% are inconclusive (Conners, 
2004).  Of the 66 valid profiles, 46 scored above 50%, 7 scored below 5 % and 13 
scored at 50% (M = 68.6, SD = 19.28). Using a one-sample z-test, the chance that this 
sample was drawn from a normal population are less than one in one thousand. This 
finding confirms that the sample was drawn from a population with lower than 
average performance on this measure as well. These findings are comparable to the 
results of other reports in the literature related to attention, impulsivity, activation and 
arousal being affected in samples of adults with substance use disorders. For example, 
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as discussed in the literature review above, others have observed impaired attention in 
adults in substance use treatment (Roselli et e al., 2001). Similar to the D-KEFS 
results, these results are consistent with defined damage to the frontal lobe and related 
skill of attention, impulsivity and perseveration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.14 
 
CPT II confidence index 
  
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 23.06 1 1.4 1.5 1.5 
28.53 1 1.4 1.5 3.0 
41.2 1 1.4 1.5 4.5 
47.29 1 1.4 1.5 6.1 
49.9 3 4.3 4.5 10.6 
50 13 18.8 19.7 30.3 
53.27 1 1.4 1.5 31.8 
53.43 1 1.4 1.5 33.3 
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53.77 1 1.4 1.5 34.8 
56.52 2 2.9 3.0 37.9 
57.47 1 1.4 1.5 39.4 
59.29 1 1.4 1.5 40.9 
60.57 1 1.4 1.5 42.4 
62.22 1 1.4 1.5 43.9 
62.85 1 1.4 1.5 45.5 
66.2 1 1.4 1.5 47.0 
67.82 1 1.4 1.5 48.5 
68.1 1 1.4 1.5 50.0 
69.47 1 1.4 1.5 51.5 
69.62 1 1.4 1.5 53.0 
70.76 1 1.4 1.5 54.5 
72.04 1 1.4 1.5 56.1 
73.31 1 1.4 1.5 57.6 
75.56 1 1.4 1.5 59.1 
76.68 1 1.4 1.5 60.6 
77.46 1 1.4 1.5 62.1 
78.19 1 1.4 1.5 63.6 
78.71 1 1.4 1.5 65.2 
 
79.48 1 1.4 1.5 66.7 
79.66 1 1.4 1.5 68.2 
80.48 1 1.4 1.5 69.7 
80.61 1 1.4 1.5 71.2 
80.67 1 1.4 1.5 72.7 
82.02 1 1.4 1.5 74.2 
82.67 1 1.4 1.5 75.8 
82.7 1 1.4 1.5 77.3 
84.28 1 1.4 1.5 78.8 
86.3 1 1.4 1.5 80.3 
86.64 1 1.4 1.5 81.8 
87.08 1 1.4 1.5 83.3 
91.1 1 1.4 1.5 84.8 
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91.51 1 1.4 1.5 86.4 
93.77 1 1.4 1.5 87.9 
99.9 8 11.6 12.1 100.0 
Total 66 95.7 100.0  
Missing 999 3 4.3   
Total 69 100.0   
 
 Wechsler Test of Adult Reading (WTAR). 
 We collected data on the WTAR on all participants with the intention of using 
the information for an estimate of premorbid intelligence. However, since we were 
only giving the WASI instead of a full WAIS, we were unable to calculate the 
premorbid functioning. Personal communication with Amy Gabel, PhD, the Director 
of Client Consultation and Training at Pearson confirmed that there is not data on 
using the WASI with the WTAR and that the WASI was not intended to replace the 
WAIS in this situation. (Personal communication, 11-4-2008). Therefore, the WTAR 
results will not be included. 
 WASI. 
Though many short forms of the Wechsler Scales exist, the WASI was 
developed to provide a consistent, well normed, brief measure of intelligence (Keith, 
Lindskog & Smith, 2004).  The WASI is available in a four or two subtest format 
giving the administrator control over the time and depth of the assessment (Keith, 
Lindskog & Smith, 2004). For this study, we used the two subtest form of the WASI 
which includes the Vocabulary subtest and the Matrix Reasoning subtest resulting in 
a Full Scale IQ (FSIQ) score with a 15 minute administration time (Harcourt 
Assessment, retrieved April 27, 2006). For all subtests, raw scores are converted to T 
scores with all IQ scores having a mean of 100 and a standard deviation of 15  (Keith 
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et al., 2004). Of the 62 valid profiles for the WASI, 5 scored in the extremely low IQ 
range (< 69), 9 scored in the borderline range (70-79), 11 scored in the low average 
range (80-89), 28 in the average range (90-109), 8 in the high average range (110-
119) and 1 in the superior range (120-129). The mean for the WASI IQ score was 
92.64 with a standard deviation of 15.2.   According to the one-sample z-test, samples 
of 68 with mean less than 97.66 have a less than .05 chance of occurring if the sample 
was drawn from a population with a mean of 100.  The observed sample mean falls 
below this threshold level, suggesting that the present sample has a significantly 
lower IQ level. Though the WASI is not an assessment that is specifically associated 
with the frontal lobe, it does offer additional useful information to incorporate into 
our overall assessment of the participants executive functioning. 
 
 
 
 
 
 
 
 
 
 
 
Table 4.15 
 
WASI IQ score 
  
Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 60 1 1.4 1.6 1.6 
62 2 2.9 3.2 4.8 
66 1 1.4 1.6 6.5 
69 1 1.4 1.6 8.1 
72 1 1.4 1.6 9.7 
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WASI IQ score 
73 3 4.3 4.8 14.5 
75 2 2.9 3.2 17.7 
78 1 1.4 1.6 19.4 
79 2 2.9 3.2 22.6 
80 2 2.9 3.2 25.8 
82 1 1.4 1.6 27.4 
86 2 2.9 3.2 30.6 
88 3 4.3 4.8 35.5 
89 3 4.3 4.8 40.3 
90 2 2.9 3.2 43.5 
91 3 4.3 4.8 48.4 
93 1 1.4 1.6 50.0 
94 1 1.4 1.6 51.6 
96 3 4.3 4.8 56.5 
98 3 4.3 4.8 61.3 
99 3 4.3 4.8 66.1 
101 4 5.8 6.5 72.6 
103 1 1.4 1.6 74.2 
104 2 2.9 3.2 77.4 
105 1 1.4 1.6 79.0 
108 2 2.9 3.2 82.3 
109 2 2.9 3.2 85.5 
110 2 2.9 3.2 88.7 
112 1 1.4 1.6 90.3 
113 2 2.9 3.2 93.5 
115 1 1.4 1.6 95.2 
118 2 2.9 3.2 98.4 
121 1 1.4 1.6 100.0 
Total 62 89.9 100.0  
Missing 999 7 10.1   
Total 69 100.0   
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Drop Out and Survival in Treatment 
 Of the 68 participants followed in this study, 33 stayed in treatment past 90 
days (48.5%) and 35 dropped out prior to 90 days (51.5%). Likewise the participant’s 
length of time in treatment from first day of treatment to last day of treatment was a 
minimum of 13 days and a maximum of 426 with a mean of 120.2 and a standard 
deviation of 97.03.  
Summary of Descriptives 
 This study utilized data from 68 non-married males with an average age of 45.  
In our sample 72% had a high school education or beyond, and the majority were 
African American (66.2%) or Caucasian (25%). Data was collected and analyzed on 
neuropsychological functioning using subtest of the D-KEFS, WASI IQ and the CPT 
II. The finding suggests that the sample was drawn from a population with a lower 
than average level of performance on all measures. There was no correlation between 
age, education and the reported neuropsychological deficits.  
Neuropsychological Deficits Predicting Attrition 
To answer our second research question both demographic and psychological 
variables were considered as potential predictors of treatment attrition (defined in 
terms of receiving fewer than 90 days of treatment, versus 90 days or more of 
treatment).  The 90 day mark is used by many researchers as the cutoff for treatment 
retention and is identified as many by an average length of stay (Katz, King, 
Schwartz, Weintraub, Barksdale, Robinson and Brown, 2005).  
In order to identify demographic predictors of treatment attrition, independent 
groups t-tests were conducted to compare levels of continuous variables, such as age, 
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between patients who dropped out and those who continued.  Chi-squared tests of 
independence were employed to determine whether dropping out was significantly 
associated with education, marital status, race, and prior experience of having ADOA 
treatment. Of these demographic variables, only prior treatment experience was a 
significant predictor of dropout.  As shown in Table 4.16, patients who had no prior 
treatment experience were more likely to drop out (Chi-squared = 4.664; df = 1; p < 
.05). 
 
 
 
 
Table 4.16 
Dropout Rates By Previous Treatment History 
             Dropout      
     Yes  No 
_______________________________________________________ 
Prior Treatment History  22 (44%) 28 (56%) 
No Prior Treatment History  12 (75%)   4 (25%) 
_______________________________________________________ 
 
Initial efforts to identify such predictors employed Pearson’s correlations to 
examine the linear relationship between neuropsychological measures and length of 
treatment, as well as independent groups t-tests to test the significance of mean 
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differences in neuropsychological test scores between participants who dropped out 
before completing 90 days of treatment, and those who received 90 or more days of 
treatment.  No statistically significant linear relationships were found between 
neuropsychological measures and these indices of length of treatment. 
 The absence of significant linear effects might be understandable if the 
relationships between neuropsychological variables and length of treatment was 
actually curvilinear.  Linear correlations may be quite weak when the underlying 
relationship between two variables is U-shaped.  To detect the presence of curvilinear 
relationships, scatterplots of data were inspected. The Classification and Regression 
Trees (CART) program was used to identify cut off points for IQ computationally 
instead of just visually inspecting the scatterplots and identifying categories 
(Breiman, Friedman, Stone & Olshen, 1984). The CART software automatically tries 
out different ways of categorizing the WAIS scores. The cutting point that best 
predicts the dependent variable is selected. The CART program is regarded as an 
exploratory data analysis technique (Breiman, Friedman, Stone & Olshen, 1984). The 
distribution of WASI IQ scores with dropping out, as well as with total days of 
treatment, appeared to show a curvilinear relationship.  As shown in Table 4.17, 
patients with IQ scores that were low to average were more likely to drop out. 
Patients with average and above IQ scores, as well as those with borderline to low IQ 
scores, were less likely to drop out of treatment (Chi-squared = 10.75; df =2 ; p < 
.01).  
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Table 4.17 
Dropout Rates By WASI IQ 
                 Dropout      
    Yes  No 
_______________________________________________________ 
WASI  Below 77    2 (18.2%)   9 (81.8%) 
WASI  77-95   16 (76.2%)   5 (23.8%)    
  
WASI Above 95  13 (43.3%) 17 (56.7%)  
___________________________________ 
 
Prediction of Attrition and Continuation in Treatment 
 The main analyses of the present investigation utilized logistic regression and 
survival analysis to predict attrition and continuation in treatment.  Logistic 
regression was utilized to assess the unique contributions of predictors (i.e., prior 
treatment, WASI IQ level) on the binary outcome of dropping out before 90 days of 
treatment or continuing.  For the survival analysis, Cox regression was utilized to 
examine the association between predictors and length of treatment.  WASI IQ level 
was coded in the manner described above in order to examine curvilinear effects of 
IQ. 
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Logistic Regression 
 Both Prior Treatment and WASI IQ level were entered into a logistic 
regression equation to predict the probability of dropping out of treatment before 
completing 90 days.  The regression analysis was set up so that the medium level of 
the WASI IQ variable served as a reference category against which the lowest and 
highest levels were contrasted.  As shown in Table 4.18, only WASI IQ, not prior 
treatment, made a significant unique contribution to the prediction of dropping out.  
Specifically, patients with low to average IQ scores (77-95) were more likely to drop 
out than those with borderline to low IQ scores (below 77). 
Table 4.18 
Logistic Regression Predicting Dropout Rates From Prior Treatment and WASI IQ 
Level 
     Beta SE Wald df Significance 
____________________________________________________________________
  
Prior Treatment   -.971 .752 1.660 1 .196 
WASI Level      6.409 2 .041 
 Low vs.Medium  -2.398 .956 6.295 1 .012 
 High vs. Medium   -0.979  .682 2.061 1 .376 
Constant       .518 .660 0.615 1 .433 
___________________________________________________________________ 
The beta weights in logistic regression are conceptually like those in ordinary least 
squares regression, only now they are predicting the likelihood of dropping out of 
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treatment.  A positive beta means that higher scores on the predictor are associated 
with a greater likelihood of dropping out. A negative beta means that higher scores on 
the predictor are associated with a lower likelihood of dropping out. The Wald 
statistic indicates whether the beta weight is statistically significant.  Thus, the results 
of the logistic regression indicate that subjects with borderline to low IQ scores are 
significantly less likely to drop out than those with average or above scores.  There is 
a non-significant trend toward lower dropout rates for subjects who have had prior 
treatment, as well as those who have relatively high IQ scores (i.e.., IQ  > 95).  While 
there is no precise formula for computation of R-squared in logistic regression, there 
are methods for the computation of an analogous measure of effect size, or “pseudo 
R-squared”.  The Cox and Snell R-Square for the logistic regression model presented 
above is .182, while the Nagelkerke R-Square is .243.  The overall model accounted 
for a substantial portion of the variance in the dependent variables.   
Survival Analysis/Cox Regression 
Both Prior Treatment and WASI IQ Level were entered into a Cox regression 
equation to predict the survival in treatment (i.e. number of days between the start and 
end of treatment).  As in the preceding analyses, the medium level of the WASI IQ 
variable (low to average IQ) served as a reference category against which the lowest 
(borderline to low) and highest (average and above) levels were contrasted.  As 
shown in Table 4.19, one of the WASI IQ contrasts, and not prior treatment, made a 
significant unique contribution to the prediction of survival.  Patients with low to 
average IQ scores (77-95) had shorter survival times than those with borderline to 
low IQ scores (below 77). 
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Table 4.19 
Cox Regression Predicting Survival Rates From Prior Treatment and WASI IQ Level 
     Beta SE Wald df Significance 
____________________________________________________________________
  
Prior Treatment   -0.324 .315 1.054 1 .305 
WASI Level      4.911 2 .086 
 Low vs. Medium  -0.851 .386 4.853 1 .028 
 High vs. Medium  -0.383 .311 1.518 1 .218 
____________________________________________________________________ 
In the Cox Regression, a negative Beta weight indicates a lower chance of 
dropping out.  The Wald statistic again provides a test of the null hypothesis that the 
Beta population parameter equals zero.  Thus, subjects with borderline to low IQ 
(below 77) have a significantly lower chance of dropping out across time (i.e., they 
will remain in treatment for a longer time).  There is a non-significant trends toward 
longer survival among subjects with prior treatment histories and average to high IQ 
(over 95).  
Summary of Logistic Regression and Survival Analysis 
 The findings of the present study suggest that general intelligence, as assessed 
by the WASI, predicts dropout and survival in treatment.  The effects of IQ are 
significant even after controlling for, or partialling out, the effects of prior treatment 
history on dropout rates.  Conversely, the effects of prior treatment on dropping out 
are no longer significant when WASI IQ is entered into the equation.  This suggests 
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that the relationship between prior treatment history and dropping out might be 
explained in part by differences in WASI IQ.  Throughout these analyses, the effects 
of WASI IQ are curvilinear: patients with low to average IQ are more likely to drop 
out than those with borderline to low IQ, while those with average or above IQ have 
an intermediate level of dropping out or persisting in treatment.  
Correlations Affecting Attrition and Length of Treatment 
 In addition to the above statistics, we decided to run further correlations to 
evaluate whether there were relationships between the NP variables, IQ and prior 
treatment and whether these relationships affected attrition or length of stay in 
treatment.  
 Some correlations were found to exist between the NP variables and IQ which 
intuitively makes sense and has been found by other researchers (Zinn, Stein & 
Swartzwelder, 2004). All four of the D-KEFS subtests used (Trail Making Test, Color 
Word, Verbal Fluency and Tower) had sections that were significantly correlated with 
IQ. These results can be viewed in table 4.20 below.  
Table 4.20 
 
NP and WASI Correlations 
 
 NP Measure 
  
 Correlation with 
WASI IQ 
TMTvisscRW  Trail making test visual 
scanning raw 
Pearson Correlation 
-.299 
  
Sig. (2-tailed) .018 
  
N 62 
TMTvisscSC  Trail making test visual 
scanning scaled 
Pearson Correlation 
.297 
  
Sig. (2-tailed) 
.019 
  
N 62 
TMTnumRW  trail making test number Pearson Correlation -.492 
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sequence raw 
  
Sig. (2-tailed) .000 
  
N 
62 
TMTnumSC  trail making test number 
sequence scaled 
Pearson Correlation 
.508 
  
Sig. (2-tailed) .000 
  
N 62 
TMTletRW  trail making test letter 
sequence raw 
Pearson Correlation 
-.489 
  
Sig. (2-tailed) .000 
  
N 62 
TMTletSC  trail making test letter 
sequence scaled 
Pearson Correlation 
.542 
  
Sig. (2-tailed) .000 
  
N 62 
TMTNLSRAW  Trail Making 
Num/Letter Raw Score 
Pearson Correlation 
-.667 
  
Sig. (2-tailed) .000 
  
N 60 
TMTNLSSC  Trail Making Number 
letter sequencing Scaled score 
Pearson Correlation 
.672 
  
Sig. (2-tailed) .000 
  
N 60 
TMTmsRAW  Trails motor speed raw Pearson Correlation -.359 
  
Sig. (2-tailed) .005 
  
N 61 
TMTmsSC  trails motor speed scaled Pearson Correlation .344 
  
Sig. (2-tailed) .007 
  
N 61 
TMTcmbSS  trails combined number + 
letter  sum of scaled scores 
Pearson Correlation 
.572 
  
Sig. (2-tailed) .000 
  
N 62 
TMTcmbCS  trails combined number+ 
letter sequencing composite scaled 
score 
Pearson Correlation 
.575 
  
Sig. (2-tailed) .000 
  
N 62 
TMTSvVSSSD  trails switching vs. 
visual scanning scaled score dif 
Pearson Correlation 
.394 
  
Sig. (2-tailed) .002 
  
N 60 
TMTSvVSCS   trailsswitching vs. 
visual sanning contrast scaled score 
Pearson Correlation 
.416 
  
Sig. (2-tailed) .001 
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N 60 
TMTSvNSSSD  trails switching vs 
number sequencing scaled score dif 
Pearson Correlation 
.192 
  
Sig. (2-tailed) .141 
  
N 60 
TMTSvNSCS  trails switiching vs. 
number sequencing contrast sclaed 
score 
Pearson Correlation 
.178 
  
Sig. (2-tailed) .173 
  
N 60 
TMTSvLSSD  Trails switching vs letter 
sequencing scaled score dif 
Pearson Correlation 
.150 
  
Sig. (2-tailed) .251 
  
N 60 
TMTSvLSCS  trailsswitching vs. letter 
sequencing scaled score contrast scaled 
score 
Pearson Correlation 
.146 
  
Sig. (2-tailed) .266 
  
N 60 
TMTSvCmbSSD  trails switching 
vs.combined scaled score dif 
Pearson Correlation 
.103 
  
Sig. (2-tailed) .432 
  
N 60 
TMTSvCmbCS  trails switching vs. 
combined contrasst scaled score 
Pearson Correlation 
.098 
  
Sig. (2-tailed) .456 
  
N 60 
TMTSvMSSSD  trails switching vs. 
motor speed scaled score dif 
Pearson Correlation 
.423 
  
Sig. (2-tailed) .001 
  
N 60 
TMTSvMSCS  trails switching vs. 
motor speed contrast scaled score 
Pearson Correlation 
.416 
  
Sig. (2-tailed) .001 
  
N 60 
VFLFtotalRW  verbal fluency letter 
fluency total raw 
Pearson Correlation 
.579 
  
Sig. (2-tailed) .000 
  
N 62 
VFLFtotalSC  verbal fluency letter 
fluency total scaled 
Pearson Correlation 
.573 
  
Sig. (2-tailed) .000 
  
N 62 
VFCFtotalRW  verbal fluency category 
fluency total raw 
Pearson Correlation 
.601 
  
Sig. (2-tailed) .000 
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N 62 
VFCFtotalSC  verbal fluency category 
fluency total scaled 
Pearson Correlation 
.171 
  
Sig. (2-tailed) .185 
  
N 62 
VFCatSwRW  verbal fluency category 
switching total correct raw 
Pearson Correlation 
.434 
  
Sig. (2-tailed) .000 
  
N 62 
VFCatSwSC  verbal fluency category 
switching total correct scaled 
Pearson Correlation 
.418 
  
Sig. (2-tailed) .001 
  
N 62 
VFtotalSwRW  verbal fluency category 
switching total switching Raw 
Pearson Correlation 
.494 
  
Sig. (2-tailed) .000 
  
N 62 
VFtotalSwSC  verbal fluency category 
switching total switching scaled 
Pearson Correlation 
.482 
  
Sig. (2-tailed) .000 
  
N 62 
VFLFvsCFSSD  verbal fluency letter 
fluency vs category fluency Scaled 
Score Difference 
Pearson Correlation 
-.023 
  
Sig. (2-tailed) .862 
  
N 62 
VFLFvsCFCSS  verbal fluency letter 
fluency vs category fluency Contrast 
Scaled Score 
Pearson Correlation 
-.023 
  
Sig. (2-tailed) .862 
  
N 62 
VFCSvsCFSSD  verbal fluency 
category switching vs category fluency 
Scaled Score Difference 
Pearson Correlation 
-.139 
  
Sig. (2-tailed) .281 
  
N 62 
VFCSvsCFCSS  verbal fluency 
category switching vs category fluency 
Contrast Scaled Score 
Pearson Correlation 
-.125 
  
Sig. (2-tailed) .333 
  
N 62 
VF1stRW  verbal fluency 1st interval 
total correct raw 
Pearson Correlation 
.526 
  
Sig. (2-tailed) .000 
  
N 62 
VF1stSC  verbal fluency 1st interval Pearson Correlation .517 
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total correct scale 
  
Sig. (2-tailed) .000 
  
N 62 
VF2ndRW  verbal fluency 2nd interval 
total correct raw 
Pearson Correlation 
.611 
  
Sig. (2-tailed) .000 
  
N 62 
VF2ndSc  verbal fluency 2nd interval 
total correct scale 
Pearson Correlation 
.599 
  
Sig. (2-tailed) .000 
  
N 62 
VF3rdRW  verbal fluency 3rd interval 
total correct raw 
Pearson Correlation 
.562 
  
Sig. (2-tailed) .000 
  
N 62 
VF3rdSC  verbal fluency 3rd interval 
total correct scale 
Pearson Correlation 
.549 
  
Sig. (2-tailed) .000 
  
N 62 
VF4thRW  verbal fluency 4th interval 
total correct raw 
Pearson Correlation 
.555 
  
Sig. (2-tailed) .000 
  
N 62 
VF4thSC  verbal fluency 4th interval 
total correct scale 
Pearson Correlation 
.553 
  
Sig. (2-tailed) .000 
  
N 62 
VFSLerrRW  verbal fluency set loss 
errors raw 
Pearson Correlation 
-.186 
  
Sig. (2-tailed) .147 
  
N 62 
VFSLerrSC  verbal fluency set loss 
errors scaled 
Pearson Correlation 
.177 
  
Sig. (2-tailed) .168 
  
N 62 
VFREPerrRW  verbal fluency 
repetition errors raw 
Pearson Correlation 
-.011 
  
Sig. (2-tailed) .931 
  
N 62 
VFREPerrSC  verbal fluency repetition 
errors scaled 
Pearson Correlation 
-.015 
  
Sig. (2-tailed) .910 
  
N 62 
VFtotrespRW  verbal fluency total 
responses-correct and incorrect-raw 
Pearson Correlation 
.545 
  
Sig. (2-tailed) .000 
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N 62 
CWclrnmRW  color word color naming 
raw 
Pearson Correlation 
-.487 
  
Sig. (2-tailed) .000 
  
N 62 
CWclrnmSC  color word color naming 
scaled 
Pearson Correlation 
.435 
  
Sig. (2-tailed) .000 
  
N 62 
CWreadRW  color word word reading 
raw 
Pearson Correlation 
-.454 
  
Sig. (2-tailed) .000 
  
N 62 
CWreadSC  color word word reading 
scaled 
Pearson Correlation 
.425 
  
Sig. (2-tailed) .001 
  
N 62 
CWinhibRW  color word inhibition raw Pearson Correlation -.555 
  
Sig. (2-tailed) .000 
  
N 62 
CWinhibSC  color word inhibition 
scaled 
Pearson Correlation 
.541 
  
Sig. (2-tailed) .000 
  
N 62 
CWinswitRW  color word 
inhibition/switching raw 
Pearson Correlation 
-.534 
  
Sig. (2-tailed) .000 
  
N 62 
CWinswitSC  color word 
inhibition/switching scaled 
Pearson Correlation 
.505 
  
Sig. (2-tailed) .000 
  
N 62 
CWcmbSSS  color word combined 
naming and reading Sum of Scaled 
Scores 
Pearson Correlation 
.459 
  
Sig. (2-tailed) .000 
  
N 62 
CWcmbCSS  color word combined 
naming and reading Composite Scaled 
Score 
Pearson Correlation 
.462 
  
Sig. (2-tailed) .000 
  
N 62 
CWErCNRW  color word error Color 
naming raw 
Pearson Correlation 
-.458 
  
Sig. (2-tailed) .000 
  
N 62 
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CWErCNSC  color word error color 
naming scaled 
Pearson Correlation 
.357 
  
Sig. (2-tailed) .004 
  
N 62 
CWErWRRW  Color word error Word 
reading Raw 
Pearson Correlation 
-.338 
  
Sig. (2-tailed) .007 
  
N 62 
CWErWRSC  Color word error Word 
reading scaled 
Pearson Correlation 
.394 
  
Sig. (2-tailed) .002 
  
N 62 
CWErInhRW  Color word error 
inhibition raw 
Pearson Correlation 
-.543 
  
Sig. (2-tailed) .000 
  
N 62 
CWErInhSc  Color word error 
inhibition scaled 
Pearson Correlation 
.553 
  
Sig. (2-tailed) .000 
  
N 62 
CWErInSwRw  Color Word Error 
inhibition/Switching raw 
Pearson Correlation 
-.560 
  
Sig. (2-tailed) .000 
  
N 62 
CWErInSwSc  Color Word Error 
Inhibition/Switching Scaled 
Pearson Correlation 
.592 
  
Sig. (2-tailed) .000 
  
N 62 
TTtotalRW  Tower Test total 
achievement score raw 
Pearson Correlation 
.463 
  
Sig. (2-tailed) .000 
  
N 61 
TTtotalSC  Tower Test total 
achievement score scaled 
Pearson Correlation 
.448 
  
Sig. (2-tailed) .000 
  
N 61 
TTrulesRW  Tower Test total rule 
violations raw 
Pearson Correlation 
-.616 
  
Sig. (2-tailed) .000 
  
N 61 
TTrulesPR  Tower Test total rule 
violations cumulative percentile rank 
Pearson Correlation 
.577 
  
Sig. (2-tailed) .000 
  
N 61 
TT1stmvtmR  Tower test mean 1st 
move time ratio score 
Pearson Correlation 
.026 
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Sig. (2-tailed) .845 
  
N 61 
TT1stmvtmS  Tower test mean 1st 
move time Scaled score 
Pearson Correlation 
-.011 
  
Sig. (2-tailed) .935 
  
N 61 
TTtmprmvR  Tower test time per move 
ratio score 
Pearson Correlation 
-.219 
  
Sig. (2-tailed) .090 
  
N 61 
TTtmprmvS  Tower test time per move 
scaled score 
Pearson Correlation 
.180 
  
Sig. (2-tailed) .165 
  
N 61 
TTmvaccR  Tower test move accuracy 
ratio score 
Pearson Correlation 
-.239 
  
Sig. (2-tailed) .064 
  
N 61 
TTmvaccSc  Tower test move accuracy 
scaled score 
Pearson Correlation 
.226 
  
Sig. (2-tailed) .080 
  
N 61 
TTruleitemR  Tower test rule violations 
per item ratio score 
Pearson Correlation 
-.651 
  
Sig. (2-tailed) .000 
  
N 61 
TTruleitemS  Tower test rule violations 
per item scaled score 
Pearson Correlation 
.645 
  
Sig. (2-tailed) .000 
  
N 61 
CPTconfind  CPT II confidence index Pearson Correlation -.178 
  
Sig. (2-tailed) .170 
  
N 61 
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 Even more interesting, is that the NP variables are significantly correlated 
with attrition and length of stay in treatment for cases that have below median IQ for 
this sample (IQ < 94). Three of the four D-KEFS subtests used correlated 
significantly on cases with IQ below 94 (Trail Making, Verbal Fluency and Tower 
Test). The results of this correlation can be viewed in table 4.21 below. 
Table 4.21 
Correlations (IQ less than 94) 
 
 (IQ less than 94) 
   
Drop out 
daysintx  
number of days 
from 1st day of 
treatment to 
last day 
TMTvisscRW  Trail making test 
visual scanning raw 
Pearson Correlation 
-.224 .055 
  
Sig. (2-tailed) .226 .769 
  
N 31 31 
TMTvisscSC  Trail making test 
visual scanning scaled 
Pearson Correlation 
.215 -.022 
  
Sig. (2-tailed) 
.245 .906 
  
N 31 31 
TMTnumRW  trail making test 
number sequence raw 
Pearson Correlation 
-.494 .240 
  
Sig. (2-tailed) .005 .193 
  
N 
31 31 
TMTnumSC  trail making test 
number sequence scaled 
Pearson Correlation 
.446 -.259 
  
Sig. (2-tailed) .012 .159 
  
N 31 31 
TMTletRW  trail making test 
letter sequence raw 
Pearson Correlation 
-.259 .119 
  
Sig. (2-tailed) .159 .524 
  
N 31 31 
TMTletSC  trail making test letter 
sequence scaled 
Pearson Correlation 
.147 -.051 
  
Sig. (2-tailed) .429 .786 
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N 31 31 
TMTNLSRAW  Trail Making 
Num/Letter Raw Score 
Pearson Correlation 
-.257 .256 
  
Sig. (2-tailed) .178 .180 
  
N 29 29 
TMTNLSSC  Trail Making 
Number letter sequencing Scaled 
score 
Pearson Correlation 
.269 -.231 
  
Sig. (2-tailed) .159 .228 
  
N 29 29 
TMTmsRAW  Trails motor speed 
raw 
Pearson Correlation 
.005 .106 
  
Sig. (2-tailed) .979 .578 
  
N 30 30 
TMTmsSC  trails motor speed 
scaled 
Pearson Correlation 
-.035 -.079 
  
Sig. (2-tailed) .854 .678 
  
N 30 30 
TMTcmbSS  trails combined 
number + letter  sum of scaled 
scores 
Pearson Correlation 
.338 -.177 
  
Sig. (2-tailed) .063 .340 
  
N 31 31 
TMTcmbCS  trails combined 
number+ letter sequencing 
composite scaled score 
Pearson Correlation 
.325 -.146 
  
Sig. (2-tailed) .074 .432 
  
N 31 31 
TMTSvVSSSD  trails switching 
vs. visual scanning scaled score 
dif 
Pearson Correlation 
.093 -.276 
  
Sig. (2-tailed) .631 .148 
  
N 29 29 
TMTSvVSCS   trailsswitching vs. 
visual sanning contrast scaled 
score 
Pearson Correlation 
.140 -.320 
  
Sig. (2-tailed) .468 .090 
  
N 29 29 
TMTSvNSSSD  trails switching 
vs number sequencing scaled 
score dif 
Pearson Correlation 
-.246 .114 
  
Sig. (2-tailed) .198 .556 
  
N 29 29 
TMTSvNSCS  trails switiching 
vs. number sequencing contrast 
sclaed score 
Pearson Correlation 
-.253 .124 
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Sig. (2-tailed) .185 .522 
  
N 29 29 
TMTSvLSSD  Trails switching vs 
letter sequencing scaled score dif 
Pearson Correlation 
.173 -.178 
  
Sig. (2-tailed) .368 .355 
  
N 29 29 
TMTSvLSCS  trailsswitching vs. 
letter sequencing scaled score 
contrast scaled score 
Pearson Correlation 
.167 -.163 
  
Sig. (2-tailed) .387 .397 
  
N 29 29 
TMTSvCmbSSD  trails switching 
vs.combined scaled score dif 
Pearson Correlation 
-.046 -.062 
  
Sig. (2-tailed) .813 .749 
  
N 29 29 
TMTSvCmbCS  trails switching 
vs. combined contrasst scaled 
score 
Pearson Correlation 
-.059 -.042 
  
Sig. (2-tailed) .761 .827 
  
N 29 29 
TMTSvMSSSD  trails switching 
vs. motor speed scaled score dif 
Pearson Correlation 
.278 -.162 
  
Sig. (2-tailed) .144 .401 
  
N 29 29 
TMTSvMSCS  trails switching 
vs. motor speed contrast scaled 
score 
Pearson Correlation 
.305 -.184 
  
Sig. (2-tailed) .108 .338 
  
N 29 29 
VFLFtotalRW  verbal fluency 
letter fluency total raw 
Pearson Correlation 
.354 -.309 
  
Sig. (2-tailed) .051 .090 
  
N 31 31 
VFLFtotalSC  verbal fluency 
letter fluency total scaled 
Pearson Correlation 
.340 -.317 
  
Sig. (2-tailed) .062 .082 
  
N 31 31 
VFCFtotalRW  verbal fluency 
category fluency total raw 
Pearson Correlation 
.305 -.186 
  
Sig. (2-tailed) .095 .315 
  
N 31 31 
VFCFtotalSC  verbal fluency 
category fluency total scaled 
Pearson Correlation 
-.096 -.041 
  
Sig. (2-tailed) .609 .829 
  
N 31 31 
VFCatSwRW  verbal fluency Pearson Correlation .134 -.002 
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category switching total correct 
raw 
  
Sig. (2-tailed) .473 .990 
  
N 31 31 
VFCatSwSC  verbal fluency 
category switching total correct 
scaled 
Pearson Correlation 
.099 .010 
  
Sig. (2-tailed) .595 .956 
  
N 31 31 
VFtotalSwRW  verbal fluency 
category switching total switching 
Raw 
Pearson Correlation 
-.001 .067 
  
Sig. (2-tailed) .998 .719 
  
N 31 31 
VFtotalSwSC  verbal fluency 
category switching total switching 
scaled 
Pearson Correlation 
-.013 .068 
  
Sig. (2-tailed) .947 .717 
  
N 31 31 
VFLFvsCFSSD  verbal fluency 
letter fluency vs category fluency 
Scaled Score Difference 
Pearson Correlation 
.047 -.088 
  
Sig. (2-tailed) .803 .639 
  
N 31 31 
VFLFvsCFCSS  verbal fluency 
letter fluency vs category fluency 
Contrast Scaled Score 
Pearson Correlation 
.047 -.088 
  
Sig. (2-tailed) .803 .639 
  
N 31 31 
VFCSvsCFSSD  verbal fluency 
category switching vs category 
fluency Scaled Score Difference 
Pearson Correlation 
-.181 .251 
  
Sig. (2-tailed) .331 .173 
  
N 31 31 
VFCSvsCFCSS  verbal fluency 
category switching vs category 
fluency Contrast Scaled Score 
Pearson Correlation 
-.181 .251 
  
Sig. (2-tailed) .331 .173 
  
N 31 31 
VF1stRW  verbal fluency 1st 
interval total correct raw 
Pearson Correlation 
.308 -.207 
  
Sig. (2-tailed) .092 .263 
  
N 31 31 
VF1stSC  verbal fluency 1st 
interval total correct scale 
Pearson Correlation 
.278 -.209 
  
Sig. (2-tailed) .130 .260 
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N 31 31 
VF2ndRW  verbal fluency 2nd 
interval total correct raw 
Pearson Correlation 
.401 -.294 
  
Sig. (2-tailed) .025 .108 
  
N 31 31 
VF2ndSc  verbal fluency 2nd 
interval total correct scale 
Pearson Correlation 
.373 -.313 
  
Sig. (2-tailed) .039 .087 
  
N 31 31 
VF3rdRW  verbal fluency 3rd 
interval total correct raw 
Pearson Correlation 
.223 -.180 
  
Sig. (2-tailed) .229 .332 
  
N 31 31 
VF3rdSC  verbal fluency 3rd 
interval total correct scale 
Pearson Correlation 
.155 -.158 
  
Sig. (2-tailed) .404 .395 
  
N 31 31 
VF4thRW  verbal fluency 4th 
interval total correct raw 
Pearson Correlation 
.232 -.146 
  
Sig. (2-tailed) .210 .433 
  
N 31 31 
VF4thSC  verbal fluency 4th 
interval total correct scale 
Pearson Correlation 
.231 -.155 
  
Sig. (2-tailed) .212 .405 
  
N 31 31 
VFSLerrRW  verbal fluency set 
loss errors raw 
Pearson Correlation 
.216 -.120 
  
Sig. (2-tailed) .244 .519 
  
N 31 31 
VFSLerrSC  verbal fluency set 
loss errors scaled 
Pearson Correlation 
-.214 .135 
  
Sig. (2-tailed) .248 .468 
  
N 31 31 
VFREPerrRW  verbal fluency 
repetition errors raw 
Pearson Correlation 
-.062 .278 
  
Sig. (2-tailed) .741 .130 
  
N 31 31 
VFREPerrSC  verbal fluency 
repetition errors scaled 
Pearson Correlation 
-.061 -.162 
  
Sig. (2-tailed) .743 .384 
  
N 31 31 
VFtotrespRW  verbal fluency 
total responses-correct and 
incorrect-raw 
Pearson Correlation 
.339 -.205 
  
Sig. (2-tailed) .063 .268 
  
N 31 31 
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CWclrnmRW  color word color 
naming raw 
Pearson Correlation 
-.325 .183 
  
Sig. (2-tailed) .075 .324 
  
N 31 31 
CWclrnmSC  color word color 
naming scaled 
Pearson Correlation 
.225 -.164 
  
Sig. (2-tailed) .224 .378 
  
N 31 31 
CWreadRW  color word word 
reading raw 
Pearson Correlation 
-.052 .030 
  
Sig. (2-tailed) .783 .874 
  
N 31 31 
CWreadSC  color word word 
reading scaled 
Pearson Correlation 
.124 -.045 
  
Sig. (2-tailed) .505 .811 
  
N 31 31 
CWinhibRW  color word 
inhibition raw 
Pearson Correlation 
-.180 .220 
  
Sig. (2-tailed) .333 .233 
  
N 31 31 
CWinhibSC  color word 
inhibition scaled 
Pearson Correlation 
.126 -.209 
  
Sig. (2-tailed) .500 .260 
  
N 31 31 
CWinswitRW  color word 
inhibition/switching raw 
Pearson Correlation 
.091 -.020 
  
Sig. (2-tailed) .626 .916 
  
N 31 31 
CWinswitSC  color word 
inhibition/switching scaled 
Pearson Correlation 
-.068 .005 
  
Sig. (2-tailed) .715 .977 
  
N 31 31 
CWcmbSSS  color word 
combined naming and reading 
Sum of Scaled Scores 
Pearson Correlation 
.186 -.112 
  
Sig. (2-tailed) .315 .549 
  
N 31 31 
CWcmbCSS  color word 
combined naming and reading 
Composite Scaled Score 
Pearson Correlation 
.166 -.096 
  
Sig. (2-tailed) .372 .607 
  
N 31 31 
CWErCNRW  color word error 
Color naming raw 
Pearson Correlation 
-.009 -.073 
  
Sig. (2-tailed) .961 .697 
  
N 31 31 
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CWErCNSC  color word error 
color naming scaled 
Pearson Correlation 
.182 -.076 
  
Sig. (2-tailed) .326 .684 
  
N 31 31 
CWErWRRW  Color word error 
Word reading Raw 
Pearson Correlation 
-.191 .004 
  
Sig. (2-tailed) .304 .984 
  
N 31 31 
CWErWRSC  Color word error 
Word reading scaled 
Pearson Correlation 
.275 -.095 
  
Sig. (2-tailed) .134 .612 
  
N 31 31 
CWErInhRW  Color word error 
inhibition raw 
Pearson Correlation 
-.167 .073 
  
Sig. (2-tailed) .369 .697 
  
N 31 31 
CWErInhSc  Color word error 
inhibition scaled 
Pearson Correlation 
.129 -.164 
  
Sig. (2-tailed) .491 .379 
  
N 31 31 
CWErInSwRw  Color Word Error 
inhibition/Switching raw 
Pearson Correlation 
-.130 -.016 
  
Sig. (2-tailed) .487 .934 
  
N 31 31 
CWErInSwSc  Color Word Error 
Inhibition/Switching Scaled 
Pearson Correlation 
.144 -.040 
  
Sig. (2-tailed) .439 .831 
  
N 31 31 
TTtotalRW  Tower Test total 
achievement score raw 
Pearson Correlation 
.300 -.120 
  
Sig. (2-tailed) .108 .529 
  
N 30 30 
TTtotalSC  Tower Test total 
achievement score scaled 
Pearson Correlation 
.293 -.112 
  
Sig. (2-tailed) .116 .554 
  
N 
30 
30 
 
 
TTrulesRW  Tower Test total rule 
violations raw 
Pearson Correlation 
-.495 .453 
  
Sig. (2-tailed) .005 .012 
  
N 30 30 
TTrulesPR  Tower Test total rule 
violations cumulative percentile 
rank 
Pearson Correlation 
.433 -.353 
  
Sig. (2-tailed) .017 .055 
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N 30 30 
TT1stmvtmR  Tower test mean 
1st move time ratio score 
Pearson Correlation 
.041 .015 
  
Sig. (2-tailed) .828 .939 
  
N 30 30 
TT1stmvtmS  Tower test mean 
1st move time Scaled score 
Pearson Correlation 
-.039 -.040 
  
Sig. (2-tailed) .837 .835 
  
N 30 30 
TTtmprmvR  Tower test time per 
move ratio score 
Pearson Correlation 
.091 .006 
  
Sig. (2-tailed) .634 .975 
  
N 30 30 
TTtmprmvS  Tower test time per 
move scaled score 
Pearson Correlation 
-.117 .020 
  
Sig. (2-tailed) .537 .917 
  
N 30 30 
TTmvaccR  Tower test move 
accuracy ratio score 
Pearson Correlation 
-.137 .135 
  
Sig. (2-tailed) .471 .476 
  
N 30 30 
TTmvaccSc  Tower test move 
accuracy scaled score 
Pearson Correlation 
.145 -.132 
  
Sig. (2-tailed) .444 .487 
  
N 30 30 
TTruleitemR  Tower test rule 
violations per item ratio score 
Pearson Correlation 
-.533 .446 
  
Sig. (2-tailed) .002 .014 
  
N 30 30 
TTruleitemS  Tower test rule 
violations per item scaled score 
Pearson Correlation 
.486 -.419 
  Sig. (2-tailed) .006 .021 
  N 30 30 
CPTconfind  CPT II confidence 
index 
Pearson Correlation 
-.335 .259 
  Sig. (2-tailed) .070 .166 
  N 30 30 
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With IQ equal to or greater than 94, none of the NP variables were statistically 
significantly correlated with attrition and survival in treatment. 
  In addition to the correlation with IQ below 94, some of the NP variables are 
correlated significantly with drop out and length of stay in treatment for cases that 
had no prior AODA treatment. It appears that the NP variables are more important in 
cases that have had no prior treatment than in cases that had prior treatment. Again, 
caution must be taked due to the small sample sizes. Two of the four D-KEFS 
subtests used correlated significantly in cases with no prior treatment (Verbal Fluency 
and Tower Test). The results can be reviewed in table 4.22. 
Table 4.22  
Correlations (No Prior AODA Treatment) 
 
 (No Prior AODA Treatment) 
   
Drop out 
daysintx  
number of days 
from 1st day of 
treatment to 
last day 
TMTvisscRW  Trail making test 
visual scanning raw 
Pearson Correlation 
.235 -.225 
  
Sig. (2-tailed) .381 .402 
  
N 16 16 
TMTvisscSC  Trail making test 
visual scanning scaled 
Pearson Correlation 
-.225 .202 
  
Sig. (2-tailed) 
.402 .453 
  
N 16 16 
TMTnumRW  trail making test 
number sequence raw 
Pearson Correlation 
-.288 .097 
  
Sig. (2-tailed) .279 .722 
  
N 
16 16 
TMTnumSC  trail making test 
number sequence scaled 
Pearson Correlation 
.346 -.139 
  
Sig. (2-tailed) .189 .609 
  
N 16 16 
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TMTletRW  trail making test 
letter sequence raw 
Pearson Correlation 
.199 -.223 
  
Sig. (2-tailed) .459 .405 
  
N 16 16 
TMTletSC  trail making test letter 
sequence scaled 
Pearson Correlation 
-.179 .205 
  
Sig. (2-tailed) .507 .446 
  
N 16 16 
TMTNLSRAW  Trail Making 
Num/Letter Raw Score 
Pearson Correlation 
-.106 .136 
  
Sig. (2-tailed) .696 .617 
  
N 16 16 
TMTNLSSC  Trail Making 
Number letter sequencing Scaled 
score 
Pearson Correlation 
.206 -.252 
  
Sig. (2-tailed) .444 .346 
  
N 16 16 
TMTmsRAW  Trails motor speed 
raw 
Pearson Correlation 
-.079 .163 
  
Sig. (2-tailed) .771 .546 
  
N 16 16 
TMTmsSC  trails motor speed 
scaled 
Pearson Correlation 
.073 -.166 
  
Sig. (2-tailed) .789 .539 
  
N 16 16 
TMTcmbSS  trails combined 
number + letter  sum of scaled 
scores 
Pearson Correlation 
.090 .040 
  
Sig. (2-tailed) .740 .883 
  
N 16 16 
TMTcmbCS  trails combined 
number+ letter sequencing 
composite scaled score 
Pearson Correlation 
.064 .081 
  
Sig. (2-tailed) .814 .765 
  
N 16 16 
TMTSvVSSSD  trails switching 
vs. visual scanning scaled score 
dif 
Pearson Correlation 
.413 -.431 
  
Sig. (2-tailed) .112 .096 
  
N 16 16 
TMTSvVSCS   trailsswitching vs. 
visual sanning contrast scaled 
score 
Pearson Correlation 
.409 -.431 
  
Sig. (2-tailed) .115 .096 
  
N 16 16 
TMTSvNSSSD  trails switching Pearson Correlation -.146 -.117 
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vs number sequencing scaled 
score dif 
  
Sig. (2-tailed) .590 .666 
  
N 16 16 
TMTSvNSCS  trails switiching 
vs. number sequencing contrast 
sclaed score 
Pearson Correlation 
-.163 -.106 
  
Sig. (2-tailed) .546 .696 
  
N 16 16 
TMTSvLSSD  Trails switching vs 
letter sequencing scaled score dif 
Pearson Correlation 
.342 -.405 
  
Sig. (2-tailed) .195 .119 
  
N 16 16 
TMTSvLSCS  trailsswitching vs. 
letter sequencing scaled score 
contrast scaled score 
Pearson Correlation 
.328 -.384 
  
Sig. (2-tailed) .216 .142 
  
N 16 16 
TMTSvCmbSSD  trails switching 
vs.combined scaled score dif 
Pearson Correlation 
.135 -.320 
  
Sig. (2-tailed) .619 .228 
  
N 16 16 
TMTSvCmbCS  trails switching 
vs. combined contrasst scaled 
score 
Pearson Correlation 
.109 -.293 
  
Sig. (2-tailed) .688 .272 
  
N 16 16 
TMTSvMSSSD  trails switching 
vs. motor speed scaled score dif 
Pearson Correlation 
.146 -.108 
  
Sig. (2-tailed) .589 .692 
  
N 16 16 
TMTSvMSCS  trails switching 
vs. motor speed contrast scaled 
score 
Pearson Correlation 
.146 -.108 
  
Sig. (2-tailed) .589 .692 
  
N 16 16 
VFLFtotalRW  verbal fluency 
letter fluency total raw 
Pearson Correlation 
-.172 .040 
  
Sig. (2-tailed) .525 .882 
  
N 16 16 
VFLFtotalSC  verbal fluency 
letter fluency total scaled 
Pearson Correlation 
-.187 .064 
  
Sig. (2-tailed) .487 .813 
  
N 16 16 
VFCFtotalRW  verbal fluency 
category fluency total raw 
Pearson Correlation 
.112 -.110 
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Sig. (2-tailed) .679 .686 
  
N 16 16 
VFCFtotalSC  verbal fluency 
category fluency total scaled 
Pearson Correlation 
.163 -.174 
  
Sig. (2-tailed) .547 .518 
  
N 16 16 
VFCatSwRW  verbal fluency 
category switching total correct 
raw 
Pearson Correlation 
-.065 -.017 
  
Sig. (2-tailed) .810 .949 
  
N 16 16 
VFCatSwSC  verbal fluency 
category switching total correct 
scaled 
Pearson Correlation 
-.047 -.046 
  
Sig. (2-tailed) .861 .867 
  
N 16 16 
VFtotalSwRW  verbal fluency 
category switching total switching 
Raw 
Pearson Correlation 
-.115 -.026 
  
Sig. (2-tailed) .671 .925 
  
N 16 16 
VFtotalSwSC  verbal fluency 
category switching total switching 
scaled 
Pearson Correlation 
-.105 -.038 
  
Sig. (2-tailed) .698 .889 
  
N 16 16 
VFLFvsCFSSD  verbal fluency 
letter fluency vs category fluency 
Scaled Score Difference 
Pearson Correlation 
-.323 .215 
  
Sig. (2-tailed) .223 .424 
  
N 16 16 
VFLFvsCFCSS  verbal fluency 
letter fluency vs category fluency 
Contrast Scaled Score 
Pearson Correlation 
-.323 .215 
  
Sig. (2-tailed) .223 .424 
  
N 16 16 
VFCSvsCFSSD  verbal fluency 
category switching vs category 
fluency Scaled Score Difference 
Pearson Correlation 
-.185 .088 
  
Sig. (2-tailed) .493 .747 
  
N 16 16 
VFCSvsCFCSS  verbal fluency 
category switching vs category 
fluency Contrast Scaled Score 
Pearson Correlation 
-.185 .088 
  
Sig. (2-tailed) .493 .747 
  
N 16 16 
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VF1stRW  verbal fluency 1st 
interval total correct raw 
Pearson Correlation 
.238 -.267 
  
Sig. (2-tailed) .375 .318 
  
N 16 16 
VF1stSC  verbal fluency 1st 
interval total correct scale 
Pearson Correlation 
.259 -.298 
  
Sig. (2-tailed) .333 .262 
  
N 16 16 
VF2ndRW  verbal fluency 2nd 
interval total correct raw 
Pearson Correlation 
.156 -.236 
  
Sig. (2-tailed) .565 .378 
  
N 16 16 
VF2ndSc  verbal fluency 2nd 
interval total correct scale 
Pearson Correlation 
.168 -.274 
  
Sig. (2-tailed) .533 .305 
  
N 16 16 
VF3rdRW  verbal fluency 3rd 
interval total correct raw 
Pearson Correlation 
-.462 .357 
  
Sig. (2-tailed) .071 .175 
  
N 16 16 
VF3rdSC  verbal fluency 3rd 
interval total correct scale 
Pearson Correlation 
-.593 .464 
  
Sig. (2-tailed) .015 .070 
  
N 16 16 
VF4thRW  verbal fluency 4th 
interval total correct raw 
Pearson Correlation 
-.403 .287 
  
Sig. (2-tailed) .121 .281 
  
N 16 16 
VF4thSC  verbal fluency 4th 
interval total correct scale 
Pearson Correlation 
-.410 .286 
  
Sig. (2-tailed) .115 .283 
  
N 16 16 
VFSLerrRW  verbal fluency set 
loss errors raw 
Pearson Correlation 
-.133 .256 
  
Sig. (2-tailed) .623 .338 
  
N 16 16 
VFSLerrSC  verbal fluency set 
loss errors scaled 
Pearson Correlation 
.182 -.289 
  
Sig. (2-tailed) .501 .277 
  
N 16 16 
VFREPerrRW  verbal fluency 
repetition errors raw 
Pearson Correlation 
.217 -.257 
  
Sig. (2-tailed) .419 .336 
  
N 16 16 
VFREPerrSC  verbal fluency 
repetition errors scaled 
Pearson Correlation 
-.238 .263 
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Sig. (2-tailed) .374 .325 
  
N 16 16 
VFtotrespRW  verbal fluency 
total responses-correct and 
incorrect-raw 
Pearson Correlation 
-.041 -.051 
  
Sig. (2-tailed) .881 .851 
  
N 16 16 
CWclrnmRW  color word color 
naming raw 
Pearson Correlation 
-.374 .441 
  
Sig. (2-tailed) .153 .087 
  
N 16 16 
CWclrnmSC  color word color 
naming scaled 
Pearson Correlation 
.406 -.472 
  
Sig. (2-tailed) .119 .065 
  
N 16 16 
CWreadRW  color word word 
reading raw 
Pearson Correlation 
-.011 .088 
  
Sig. (2-tailed) .969 .746 
  
N 16 16 
CWreadSC  color word word 
reading scaled 
Pearson Correlation 
.123 -.152 
  
Sig. (2-tailed) .649 .574 
  
N 16 16 
CWinhibRW  color word 
inhibition raw 
Pearson Correlation 
-.433 .512 
  
Sig. (2-tailed) .094 .043 
  
N 16 16 
CWinhibSC  color word 
inhibition scaled 
Pearson Correlation 
.372 -.466 
  
Sig. (2-tailed) .156 .069 
  
N 16 16 
CWinswitRW  color word 
inhibition/switching raw 
Pearson Correlation 
-.276 .440 
  
Sig. (2-tailed) .302 .088 
  
N 16 16 
CWinswitSC  color word 
inhibition/switching scaled 
Pearson Correlation 
.272 -.461 
  
Sig. (2-tailed) .308 .072 
  
N 16 16 
CWcmbSSS  color word 
combined naming and reading 
Sum of Scaled Scores 
Pearson Correlation 
.278 -.329 
  
Sig. (2-tailed) .296 .213 
  
N 16 16 
CWcmbCSS  color word 
combined naming and reading 
Pearson Correlation 
.242 -.298 
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Composite Scaled Score 
  
Sig. (2-tailed) .367 .261 
  
N 16 16 
CWErCNRW  color word error 
Color naming raw 
Pearson Correlation 
.148 -.147 
  
Sig. (2-tailed) .584 .588 
  
N 16 16 
CWErCNSC  color word error 
color naming scaled 
Pearson Correlation 
-.137 .144 
  
Sig. (2-tailed) .614 .594 
  
N 16 16 
CWErWRRW  Color word error 
Word reading Raw 
Pearson Correlation 
.000 -.144 
  
Sig. (2-tailed) 1.000 .594 
  
N 16 16 
CWErWRSC  Color word error 
Word reading scaled 
Pearson Correlation 
.197 .083 
  
Sig. (2-tailed) .464 .760 
  
N 16 16 
CWErInhRW  Color word error 
inhibition raw 
Pearson Correlation 
-.238 .296 
  
Sig. (2-tailed) .374 .266 
  
N 16 16 
CWErInhSc  Color word error 
inhibition scaled 
Pearson Correlation 
.257 -.344 
  
Sig. (2-tailed) .336 .193 
  
N 16 16 
CWErInSwRw  Color Word Error 
inhibition/Switching raw 
Pearson Correlation 
.044 .096 
  
Sig. (2-tailed) .872 .724 
  
N 16 16 
CWErInSwSc  Color Word Error 
Inhibition/Switching Scaled 
Pearson Correlation 
-.041 -.100 
  
Sig. (2-tailed) .881 .713 
  
N 16 16 
TTtotalRW  Tower Test total 
achievement score raw 
Pearson Correlation 
.644 -.506 
  
Sig. (2-tailed) .007 .046 
  
N 16 16 
TTtotalSC  Tower Test total 
achievement score scaled 
Pearson Correlation 
.625 -.478 
  
Sig. (2-tailed) .010 .061 
  
N 16 16 
TTrulesRW  Tower Test total rule 
violations raw 
Pearson Correlation 
-.756 .669 
  
Sig. (2-tailed) .001 .005 
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N 16 16 
TTrulesPR  Tower Test total rule 
violations cumulative percentile 
rank 
Pearson Correlation 
.572 -.553 
  
Sig. (2-tailed) .020 .026 
  
N 16 16 
TT1stmvtmR  Tower test mean 
1st move time ratio score 
Pearson Correlation 
-.197 .220 
  
Sig. (2-tailed) .465 .414 
  
N 16 16 
TT1stmvtmS  Tower test mean 
1st move time Scaled score 
Pearson Correlation 
.277 -.327 
  
Sig. (2-tailed) .298 .217 
  
N 16 16 
TTtmprmvR  Tower test time per 
move ratio score 
Pearson Correlation 
-.468 .506 
  
Sig. (2-tailed) .068 .045 
  
N 16 16 
TTtmprmvS  Tower test time per 
move scaled score 
Pearson Correlation 
.454 -.523 
  
Sig. (2-tailed) .077 .038 
  N 16 16 
TTmvaccR  Tower test move 
accuracy ratio score 
Pearson Correlation 
-.113 .132 
  Sig. (2-tailed) .677 .625 
  N 16 16 
TTmvaccSc  Tower test move 
accuracy scaled score 
Pearson Correlation 
.084 -.091 
  Sig. (2-tailed) .756 .737 
  N 16 16 
TTruleitemR  Tower test rule 
violations per item ratio score 
Pearson Correlation 
-.747 .671 
  Sig. (2-tailed) .001 .004 
  N 16 16 
TTruleitemS  Tower test rule 
violations per item scaled score 
Pearson Correlation 
.701 -.661 
  Sig. (2-tailed) .003 .005 
  N 16 16 
CPTconfind  CPT II confidence 
index 
Pearson Correlation 
-.168 .254 
  Sig. (2-tailed) .534 .343 
  N 16 16 
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Summary of Correlations 
 Most importantly, the correlations show that some of the NP variables are 
correlated significantly with attrition and survival in treatment for cases that have 
below median (94) IQ. Furthermore, some of the NP variables are correlated 
significantly with drop out and survival in treatment in cases that had no prior 
treatment.  The NP variables that show statistically significant correlations include 
Trail Making, Verbal Fluency and Tower test for cases with below median IQ and 
Verbal Fluency and Tower test for no prior AODA treatment. The Color Word 
Subtest did correlate with IQ but not when looking at the relationship with drop out or 
length of stay in treatment. The CPT II test showed no statistically significant 
correlation. These results will be discussed in further detail in the discussion section. 
Effect Size 
Finally, as previously mentioned, no relative effect sizes could be found to be 
used to determine sample size for this study. Therefore, effect sizes were calculated 
and reported on as another valuable outcome of this study. Information on effect sizes 
is valuable as it can help determine which variables look most promising as possible 
predictors of attrition and to provide information on how many more cases one would 
have to add to the sample size to obtain sufficient statistical power. Effect sizes were 
computed as the square of the correlation between each NP measure and each 
outcome. As can be seen in Table 4.23, the effect sizes overall are fairly small. The 
largest effect size is for the variable Tower Test Rule Violations Per Item Ration 
Score which has an effect size close to 6% (.059). Again, caution must be taken with 
interpreting these effect sizes due to small sample size. Using the G-Power software 
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package (Erdfelder, Faul & Buchner, 1996) power and sample size were calculated. 
In order to attain statistical power of .80 (meaning there is an 80% chance of rejecting 
the null hypothesis) we would need a sample size of 98 (Erdfelder, Faul & Buchner, 
1996). To obtain a power of .95, we would need a sample size of 170 (Erdfelder, Faul 
& Buchner, 19696).  
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Table 4.23 
Effect Sizes for NP Measures on Length of Treatment and Dropout. 
 
 
 
          Correlation           Effect Size   Correlation    Effect Size 
  
 
 
Length of 
 treatment-days 
Length of  
treatment -days Dropout   Dropout 
     
Trail making test visual scanning 
raw -0.028 0.000784 0.064 0.004096 
Trail making test visual scanning 
scaled 0.025 0.000625 -0.046 0.002116 
trail making test number 
sequence raw 0.133 0.017689 -0.23 0.0529 
trail making test number 
sequence scaled -0.128 0.016384 0.172 0.029584 
trail making test letter sequence 
raw 0.043 0.001849 -0.082 0.006724 
trail making test letter sequence 
scaled -0.01 0.0001 -0.007 0.000049 
Trail Making Num/Letter Raw 
Score 0.032 0.001024 -0.017 0.000289 
Trail Making Number letter 
sequencing Scaled score -0.014 0.000196 0.011 0.000121 
Trails motor speed raw 0.155 0.024025 -0.065 0.004225 
trails motor speed scaled 
-0.147 0.021609 0.042 0.001764 
trails combined number + letter 
sum of scaled scores -0.075 0.005625 0.09 0.0081 
trails combined number+ letter 
sequencing composite scaled 
score -0.058 0.003364 0.083 0.006889 
trails switching vs. visual 
scanning scaled score dif -0.037 0.001369 0.057 0.003249 
trailsswitching vs. visual sanning 
contrast scaled score -0.039 0.001521 0.062 0.003844 
trails switching vs number 
sequencing scaled score dif 0.159 0.025281 -0.183 0.033489 
trails switiching vs. number 
sequencing contrast sclaed 
score 0.163 0.026569 -0.184 0.033856 
Trails switching vs letter 
sequencing scaled score dif 0.002 0.000004 0.048 0.002304 
trailsswitching vs. letter 
sequencing scaled score 
contrast scaled score 0.01 0.0001 0.044 0.001936 
trails switching vs.combined 
scaled score dif 0.075 0.005625 -0.075 0.005625 
trails switching vs. combined 
contrasst scaled score 0.084 0.007056 -0.081 0.006561 
trails switching vs. motor speed 
scaled score dif 0.113 0.012769 -0.036 0.001296 
trails switching vs. motor speed 
contrast scaled score 0.103 0.010609 -0.024 0.000576 
verbal fluency letter fluency total 
raw -0.065 0.004225 0.095 0.009025 
verbal fluency letter fluency total 
scaled -0.043 0.001849 0.067 0.004489 
verbal fluency category fluency 
total raw -0.109 0.011881 0.149 0.022201 
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verbal fluency category fluency 
total scaled -0.055 0.003025 -0.036 0.001296 
verbal fluency category switching 
total correct raw -0.038 0.001444 0.024 0.000576 
verbal fluency category switching 
total correct scaled -0.045 0.002025 0.023 0.000529 
verbal fluency category switching 
total switching Raw -0.03 0.0009 -0.06 0.0036 
verbal fluency category switching 
total switching scaled -0.032 0.001024 -0.066 0.004356 
verbal fluency letter fluency vs 
category fluency Scaled Score 
Difference 0.1 0.01 -0.089 0.007921 
verbal fluency letter fluency vs 
category fluency Contrast Scaled 
Score 0.1 0.01 -0.089 0.007921 
verbal fluency category switching 
vs category fluency Scaled 
Score Difference 0.083 0.006889 -0.123 0.015129 
verbal fluency category switching 
vs category fluency Contrast 
Scaled Score 0.084 0.007056 -0.136 0.018496 
verbal fluency 1st interval total 
correct raw -0.04 0.0016 0.101 0.010201 
verbal fluency 1st interval total 
correct scale -0.035 0.001225 0.091 0.008281 
verbal fluency 2nd interval total 
correct raw -0.154 0.023716 0.142 0.020164 
verbal fluency 2nd interval total 
correct scale -0.153 0.023409 0.124 0.015376 
verbal fluency 3rd interval total 
correct raw -0.061 0.003721 0.082 0.006724 
verbal fluency 3rd interval total 
correct scale -0.049 0.002401 0.054 0.002916 
verbal fluency 4th interval total 
correct raw -0.067 0.004489 0.087 0.007569 
verbal fluency 4th interval total 
correct scale -0.069 0.004761 0.092 0.008464 
verbal fluency set loss errors raw 0.014 0.000196 0.051 0.002601 
verbal fluency set loss errors 
scaled -0.03 0.0009 -0.021 0.000441 
verbal fluency repetition errors 
raw 0.207 0.042849 -0.077 0.005929 
verbal fluency repetition errors 
scaled -0.138 0.019044 0.02 0.0004 
verbal fluency total responses-
correct and incorrect-raw -0.049 0.002401 0.141 0.019881 
color word color naming raw 0.161 0.025921 -0.193 0.037249 
color word color naming scaled 
-0.175 0.030625 0.144 0.020736 
color word word reading raw 0.081 0.006561 -0.056 0.003136 
color word word reading scaled 
-0.121 0.014641 0.11 0.0121 
color word inhibition raw 0.157 0.024649 -0.016 0.000256 
color word inhibition scaled 
-0.171 0.029241 0.01 0.0001 
color word inhibition/switching 
raw 0.067 0.004489 0.075 0.005625 
color word inhibition/switching 
scaled -0.101 0.010201 -0.047 0.002209 
color word combined naming 
and reading Sum of Scaled 
Scores -0.158 0.024964 0.136 0.018496 
color word combined naming 
and reading Composite Scaled 
Score -0.152 0.023104 0.129 0.016641 
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color word error Color naming 
raw -0.086 0.007396 0.055 0.003025 
color word error color naming 
scaled 0.034 0.001156 -0.027 0.000729 
Color word error Word reading 
Raw -0.02 0.0004 -0.109 0.011881 
Color word error Word reading 
scaled -0.001 0.000001 0.126 0.015876 
Color word error inhibition raw 0.076 0.005776 -0.103 0.010609 
Color word error inhibition scaled 
-0.127 0.016129 0.065 0.004225 
Color Word Error 
inhibition/Switching raw -0.053 0.002809 -0.008 0.000064 
Color Word Error 
Inhibition/Switching Scaled 0.001 0.000001 0.027 0.000729 
Tower Test total achievement 
score raw -0.058 0.003364 0.187 0.034969 
Tower Test total achievement 
score scaled -0.052 0.002704 0.183 0.033489 
Tower Test total rule violations 
raw 0.232 0.053824 -0.212 0.044944 
Tower Test total rule violations 
cumulative percentile rank -0.135 0.018225 0.095 0.009025 
Tower test mean 1st move time 
ratio score 0.103 0.010609 -0.07 0.0049 
Tower test mean 1st move time 
Scaled score -0.074 0.005476 0.045 0.002025 
Tower test time per move ratio 
score 0.175 0.030625 -0.115 0.013225 
Tower test time per move scaled 
score -0.178 0.031684 0.121 0.014641 
Tower test move accuracy ratio 
score -0.118 0.013924 0.097 0.009409 
Tower test move accuracy 
scaled score 0.116 0.013456 -0.089 0.007921 
Tower test rule violations per 
item ratio score 0.243 0.059049 -0.244 0.059536 
Tower test rule violations per 
item scaled score -0.214 0.045796 0.206 0.042436 
WASI vocab raw score 
-0.033 0.001089 0.035 0.001225 
WASI vocab T-score 
-0.047 0.002209 0.036 0.001296 
WASI matrix reasoning raw 
score -0.146 0.021316 0.14 0.0196 
WASI matrix reasoning T-score 
-0.155 0.024025 0.135 0.018225 
WASI sum of T-scores 
-0.135 0.018225 0.128 0.016384 
WASI IQ score 
-0.13 0.0169 0.109 0.011881 
CPT II confidence index 
-0.025 0.000625 -0.021 0.000441 
WTAR Standard Score 0.003 0.000009 -0.053 0.002809 
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Chapter V: Discussion 
 The purpose of this study was to assess the neuropsychological functioning of 
clients who meet diagnostic criteria for substance dependence according to the 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition - Text 
Revision (DSM IV-TR; APA, 2000) and to examine the relationship between 
neuropsychological functioning and treatment attrition rates. Specifically, the 
executive functioning of individuals was evaluated. Furthermore, the relationships 
between substance use diagnosis, treatment attrition, and neuropsychological 
functioning was investigated. It may be that understanding how deficits in 
neuropsychological functioning affect an individual’s behaviors (e.g., relapse, 
missing treatment sessions, and dropping out of treatment) may help to change 
attitudes of clinicians and others who may currently negatively stigmatize those with 
substance use disorders (e.g., believing that the individual is lazy, unmotivated, etc.). 
Understanding the relationships between substance use diagnosis, attrition, and 
neuropsychological functioning could prove extremely useful in substance use 
disorder program development, treatment planning, clinician training and stigma 
reduction.      
 Neuropsychological and cognitive impairment in substance abusing 
participants as well as homeless participants has also been reported in existing 
research as discussed previously. Therefore, the results of this study add to the 
existing research that confirms that people with a substance abuse issue as well as 
homeless individuals have a much greater occurrence of NP deficit than the general 
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population. Though much has been written about impairment in homeless substance 
abusing people, very little has been written about the relationship of 
neuropsychological impairment and attrition in treatment. As there is still a paucity of 
research in this area, the results of this study with regards to neuropsychological 
deficit, drop out and attrition add to the existing research.   
 
                                   Interpretation of Findings 
Summary 
 This study examined the neuropsychological functioning of homeless, 
substance dependent men and how this affected attrition, survival in treatment and 
relapse. In summary, the neuropsychological (NP) functioning of this group of 68 
adult males located in the Guesthouse Shelter of Milwaukee as a whole, showed 
statistically significant impaired functioning on all measures; though not every 
individual was impaired on every measure, some were impaired on each measure. For 
example, using a threshold of two standard deviations below the mean, (the threshold 
of two SD was used as this is often used as a threshold of abnormality, for example, T 
scores of 70 or higher are noted on psychodiagnostic measures such as the MMPI) 
24.6% were impaired on the Trail Making Test Number Sequencing and Letter 
Sequencing Scaled score, 23.2% were impaired on the Verbal Fluency Category 
Switching Scaled score and 26.1% were impaired on the Color Word Naming Scaled 
score. Likewise, with a score of greater than 50% indicating impairment, 66.7% were 
impaired on the CPT II. Finally, the WASI IQ score showed 7.2 % impaired. Of the 
neuropsychological variables, only the WASI IQ predicted attrition and length of stay 
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except not in the expected linear relationship. The WASI IQ showed a curvilinear 
relationship to drop out and attrition. Prior to examining the results of this study, I 
had expected to see a linear relationship exist between low IQ and high attrition. The 
results of this study showed that participants with a low to average WASI IQ score 
(77-95) were statistically significantly more likely (than those with a borderline to 
low IQ - <77 or average to high IQ - >95) to drop out (p = .012) and more likely to 
have shorter lengths of stay in treatment (p = .028). In addition, some NP variables 
did show a relationship with drop out and length of stay when looking at cases with a 
median IQ below 94 and those with no prior AODA treatment. 
Neuropsychological Impairment as Indicated by the D-KEFS, CPT II, and WASI  
      The results of this study indicated that this sample was drawn from a population 
with a lower than average level of performance on all measures. Specifically, the 
mean standardized scores for all of the D-KEFS subtests including the Tower Test, 
Verbal Fluency, Color Word and Trail Making test was lower than the criterion level 
of 9.29 set for rejecting the null hypothesis based on the one sample z test. These 
assessments were all chosen based on their ability to assess executive functions which 
are specifically associated with the frontal lobe- the brain area of primary interest in 
this study. Likewise, using a one sample z-test, the chance that this sample was drawn 
from a normal population on the CPT II test are less than one in one thousand. 
Finally, according to the one-sample z-test, the results of the WASI IQ subtest show 
that samples of 68 with mean less than 97.66 have a less than .05 chance of occurring 
if the sample was drawn from a population with a mean of 100.  The observed sample 
mean falls below this threshold level, suggesting that the present sample has a 
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significantly lower IQ level. In practical terms, this indicates that our sample of 
substance abusing homeless men have a much lower level of cognitive functioning 
than the general population of non-homeless, non-substance abusing men. We cannot 
assume causation – that substance use or homelessness causes the impairment- or that 
the impairment causes homelessness or substance use. However, we can state that this 
sample in general is impaired and this information needs to be utilized when treating 
homeless, substance using men. 
 There are multiple implications of the severity of the NP deficit found in this 
sample. The NP impairment found by this study, as well as other studies (Burra, 
Stergiopoulos, & Rourke, 2009; Spence, Stevens & Parks, 2004), suggests that more 
thorough evaluation of NP strengths and weaknesses should be afforded to all 
homeless and/or substance abusing clients to develop better-tailored treatment 
programs and resources. Although we cannot make definitive causal connections 
from this study this information will be helpful for treatment providers to recognize 
the deficits as a limitation in the population they are serving. Though not presuming 
causation from these results, it is the opinion of this writer that a circular relationship 
exists between NP function, substance use, homelessness and attrition with each of 
these variables having a cause and effect relationship with each other. For example, 
substance use can cause NP impairment; NP impairment can cause individuals to 
make poor choices about substance use. Likewise, NP function can affect attrition; 
attrition/dropping out of treatment can cause one to be more likely to abuse 
substances causing more NP damage.  Clinicians need to be cognizant that the 
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discussed deficits likely impair a homeless person’s ability to maintain stable housing 
and follow clinician/staff recommendations.  
The NP deficits examined in this study primarily address executive function 
skills which are specifically associated with the frontal lobe and include four 
components of (a) volition, (b) planning (c) purposive action, and (d) effective 
performance (Lezak, 1995; Lezak et al, 2004). These primary skill areas need to be 
taken into consideration with all goal and treatment planning. For example, clients 
would benefit from assistance in developing concrete goals, reduced to small, short 
term objectives. Likewise, they would need encouragement and instruction on how to 
begin addressing each goal. All instruction and education should be given in multiple 
media (written, verbal, auditory, etc) with frequent reminders. In addition to the NP 
components examined by the D-KEFS, the CPT II provides information on attention, 
impulsivity, activation/arousal and difficulties in maintaining vigilance (IPS, 2005). 
These specific skills are associated with the dorsal lateral prefrontal cortex. The CPT 
II is a simple, fast, computer generated instrument that would be easy for clinician to 
utilize upon primary assessment of clients that are homeless or struggling with 
substance abuse. This information could be used to increase client and clinician 
insight and develop goals specific to maintaining attention. For example, clients 
might be given a binder with all important information to bring with them to each 
appointment. Likewise, they could be given a wallet size card with reminders of 
important dates or aspects of treatment. Furthermore, calendars could be given to all 
clients and clinicians could be trained to remind the client to write all goals on the 
calendar- including self-care goals, formal appointments and social activities.  
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Though overall, all four D-KEFS subtests showed impairment in skills 
associated with the frontal lobe, it is the opinion of this writer that much detail related 
to frontal lobe function was still missed. For example, I do not believe any of these 
instruments adequately evaluate the frontal lobe function of behavior starting. With a 
guided assessment, someone facilitating the moves of the participant, behavior 
starting is difficult to assess. Likewise, purposive action, the gap between a client 
stating their intentions, and actually following through on the necessary behaviors is 
an important component of the frontal lobe (Lezak, 2004). This actual skill is difficult 
to assess during formal assessment as the facilitator again constantly guides the 
participant. In real life, people do not have someone with them prompting all the 
necessary, appropriate behaviors. This appears to be the paradoxical nature of all of 
the assessments used in the battery for this research. As these are formal, structured 
assessments, it is difficult to assess some of the more discretionary frontal lobe 
functions. However, all of the assessments were chosen due to their proclaimed 
ability to capture these skills. It is the opinion of this writer that these assessments did 
not adequately capture those components of the dorsal lateral frontal lobe.  
Cognitive Functioning Predictive of Attrition and Survival in Treatment 
 For this study, general intelligence, as assessed by the WASI, predicts drop 
out and survival in treatment. Specifically, subjects with average to above IQ (>95), 
as well as those with borderline to low IQ (<77) were less likely to drop out of 
treatment, whereas subjects with an IQ between 77-95 were more likely to drop out.  
Likewise, subjects with low to average IQ (77-95) had shorter survival times (i.e., 
“time in treatment”) than those with borderline to  low IQ (<77). More precisely, 
  186 
 
participants with a low to average WASI IQ score (77-95) were statistically 
significantly more likely to drop out (p = .012) and more likely to have shorter 
lengths of stay in treatment (p= .028). These findings indicate that one can predict 
drop out and length of time in treatment by evaluating the IQ of the participant. 
However, as previously mentioned, caution must be taken given the small sample 
size. Confidence in these results could be increased with a study that used a larger 
sample. Specifically, a Beta of -2.398 (p = .012) was found for predicting drop out 
and a Beta of  -851 (p = .028) was found for predicting survival in treatment. 
Evaluating the strength of this Beta can be complicated with a binary logistic 
regression as there is no precise equivalent to an effect size measure like r-squared 
when predicting a binary outcome (Garson, 2009, retrieved June 9, 2009). We have 
no exact equivalent to r-squared because our dependent variable is not a continuous 
variable. Rather, the dependent variable is dichotomous- the odds of dropping out or 
not. Table 4.17 above shows the percentage of drop out by IQ. The group with IQ 
between 77 and 95 were over four times more likely to drop out than those with an IQ 
below 77, and almost twice as likely to drop out than those with an IQ over 95. 
          To compare these results to existing research, cognitive impairment has been 
found by multiple researchers in substance abusing adults (Grohman & Fals Stewart, 
2004) as well as homeless males (Buhrich, Hodder & Teesson, 2000; Burra, 
Stergiopoulos & Rourke, 2009; Spence, Stevens & Parks, 2004 ). In addition, 
cognitive deficits predicting low treatment retention have also been found by other 
researchers (Aharonovich, Hasin, Brooks, Liu, Bisage & Nunes, 2005: Fals Stewart & 
Lucente, 1994). On the contrary, other researchers have found no difference in 
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treatment retention between high and low cognitive ability (Katz, King, Schwartz, 
Weintraub, Barksdale, Robinson and Brown, 2005).  
 The finding that low to average cognitive functioning (IQ between 77 and 95) 
(as opposed to borderline to low functioning, IQ below 77) is predictive of drop out 
and survival in treatment has implications for barriers to treatment, treatment 
planning, clinician training, and continued substance use in clients. These factors, in 
turn, can have an effect on the community, family and funding sources. To speculate, 
it appears that patients need to have a minimal level of cognitive functioning in order 
to drop out of treatment. For example, the results of this study indicate that those with 
an IQ between 77 and 95 were statistically significantly more likely to drop out (p = 
.012). To be precise, the group with IQ between 77 and 95 were over four times more 
likely to drop out than those with an IQ below 77, and almost twice as likely to drop 
out than those with an IQ over 95. Again, in speculation, for the borderline to low IQ 
patients, treatment might serve as a kind of sheltered environment.  Patients with low 
to average IQ may have just enough cognitive functioning to follow through on a bad 
decision about dropping out.  Patients with average and above IQ are perhaps more 
likely to make a good decision regarding persistence in treatment. Those with average 
and above IQ might be better able to recognize the benefits of treatment such as 
abstinence, improved mood, improved family functioning and resolution of legal 
conflicts. Likewise, those with average and above IQ might also be better able to 
recognize the negative consequences of dropping out such as continued substance 
use, health issues and family disappointment. However, there are many words of 
caution when using and interpreting the results of IQ tests. For example, the Wechsler 
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Adult Intelligence Scales were not designed to assess brain damaged patients and are 
considered “insensitive to their neurobehavioral problems and cognitive deficits” 
(Sbordone, Saul & Purisch, 2007, p.357). Likewise, there are many additional 
concerns reported about the use of the Wechsler IQ including over-interpretation of 
subtest scores, belief that norms may not be applicable for ethnic minorities, 
complexity of scoring lending itself to clerical errors by examiners, and subjectivity 
in scoring (Groth-Marnat, 2003).  Furthermore, there is question related to the actual 
meaning of IQ scores. Many misconceptions are made regarding IQ scores. IQ scores 
are not fixed and they are “not exact, precise measurements” (Groth-Marnat, 2003, p. 
140). When interpreting intelligence scores, one needs to remember that IQ scores are 
estimates that can be related to a variety of environmental factors (Groth-Marnat, 
2003). 
 Clinicians need to be cognizant of the prevalence of cognitive impairment in 
substance using clients and the potential negative impact this can have on drop out 
and survival in treatment. In addition, clinicians might be more likely to give 
additional attention to the clients with borderline to low IQ. However the results of 
this study indicate that it is actually the clients in the low to average, not borderline to 
low range, who may need extra effort. Clinicians should partake in additional training 
to increase assessment skills to identify clients with low to average IQ. Utilizing a 
simple, brief, assessment tool, such as the WASI, could provide valuable information 
to clinicians if included in the standard intake assessment. All clients should be 
screened for cognitive impairment during the initial assessment with those with low 
to average IQ being offered additional support services through the treatment process. 
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Clients that appear to be struggling may need to be referred to a more structured or 
intense program during the initial months of recovery. 
 Specific techniques can be employed toward improving outcomes for 
substance users with cognitive deficits. For example, drug counseling that makes use 
of mapping techniques has been shown to improve treatment outcome by addressing 
planning and problem solving issues (Czuchry & Dansereau, 2003b). Mapping 
techniques would not only be helpful for the client with cognitive deficit, but also the 
clients with NP deficits addressed above. Using mapping techniques that address 
planning and problem solving would offer support to clients with NP impairment, 
especially executive function impairment. Any and all repetition and guidance in 
planning and problem solving skills will assist these individuals in compensating for 
such deficits.  
Strategies used to address cognitive dysfunction in patients with traumatic 
head injuries can also be helpful with cognitively impaired substance abusers (Ersche 
& Sahakian, 2007). For example, information should be presented to clients in a 
variety of modalities such as written, oral, auditory and visual. Education should be 
done slowly with repetition and paraphrasing encouraged by the client (William & 
Evans, 2003). In addition, communication between all clinical staff will help to 
ensure that cognitively impaired clients are not perceived as deceitful or 
manipulative. Likewise, treatment providers must keep in mind that cognitively 
impaired clients' nonadherence to treatment may be a result of the impairment and not 
caused by denial, resistance, or unwillingness to accept care (SAMHSA, 1998).  
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 Clients demonstrating a low to average IQ warrant special attention in regard 
to disengaging from services. The client should be made aware of their risk of 
dropping out or not staying in treatment. This should be discussed thoroughly and 
goals implemented to address this risk. For example, clients could be given a list of 
people to call when having thoughts of not returning to treatment. Likewise, the topic 
of dropping out of treatment should be added to the agenda of regularly addressed 
issues in the treatment process. Finally, therapist awareness could be elevated by 
providing a visual cue on the charts of at risk clients. For example, clients at high risk 
could have a different color label on their chart.  
 
 
Neuropsychological Function and Attrition/Survival in Treatment 
 Although some research has indicated a possible relationship (with the 
assumption that poor NP function would increase attrition) between 
neuropsychological functioning and attrition rates (Zinn et al., 2004) there is still a 
paucity of research on this topic. Some authors acknowledged that 
neuropsychological impairment may negatively affect attrition and treatment success 
but they have not formally evaluated retention and/or attrition (Zinn et al., 2004). As 
discussed above, researchers suggest that a relationship between neuropsychological 
functioning and treatment outcome exists, but empirical attempts to document this 
relationship have been met with limited success.   
The results of this study show that there is a relationship between the 
neuropsychological variables (D-KEFS) and attrition rates with below median IQ 
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(below 94) and no prior AODA treatment. However, caution must be taken regarding 
the confidence in this data due to the small sample size. Specifically, the NP variables 
that show statistically significant correlations include Trail Making, Verbal Fluency 
and Tower test for cases with below median IQ and Verbal Fluency and Tower test 
for no prior AODA treatment. The results indicate that for most of the subtest 
relationships, there was a negative correlation indicating that the better the subject 
performed on the measure, the more likely he was to drop out of treatment and/or 
have a shorter length of stay in treatment. Although perhaps counterintuitive the 
results are indeed interesting.   
 The three subtests shown to be predictive of drop out and/or length of stay 
include the Trail Making test, the Verbal Fluency and the Tower Test. (All three were 
predictive for subjects with below median IQ and Verbal Fluency and Tower test 
were predictive in subjects with no prior treatment) The Trail making test measures 
flexibility of thinking on a visual motor task. There is a negative correlation between 
the trail making test number sequencing raw score and participant drop out for 
subjects with below median IQ (r = -.494, p = .005) indicating that the better they 
scored, the more likely they were to drop out. The r squared for this correlation is .24 
indicating that 24% of the variance of the drop out can be accounted for by trail 
making test predictor. This is a relatively strong prediction. (As a general rule, 
correlations that account for 10% or less of the variance are weak, those that account 
for more than 25% are quite strong; Cohen, 1977) 
This subtest requires the individual to visually scan and sequence numbers. This 
subtest might be more of an indication of cognitive functioning and therefore may be 
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an indication of participants with moderate functioning being more likely to drop out 
as indicated by the WASI scores being predictive of drop out.  Likewise, two of the 
Tower Test scores, which measure spatial planning, rule violation, inhibition of 
impulsive responding, inhibition of perseverative responding and establishing and 
maintaining an instructional set, also showed a negative correlation. Specifically the 
tower test total rule violations raw score was r = -.495, p = .005 (with an r squared of 
.24, again relatively strong prediction) and tower test rule violations per item ratio 
score was r = -.533, p = .002 (with an r squared of .28). This score indicates that the 
more rule violations a participant had, the less likely they were to drop out or the 
better they did, the more likely they were to drop out.  Similarly, two of the Tower 
test subtests for subjects that had no prior treatment also showed a correlation that 
indicates the better the participant performed, the more likely they were to drop out or 
have a decreased length of stay. The tower test total achievement raw score has a 
correlation of r = .644, p = .007 (with an r squared of .40, predictive strength 
increasing) and tower test total rule violations raw score has a correlation of r = -.756, 
p = .001 (a very strong prediction with an r squared of  .56). The only NP subtests 
that indicated that the better a subject performed, the less likely they were to drop out 
was the Verbal Fluency third interval for subjects with no prior treatment (r = -.593, p 
= .015, r squared of .34) and the Verbal Fluency second interval total correct score 
showed a correlation of  r = .401, p = .025 (a somewhat weaker predictor with an r 
squared of .16) However, these scores are simply an indication of a subject’s ability 
to sustain a verbal response over time and are  therefore not one of the more global or 
primary scores.  
  193 
 
 We initially had expected to see those with lower NP performance be more 
likely to drop out and have a lower length of treatment. Though initially the present 
study results appear counterintuitive, the fact that the groups either had below median 
IQ or no prior treatment might assist in interpretation. It may be that those with lower 
IQ that scored better on the NP measures had greater confidence to feel they do not 
need treatment. The higher NP function and lower cognitive ability might lend itself 
to poor decisions and an inability to see the potential benefits of treatment. Likewise, 
as discussed above, any impairment in cognitive functioning can affect a person’s 
ability to make a good decision. It may be that the lower cognitive functioning 
encouraged a bad decision to drop out of treatment. However, it may also be that 
those with lower IQ do not benefit as quickly as others. The difference may not be 
related to decision-making abilities, but simply that they are slower to benefit from 
treatment. Furthermore, it could be that the WASI IQ score is more an indication of 
personality functioning than previously believed and that is what is actually affecting 
the decision to drop out. Personality variables are considered important when 
evaluating intelligence (Groth-Marnat, 2003). Indeed, Wechsler himself believed that 
intelligence is influenced by personality as well as other component such as anxiety 
(Groth-Marnat, 2003). Caution must be taken when interpreting the results of those 
with no prior treatment as only 16 individuals had no prior treatment. Re-evaluating 
this issue with a larger sample size could help clarify the results.  Other factors that 
we were not able to formally evaluate in this study also need to be considered in 
future research. For example, personality was not directly assessed by this study and 
would be an interesting piece to incorporate in future research.  
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 Also interesting is that the NP subtests that showed no correlation with drop 
out or attrition - Color Word and CPT II - are both tests of inhibition and impulsivity. 
Though participants were statistically significantly impaired on both of these 
measures, neither showed a correlation for participants with below median IQ or 
those with no prior treatment. This suggests that these aspects of NP impairment are 
less important when evaluating treatment retention (though still important for 
treatment planning). It may be that once individuals are engaged in treatment, the 
impulsivity and inhibition are affecting their performance in treatment, but not 
whether or not they stay in treatment.  
 The extent of neuropsychological and cognitive deficit found in individuals 
with a substance use disorder and/or homeless individuals suggests that increased 
assessment upon intake should be standard to accurately evaluate the specific needs 
of individuals, effective treatment planning and efficient disbursement of resources.  
These results indicate that clinicians need to develop highly individualized treatment 
plans utilizing specific strengths and identifying weaknesses for each individual for 
those with and without NP deficits to decrease attrition and increase length of stay. In 
addition, based on the results of this study, special attention may need to be paid to 
those with below median IQ and those with no prior treatment. As discussed above, 
special measures can be taken to help flag the clients that may be more at risk. 
Likewise, the clients that are identified to be at greater risk of dropping out should be 
educated about this and specific treatment goals implemented regarding treatment 
attendance and completion. These clients would also benefit from education 
regarding the specific expectations and timeline of treatment. One of the subtests 
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negatively correlated with drop out is the Tower Test. This test addresses the ability 
to follow rules. In this study, the better the client did with this, the more likely they 
were to drop out. Clinicians could make use of this strength and actually implement 
rules that the clients are asked to follow about staying in treatment. Clients could sign 
an agreement at the beginning of treatment specifying the required attendance and 
length of treatment and their willingness to comply. The ability to follow rules was 
shown to be one of the predictors to drop out. This is not to say that following rules 
caused drop out, however making use of this strength might actually help improve 
retention. Likewise, behavior modification and contingency management approaches 
could also be implemented. Participants could be rewarded at intervals in treatment 
with products such as tokens indicating length of sobriety (as used in AA), products 
with clinic insignia (t-shirts, pens, bags) or gift certificates to healthy social functions 
such as movies or restaurants.  
 Though the results of this study do not specifically support the need for 
increased NP and cognitive assessment at time of intake, they do seem to suggest that 
clients would benefit from increased assessment. Increased NP assessment at time of 
intake can provide specific strengths and weaknesses of each individual to allow the 
clinician to develop treatment approaches that may best suit a clients needs. The 
importance of individualized treatment planning cannot be overstated and is well 
supported in the literature (Adams, 2004). In addition, this would aid in educating the 
clinician and reducing stigma. The “lazy” “unmotivated” client might actually have 
serious NP and/or cognitive deficits. This could impact provider perception and 
expectations. If a provider understands the issues of the client and is given tools to 
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address the issues, the provider will be more effective. This alone could lead to 
improved retention. Conversely, if the provider is frustrated and misidentifies the 
deficits as a lazy client, the provider might direct their energy and resources to other 
clients they perceive as more receptive. Likewise, funding sources would be more 
likely to direct resources to clients to assist in situations where a deficit is identified 
vs. directing resources to someone they think is not wanting or ready for treatment. In 
order for programs to implement a more thorough assessment at time of intake, 
clinicians would need further training and programs would need funding for the 
assessment. Therefore, funding sources, such as private insurance and government 
resources, all need to be informed of the benefits to increased assessment to allow for 
allocation and reallocation of resources. Providers and funders alike, all need to 
rethink priorities when it comes to direction of energy to the assessment process. As 
discussed above, the current statistics on attrition and survival in treatment show 
limited success of current treatment programs.  This has an overall negative financial 
impact on individuals, families, employers and funding sources (SAMHSA 2008; 
TEDS, 2005).  Therefore, additional funding up front, could save money overall for 
the funding sources. By improving assessment, we could provide better treatment, 
and therefore have a positive impact on the rates of substance abuse. Multiple 
researchers and agencies have commented on the high cost of substance use on a 
personal and societal level as discussed thoroughly above (SAMHSA, 2008: TEDS, 
2005).  
 Additional research is warranted to continue to evaluate the relationship 
between NP functioning, attrition and survival in treatment. Additional research, with 
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a larger sample size, as well as a sample that included women and non-homeless 
individuals could prove quite useful. With a larger sample size, more variables that 
are useful for predicting drop out and attrition might be found. Furthermore, the 
ability to evaluate all people with a substance use problem, not just homeless men, 
would provide much useful information that can be generalized to more of the 
population.  
Effect Size 
As noted previously, no relative effect sizes could be found to be used to 
determine sample size for this study. Therefore, in addition to the information 
presented on neuropsychological functioning, cognitive functioning, drop out and 
attrition rates, effect sizes were calculated and reported on as another valuable 
outcome of this study. Information on effect sizes is valuable as it can help determine 
which variables look most promising as possible predictors of attrition and to provide 
information on how many more cases one would have to add to the sample size to 
obtain sufficient statistical power. Specifically, results of calculations on effect size 
and post-hoc power analysis, with alpha set at .05, showed that with a larger sample 
size (98-170) we could increase the possibility that the neuropsychological variables 
would predict drop out and attrition and could attain statistical power between .80 and 
.95. This information will be valuable to future researchers when planning similar 
studies.  
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Limitations/Suggestions for Improvements and Future Research 
 These results were limited initially by the location we chose to collect the 
data. As we were collecting data on men living in a homeless shelter, we were bound 
by rules and regulations of the shelter. We were unable to access urine screen 
information, which resulted in no information on relapse. The impact on relapse rates 
could not be calculated as we were not able to access urine analysis information. As 
urine screens were given by case managers in the Guesthouse, and not by counselors 
in the 7Cs clinic, we did not have consent to access that information. Future 
researchers operating in a homeless shelter environment will be well-served to 
establish a written agreement with the shelter and the participants to be able to access 
any objective screening measures used.  In addition, our study was cut short by a 
transition of management at the clinic which stopped our data collection at 68 
completed batteries instead of the intended 100 batteries.  
  Another important limitation of this study is that the men living in the shelter 
were required to attend substance abuse treatment. Therefore, the participation in 
treatment was not completely voluntary which could affect the participants desire to 
perform on the given assessments. 
 In addition, as it is a population of homeless men, the physical state of the 
participant at the time of testing such as fatigue or hunger could also impact 
performance affecting the validity of the results we obtained. Future researchers 
should consider utilizing a brief screening instrument to evaluate a participants 
general level of hunger or fatigue at various intervals to attempt to control for these 
  199 
 
issues. The fact that all participants were homeless men also limits the 
generalizability of this information to other populations such as women and non- 
homeless individuals. Likewise, the fact that this treatment took place at the homeless 
shelter is different from other treatment providers. The men lived in the shelter where 
they were given treatment. If discharged from the shelter, the men were unlikely to 
return to the shelter for treatment. This might have been a result of feeling 
unwelcome at the shelter in general, or maybe a desire to leave that part of their lives 
behind once they had moved on with independent housing. Most outpatient treatment 
facilities are not tied physically or emotionally to a person’s residence.  
 Limitations might also arise from the use of multiple assessors to facilitate the 
neuropsychological assessments. All assessors were masters level students that were 
trained by a licensed neuropsychologist. However, all of the assessors were new to 
the neuropsychological battery, which could affect the facilitation of the battery. 
Moreover, only subjective assessments were used to verify abstinence at time of 
testing. Future researchers may want to invest in saliva tests or quick urine screens to 
verify abstinence at time of testing. No patron is allowed to enter the Guesthouse if 
they are believed to be impaired by any substance so all are subjectively screened at 
the door. Likewise, no neuropsychological batteries were given to anyone thought to 
be impaired at the time of the assessment, but again, this was a subjective screening. 
Similarly, no objective measures were used to evaluate abstinence during treatment. 
Urine screens, blood tests, saliva samples and breathalyzers would have all provided 
objective evidence of a participant’s use. We did not have access to any of these 
results during this study.  
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 As suggested by the effect size and power calculations discussed above, 
another limitation of this study is the sample size. As stated previously, caution must 
be taken when interpreting this data due to the small sample size. Specifically, much 
caution needs to be taken when interpreting any relationship between IQ and 
attrition/length of stay due to the very small sample sizes of those calculations. Our 
calculations suggest that if we had a larger sample size (98-170) we could increase 
the possibility that the neuropsychological variables would predict drop out and 
attrition and could attain power between .80 and .95. This would mean that we are 
more likely to reject a null hypothesis and therefore increase the likelihood that what 
our results state is in fact true. Therefore, future researchers would be wise to include 
a larger sample size.  
 Finally, the mental health diagnoses were not included in this research and  
could offer another important variable when evaluating level of neuropsychological 
impairment and treatment attrition. We are not able to evaluate the possibility of 
depression, anxiety or any other mental health diagnosis that could have been a 
variable in these results. It is quite likely that many of these participants did indeed 
have a dual diagnosis. A diagnosis of a mood disorder, anxiety disorder or personality 
disorder all could impact results of cognitive and NP functioning. Likewise, these 
mental health issues could impact one’s desire and ability to remain in treatment. We 
are not able to identify if these issues existed or how they may have impacted the 
results of this study. Future researchers would be wise to evaluate these variables and 
attempt to control for them when looking at NP function and attrition.  
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  Likewise, we did not distinguish between types of substances used or length 
of substance use, which could also offer interesting information. Though we are 
interested in treating all substance abuse, the types and length of use could have 
provided more detailed information regarding drop out and survival in treatment. 
Alcohol, marijuana, cocaine and opiates all can have a negative impact on one’s 
ability to perform on cognitive and NP assessments. Furthermore, different 
substances can produce different frequency and intensity of cravings for individuals. 
The cravings alone could have a significant impact on ability to stay in treatment – 
especially in a program that will remove you from your housing if you are actively 
using. Likewise, support systems, cognitive function, neuropsychological function 
and physical health can all be impacted by type of substance used and length of use. 
This would also be another useful variable for future research for all the reasons 
stated.  
 Limitations also arise from the difference between actuarial and qualitative 
components of assessment. As previously discussed in this paper, in strict actuarial 
approaches, the neuropsychologist need not even see the patient, but rather draw 
conclusions from scores obtained by a technician (Lezak, 1995). This approach can 
be helpful for gathering statistics, but important information is lost from the missing 
qualitative component. Through the development of testing batteries developed by 
some of the leaders in the field, neuropsychology has developed into more of a mix of 
the intuitive and actuarial (Lezak, 1995). However, given that this study utilized 
multiple facilitators and the primary researcher did not meet many of the participants, 
the benefits of a more process-oriented approach were lost. Qualitative comments 
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were gathered on each participant, but the depth of the qualitative component that can 
be gathered through each assessment was lost.  
 
 
Reliability and Validity 
 There are multiple factors that can affect reliability and validity of data 
obtained in any research. First and foremost are the reliability and validity of the data 
yielded from the measures used. The reliability and validity of the data used in this 
study is discussed in detail in Chapter III under the psychometrics of each instrument. 
In addition to the specifics of each instrument, a number of authors have elaborated 
on the difficulties of using standardized assessments with ethnic minorities. Given 
that 75% of the participants in this study are non-White, this is an important factor to 
consider.  Specifically, Suzuki and Kugler, 1995 (as cited in Pope-Davis & Coleman, 
1996) summarize areas of concern including inappropriate test content, inappropriate 
standardization samples, examiner and language bias, inequitable social 
consequences, measurement of different constructs, differential predictive validity 
and differences in test taking skills. Therefore, the development of additional norms 
for these tests and others used on non -White individuals as well as homeless 
individuals would be of benefit to future researchers.  
 Furthermore, limitations in the setting could also affect the results of this study. The 
homeless shelter setting can be loud and distracting at times, which could affect the 
participant’s performance. Likewise, issues related to being homeless, such as hunger 
and fatigue can also affect one’s performance. The use of multiple assessors with 
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limited experience in facilitating NP assessments is also an important factor to 
consider when reviewing reliability and validity of the given results. Finally, though 
the D-KEFS and CPT II both have computerized scoring, the WASI was all hand 
scored. To ensure accurate scoring, licensed psychologists reviewed 20% of the 
batteries.  
 
Conclusion 
 In conclusion, the purpose of this study was to assess the neuropsychological 
functioning of clients with a substance dependence issue and to examine the 
relationship between neuropsychological functioning, length of stay in treatment and 
whether one dropped out of treatment or not. Specifically, the executive functioning 
of individuals was evaluated, as well as IQ and compared to attrition rates. In this 
study, a battery of tests including four subtests of the D-KEFS, the WASI IQ and the 
CPT II were administered to a group of 68 homeless adult males residing at the 
Guesthouse of Milwaukee. The results indicate that the neuropsychological 
functioning of this group of adult males showed statistically significant impaired 
functioning on all measures. Of the neuropsychological variables, only the WASI IQ 
predicted attrition and length of stay which showed a curvilinear relationship to drop 
out and attrition. Participants with a low to average WASI IQ score (77-95) were 
significantly more likely to drop out (p = .012) and more likely to have shorter 
lengths of stay in treatment (p = .028). In addition, the NP variables did show a 
relationship with drop out and length of stay when looking at cases with a median IQ 
below 94 and those with no prior AODA treatment. However, caution regarding 
  204 
 
interpretation was indicated due to the small sample sizes. Finally, results of 
calculations on effect size and power analysis show that with a larger sample size (98-
170) we could increase the possibility that the neuropsychological variables would 
predict drop out and attrition and could attain power between .80 and .95.  
 As there is still a paucity of research related to NP functioning, homeless 
individuals and attrition rates, this information is a valuable addition to existing 
research. In addition, this study identified implications for professionals that work 
with substance abusing individuals, specifically Individuals that are homeless with a 
substance use issue and individuals struggling with a NP deficit. As this study is 
limited to homeless males, the generalizability of this research is limited. Therefore, 
suggestions were also made for future research. 
 Overall, the importance of this research is multifaceted. The information 
regarding specific variables that are predictive of client success in treatment cannot be 
underestimated. As discussed, the severity of addiction rates and attrition rates in the 
United States dictates the need for more information regarding variables that affect 
client success in treatment. The suggestions from this research regarding therapist 
approaches, funding allocation and treatment interventions will help reduce drop 
out/attrition and ultimately help reduce the rates of relapse and continued substance 
use. Likewise, the more educated providers and the public are on neuropsychological 
function and substance use disorders/treatment, the greater reduction we will see in 
stigma. Furthermore, the information regarding effect size will help future researchers 
plan effective research designs to continue to gather information regarding NP 
function and attrition/drop out. Individuals with a substance use disorder deserve the 
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very best care we can offer. With this addition to the literature, and others, we will 
develop efficient, effective and successful treatment plans for individuals and families 
affected by substance use disorders.  
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